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It has been proposed that intracranial pressure (ICP) elevation and collateral 
failure are responsible for unexplained early neurological deterioration (END) in 
stroke. Our aim was to investigate whether cerebrospinal fluid (CSF) dynamics, 
rather than oedema, are responsible for elevation of ICP after ischaemic stroke. 
Permanent middle cerebral artery occlusion (pMCAO) was induced with an 
intraluminal filament. At 24 hours after stroke, baseline ICP was measured, and 
CSF dynamics were probed via a steady-state infusion method. For the first 
time, we found a significant correlation between the baseline ICP at 24 hours 
post-stroke and the value of CSF outflow resistance. Results show that CSF 
outflow resistance, rather than oedema, was the mechanism responsible for ICP 
elevation following ischaemic stroke. This challenges current concepts and 
suggests the possibility that intracranial hypertension may be occurring 
undetected in a much wider range of stroke patients than is currently considered 
to be the case.  
Over the last decade, there has been significant renewed interest in the 
anatomical pathways and physiological mechanisms for the circulation of CSF. 
The glymphatic system is one such pathway that has been recently 
characterised. This network drives CSF into the brain along periarterial spaces 
and interstitial fluid (ISF) out along perivenous spaces. Aquaporin-4 (AQP4) water 
channels, densely expressed at the vascular endfeet of astrocytes, facilitate 
glymphatic transport. Glymphatic failure has been linked to a broad range of 
neurodegenerative diseases including ischaemic stroke. Accordingly, if the 
glymphatic circulation is a major outflow route for CSF, glymphatic dysfunction 
following ischaemic stroke could alter CSF dynamics and, therefore, ICP.  
Nevertheless, the glymphatic hypothesis is still controversial. All in vivo and 
biomechanical modelling studies that have investigated the glymphatic system 
have been based on utilizing a solute tracer to track the movement of CSF within 
the intracranial space. Since 99% of CSF is water, it is questionable whether non-
water tracer molecules can ever show the real dynamic flow of CSF.  
Hence, we sought the develop of a new MRI method to directly image CSF 
dynamics in-vivo, by exploiting an isotopically enriched MRI tracer, namely, 
H217O. Our results reveal glymphatic flow that is dramatically faster and more 
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extensive than previously thought. Moreover, we confirm the critical role of 
aquaporin-4 (AQP4) channels in glymphatic flow by imaging CSF water dynamics 
in the brain using H217O alongside a potent blocker of AQP4. We hope in future 
that this new method can be used to investigate the responsible mechanism for 
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1 Chapter 1: Literature review 1 
This Chapter discusses the current understanding of cerebrospinal fluid (CSF) 2 
physiology and controversies in the field, while exploring how altered secretion 3 
and drainage may link to ICP in Ischaemic stroke. The Chapter closes by 4 
investigating the current and potential magnetic resonance imaging (MRI) 5 
techniques, along with non-MRI methods, for a better understanding of the CSF 6 
system. 7 
1.1 Cerebrospinal fluid dynamics  8 
1.1.1 CSF function  9 
Within the central nervous system (CNS), 60–68% of the total water content is 10 
found within the intracellular space and the remaining 32–40% occupies the 11 
extracellular compartment. CSF comprises approximately 10% of extracellular 12 
fluid (Oliver, 2004). In humans, the secretion rate is 0.3–0.4 ml min−1 and the 13 
total CSF volume is 90–150 ml (Ekstedt, 1978). CSF serves as a fluid envelope 14 
that protects the brain and spinal cord, cushioning them from mechanical injury. 15 
Further, CSF plays an essential role in maintaining homeostasis in the 16 
extracellular environment of neurons and glia. CSF is in free communication with 17 
the extracellular fluid, thus indirectly regulating its composition. CSF has also 18 
been suggested as playing a role in the clearance of potentially harmful 19 
metabolites within the CNS, particularly high-molecular weight substances such 20 
as proteins (Oliver, 2004; Hladky and Barrand, 2014). Further, reduced CSF 21 
secretion as a function of aging (Sakka, Coll and Chazal, 2011) leads to increased 22 
protein aggregation and is associated with increased beta-amyloid deposition in 23 
Alzheimer's disease (May et al., 1990; Ueno et al., 2014). 24 
1.1.2 CSF secretion 25 
According to the traditional hypothesis, CSF is formed in brain ventricles, mostly 26 
by secretion from the choroid plexus. Because of its glandular appearance and 27 
ventricular location, the choroid plexus has been suggested as the major site of 28 
CSF secretion. Some of the first supporting evidence for the role of the choroid 29 
plexus in CSF secretion came from the historical canine experiment of Dandy 30 
(Dandy and Blackfan, 1914). In his famous experiment using a dog, he 31 
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demonstrated that ventricular dilation does not occur when foramen of Monro is 1 
occluded and the choroid plexus excised from the lateral ventricle. The 2 
dilatation is observed on the side in which choroid plexuses are preserved, 3 
suggesting that choroid plexuses are the site of CSF production. Further 4 
evidence includes experiments by Welch et al. (1972) in which the authors 5 
measured the haematocrit in the main choroidal artery and choroidal vein in an 6 
animal study which demonstrated a higher haematocrit in the main choroidal 7 
vein when compared to the main choroidal artery. In addition, based on 8 
histological observation, Davson suggested that the choroid plexus structure is 9 
ideal for CSF production (Davson, Domer and Hollingsworth, 1973). The choroid 10 
plexus is highly organized and lines all the ventricles of the brain except the 11 
frontal/occipital horn of the lateral ventricles and the cerebral aqueduct. The 12 
choroid plexus is well perfused by numerous villi, each having a central capillary 13 
with fenestrated endothelium and surrounded by a single layer of secretory 14 
epithelial cells. This permits the movement of crystalloids, colloids, and fluid 15 
from the blood into the ventricles by a combined process of passive filtration of 16 
fluid across the highly permeable capillary endothelium and a regulated 17 
secretion across the single-layered choroidal epithelium (Brinker et al., 2014). 18 
The capillaries of the choroid are freely permeable to solutes. However, the 19 
tight junctions between epithelial cells of the choroid plexuses form the blood–20 
CSF barrier, which control the passage of molecules and water into the CSF 21 
(Price, 2008; Jorge, 2010). Aquaporin-1 (AQP1) water channels are highly 22 
expressed on the ventricular-facing cell plasma membrane of choroid plexus 23 
epithelial cells, suggesting a role for these water channels in CSF secretion 24 
(Mobasheri and Marples, 2004). Consistent with the classic CSF secretion theory, 25 
AQP1-null mice showed a reduction of 20% in CSF production compared with 26 
wild-type mice (0.38 ± 0.02 vs. 0.30 ± 0.01 μl min−1), suggesting a prominent role 27 
of the AQP1 on CSF formation (Oshio, 2004). 28 
Several studies have suggested structures, other than the choroid plexus, as sites 29 
of CSF production. It was shown that removal of the choroid plexuses within the 30 
bilateral ventricles had no significant effect on the amount and composition of 31 
CSF produced (Hammock and Milhorat, 1973). Other studies with radioactive 32 
water provided evidence that the brain itself is another source of CSF (Cohen 33 
and Davies, 1937; Bering, 1959; Bering and Sato, 2009). Furthermore, by 34 
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examining the ependymal surface, it was calculated that nearly 30% of the total 1 
CSF production may come from the ependyma of the spinal cord’s central canal 2 
(Pollay and Curl, 1967). Filtration or secretion of fluid across capillary walls may 3 
also contribute to total CSF production (Klarica, Radoš and Orešković, 2019). 4 
Other extrachoroidal sources of CSF proposed in the literature include the 5 
subarachnoid space, the perivascular system or the pial artery (Weed, 1914; 6 
Hassin, 1948; Sato et al., 1971), although their relative contributions have not 7 
yet been established. 8 
1.1.3 CSF absorption 9 
In 1875, Key and Peele performed crucial experiments that showed that the 10 
arachnoid villi were the drainage points connecting the CSF and blood from the 11 
venous sinuses (Key and Peele, 1875). For a long time thereafter, there was a 12 
broad consensus about arachnoid granulation (villi) being the main absorption 13 
pathway for CSF.  14 
Arachnoid granulations project from the subarachnoid space and protrude the 15 
overlying dura and invaginate through the walls of the superior sagittal sinus. 16 
Arachnoid villi act as one-way valves allowing the transcellular bulk transport of 17 
fluid with hydrostatic pressure being the main stimulus that causes these valves 18 
to open (Levine, Povlishock and Becker, 1982). Extracorporeal perfusion of 19 
excised dura has demonstrated the passage of particles up to the size of 20 
erythrocytes (~6–8 µm) at the same flow rate, suggesting that CSF compositions 21 
did not measurably affect the absorption rate (Pollay and Welch, 1962).  22 
While the arachnoid granulations (villi) provide a simple mechanism for resorbing 23 
CSF, several studies suggest that alternative mechanisms may operate as well.  24 
An interesting observation from human studies indicated that arachnoid villi do 25 
not exist during prenatal and neonatal stages (Gomez et al., 1983). Similarly, 26 
the pressure gradient necessary for CSF absorption across the arachnoid villi is 27 
not reached until several weeks after birth. Together, these data suggest the 28 
existence of alternate CSF absorption routes, at least during the foetal and 29 
neonatal stages in humans (Bueno and Garcia-Fernàndez, 2016). 30 
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Considerable volume of CSF may be absorbed into the cervical lymphatics. It has 1 
long been known that contrast material injected into the subarachnoid space 2 
can later be found in cervical and spinal lymphatics across several species (Kida, 3 
Pantazis and Weller, 1993). Other studies showed that injection of albumin dye 4 
into the lateral ventricle of rabbits travelled into the cervical lymph nodes in a 5 
few hours (Kida, Pantazis and Weller, 1993). The use of specific tracers has 6 
demonstrated an extension of the subarachnoid space that follows the olfactory 7 
tracts, crosses the cribriform plate, and projects into the nasal submucosa 8 
alongside olfactory nerves responsible for removal of some of the CSF solute. 9 
This fraction appears to be closer to 50% in rats and rabbits, but its magnitude in 10 
humans is not known (Arnold, Ritter and Wagner, 1973; Jackson, Tigges and 11 
Arnold, 1979; Szentistvanyi et al., 1984). More recent published paper 12 
convincingly provided, for the first time, evidence of the presence of lymphatic 13 
vessels immediately adjacent to the Dural sinuses of the meninges, including the 14 
superior sagittal sinus and the transverse sinuses, as well as aligning the 15 
meningeal vascular supply (Louveau et al., 2015). These lymphatic vessels were 16 
connected to deep cervical lymph nodes, expressed all the markers for 17 
endothelial cells, and carried fluid containing monocytes, macrophages (the 18 
primary immune cells within the brain) and T cells. 19 
1.1.4 CSF circulation  20 
According to the classical textbook model of CSF circulation in the brain, CSF in 21 
CNS compartment consists mainly of two kinds of motion: a net flow and a 22 
pulsatile flow. The net flow is based on a hydrostatic pressure gradient primarily 23 
between the choroidal plexus and arachnoid granulations (Pollay and Curl, 1967; 24 
Davson, 1969; Levine, Povlishock and Becker, 1982; Walter, 2015) (Figure 1-1). 25 
Pulsatile flow is based on the Monro (1783) and Kellie (1824) doctrine which 26 
states that the sum of blood, CSF, and brain parenchyma volumes is constant, 27 
limited by the volume of the skull; therefore, an increase in one compartment 28 
leads to a decrease in another one (Mokri, 2001). It results in cranio-caudal 29 
movement during the systolic phase and caudo-cranial movement during the 30 
diastolic phase (Ohara et al., 1988; Greitz, Franck and Nordell, 1993; Jeong et 31 
al., 2004). Recent research has further correlated CSF flow through the system 32 
with respiration rate (Yamada et al., 2013). Over the last decade, there has 33 
been several views imply that the whole process of CSF circulation seems to be 34 
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more complicated and reveal the need for further exploration (Iliff et al., 2012; 1 
Bakker et al., 2016; Klarica, Radoš and Orešković, 2019). A continuous pathway 2 
along the capillaries to the perivenous space has been proposed (Iliff et al., 3 
2012), and capillaries continuously filter and absorb water within the cerebral 4 
parenchyma, but not usually with a net flow of water (Klarica, Radoš and 5 
Orešković, 2019).  6 
 7 
 8 
Figure 1-1. Conventional view of CSF flow. CSF is produced mainly by the choroid plexus 9 
that surrounds the ventricles, beginning in the lateral ventricles, and flows through the 10 
ventricular spaces, the cisterns, the subarachnoid space and the spinal cord, finally to be 11 
retained in the blood at the level of the arachnoid granulation (villi). Arrows depict the flow 12 







1.1.5 The exchange between CSF and ISF 1 
To fulfil its suggested lymphatic function, CSF in the subarachnoid space must 2 
then be able to enter the brain to renew ISF, and solute must be able to drain 3 
back to CSF to achieve waste removal and volume homeostasis (Hassin, 1924; 4 
Bradbury and Kleeman, 1967). However, controversies exist regarding the nature 5 
of the exchange between ISF and CSF (Szentistvanyi et al., 1984; Abbott, 2004; 6 
Liao and Padera, 2013; Brinker et al., 2014). The movement of fluids through 7 
the brain interstitial space has been traditionally attributed to diffusion 8 
processes. Early observations by Fenstermacher and Patlak (1975) characterized 9 
the material exchange between the CSF and extracellular fluid in the brain 10 
parenchyma as a diffusion process. Nevertheless, from time to time, this 11 
hypothesis has been challenged on the basis of experimental data. When tracers 12 
of different molecular weight, including albumin (69 kDa) and polyethylene 13 
glycols (4 kDa), were injected into the caudate nucleus of rats, despite there 14 
being an approximately five-fold difference in diffusion coefficients between 15 
these molecules all were cleared with a nearly equivalent half-life (Cserr, 16 
Cooper and Milhorat, 1977). From this it was concluded that bulk flow 17 
mechanisms contributed to the clearance of tracers. Further, following the 18 
injection of horseradish peroxidase (HRP) into the lateral ventricles or 19 
subarachnoid space of anesthetized cats and dogs, Rennels et al. (1985). showed 20 
a rapid movement of the tracer into the brain along para-arterial pathways. 21 
Interestingly, a recent 3D electron microscopy (EM) reconstruction revealed that 22 
cerebral blood vessels are completely sheathed by astrocyte endfeet, ensuring 23 
the patency of this perivascular compartment (Mathiisen et al., 2010). More 24 
recently, the glymphatic system was proposed as macroscopic waste clearance 25 
system that utilizes a unique system of perivascular channels (Iliff et al., 2012).   26 
1.1.6 Glymphatic system  27 
The proposed glymphatic system operates as a clearance mechanism that relies 28 
on AQP4 water channels, expressed in the end feet of astrocytes, to facilitate 29 
CSF bulk flow through brain tissue, washing away toxic proteins and other waste 30 
as it proceeds (Figure 1-2) (Iliff et al., 2012). The dynamics of the glymphatic 31 
system were characterized by labelling CSF with fluorescent tracers injected 32 
into the cisterna magna of mice. The tracer movement was monitored in real-33 
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time using in vivo two-photon microscopy via a closed cranial window 1 
preparation, and ex vivo confocal microscopy (Iliff et al., 2012). From the 2 
subarachnoid space, CSF follows arteries at the pial surface, running across the 3 
cortical surface and descending along penetrating arteries through Virchow-4 
Robins spaces/perivascular spaces. The perivascular spaces are filled with CSF 5 
and are bordered by a leptomeningeal cell layer on both the inner wall facing 6 
the vessel and on the outer wall facing the perivascular astrocytic end feet. 7 
From the perivascular spaces, CSF then flows across the glial basement 8 
membrane and astroglial end feet bordering the brain parenchyma. AQP4 water 9 
channels are expressed in a highly polarized manner in astrocytic end feet. They 10 
operate as a highway for CSF water influx into the brain parenchyma, where it 11 
exchanges with ISF before flushing out of the brain along the perineural sheaths 12 
of cranial nerves, meningeal lymphatic vessels and arachnoid granulations 13 
(Jessen et al., 2015).   14 
Following these initial findings, further studies have found a wide variety of 15 
physical factors that affect glymphatic transport. It has been demonstrated that 16 
levels of arousal help govern glymphatic CSF and ISF dynamics. Nedergaard and 17 
colleagues revealed that the CSF influx increases naturally during sleep or 18 
ketamine/xylazine anaesthesia, which they linked with the increased 19 
extracellular space (ECS) associated with the sleep state (Xie et al., 2013). In a 20 
subsequent experiment, the crucial role of arterial pulsation was identified, by 21 
showing that glymphatic flux was diminished when the carotid artery was ligated 22 
to reduce arterial pulsatility in the brain by 50% (Iliff et al., 2013). Conversely, 23 
increasing pulsatility by 60% using an adrenergic agonist enhanced the flux (Iliff 24 
et al., 2013). These findings suggested that glymphatic flow, at least in part, is 25 
driven by arterial pulsatility and this could explain why perivascular influx occurs 26 
preferentially around pulsating arteries and not cerebral veins.  27 
Body posture also regulates clearance, with glymphatic transport being shown to 28 
be more efficient in the lateral position compared with other positions (Lee et 29 
al., 2015). Other mechanisms also have been proposed as the driving force for 30 
this flow: an overall pressure gradient created by the production of CSF in the 31 




The dysfunction of the glymphatic system has been implicated in a variety of 1 
neurologic diseases. Reduced glymphatic flow has been detected in animal 2 
models of Alzheimer’s disease (Iliff et al., 2013; Xu et al., 2015), vascular 3 
dementia (Venkat et al., 2018), traumatic brain injury (Ren et al., 2013), 4 
subarachnoid haemorrhage and acute ischaemia (Gaberel et al., 2014). 5 
1.1.7 Controversies related to Glymphatic system 6 
In contrary to initial glymphatic experiments, other researchers have found, that 7 
tracers injected directly into the parenchyma were washed out along basement 8 
membranes of capillaries and arteries, going in the opposite direction of blood 9 
flow. It was suggested that this flow is driven by the movement of smooth 10 
muscle cells (Carare et al., 2008; Bakker et al., 2016).  11 
With regard to AQP4 channels, the proposed glymphatic system emphasizes a 24 
significant role for these channels in facilitating the CSF-ISF exchange of water 25 
molecules. Monitoring CSF radiolabelled tracer movement in AQP4 knockout 26 
mice revealed a reduction of ∼65% in CSF flux through the parenchyma 27 
compared with wildtype control mice. Clearance of radiolabelled tracer 28 
substances from the brain also reduced by 55% (Iliff et al., 2012). Conversely, 29 
the contribution of AQP4 in this system has been questioned by Verkman and 30 
Smith as, in their own mouse model, AQP4 was not needed for solute removal in 31 
the brain (Smith and Verkman, 2018). With the aim of resolving this discrepant 32 
finding, a study representing the work of five research groups using five different 33 
mouse strains supported the key role of AQP4 in facilitating brain waste 34 
clearance (Mestre et al., 2018). 35 
The initial description of the glymphatic system suggested the presence of a bulk 36 
water flow directed from arterial to venous PVS through the interstitium. 37 
However, this hypothesis is controversial. Currently, one of the leading theories 38 
opposed to the glymphatic hypothesis suggests that convective flow of CSF influx 39 
takes place along the perivascular spaces of larger vessels, but that diffusion 40 
dominates in the tortuous interstitium (Brinker et al., 2014; Jin, Smith and 41 
Verkman, 2016). Further, several mathematical models proposed that high 42 
hydraulic resistance from tight extracellular spaces cannot permit bulk flow 43 
(Asgari, de Zélicourt and Kurtcuoglu, 2016; Abbott et al., 2018; Smith and 44 
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Verkman, 2018). Recently, Ray et al. simulated both interstitial diffusion and 1 
bulk flow, comparing the results with a variety of experimental data. They 2 
concluded that, for the large molecules, bulk flow may be an important 3 
mechanism of transport (Ray, Iliff and Heys, 2019).  4 
 5 
 6 
Figure 1-2. Schematic of glymphatic and perivascular waste clearance routes.  According to 7 
the glymphatic model, CSF flows along para-arterial spaces, mixes with ISF, and is cleared 8 
from the brain along para-venous spaces. Efficient glymphatic clearance of waste and 9 
solutes is dependent on fluid movement across AQP4 channels located on astrocytic end 10 
feet surrounding the parenchymal vasculature. Reproduced with permission from Conway 11 









1.2 CSF and intracranial pressure elevation in ischaemic 1 
stroke 2 
The relationship between CSF and intracranial pressure (ICP) originated in the 3 
Monro-Kellie doctrine, which proposed that, because the skull cannot expand, 4 
the sum of the volumes of the brain, cerebrospinal fluid and intracranial blood is 5 
constant (Mokri, 2001). An increase in one should be compensated by a decrease 6 
in one or both of the remaining two compartments. Once these compensatory 7 
mechanisms are exhausted, ICP will rise dramatically (Figure 1-4). Hence, CSF is 8 
an important component in maintaining a stable ICP. Most mathematical models 9 
that have been developed focus on CSF formation and resistance as key factors 10 
involved in the regulation of steady state ICP (Davson, Domer and Holungsworth, 11 
1973; Ekstedt, 1977; Marmarou, Shulman and Rosende, 1978). Davson’s 12 
mathematical model provided an improved understanding of secretion and 13 
absorption mechanisms of CSF (Davson, Domer and Hollingsworth, 1973). Davson 14 
suggested that, under normal conditions, mean ICP is balanced by CSF formation 15 
rate and absorption resistance if venous pressure remained constant (Davson, 16 
Domer and Hollingsworth, 1973): 17 
 
ICP = CSF formation rate × CSF outflow resistance
+ venous pressure 
(2.1) 
We can conclude that within the rigid, non-expandable system, mean ICP 18 
remains constant under normal balance between formation and absorption. 19 
However, when the balance is disrupted, this will result in raised ICP. 20 
Accordingly, altering CSF dynamics in terms of rates of production and outflow 21 
resistance has been considered with elevated ICP in neuropathologies including 22 
hydrocephalus (Jergović et al., 2016), idiopathic intracranial hypertension (Segal 23 
and Pollay, 1977; Fraser and Plant, 2011; Goudie, Burr and Blaikie, 2018), 24 
intracerebral haemorrhage (Williamson et al., 2019), and subarachnoid 25 




1.2.1 Ischaemic stroke 1 
Stroke is a catastrophic disease with high rates of morbidity and the fourth most 2 
frequent cause of death in the UK. Every year in the UK over 100,000 individuals 3 
suffer a stroke, which equates to a stroke occurring in the population every 5 4 
minutes (Stroke.org.uk, 2018). Between 1990 and 2010, the incidence of stroke 5 
fell by almost 25% across the UK due to improvements in stroke prevention and 6 
increasing awareness of healthy living. However, it is estimated that the 7 
incidence of stroke will increase in the coming decades in developed countries 8 
due to the ageing population and an expected increase in population size 9 
(Stevens and Emmett, 2017). The economic burden of stroke is huge. From the 10 
most recent academic and National Audit office analyses, the estimated health 11 
and societal costs of stroke are £25.6 billion annually in the UK (Stroke.org.uk, 12 
2018).  13 
The World Health Organization defined stroke as “rapidly developing clinical 14 
signs of focal (or global) disturbance of cerebral function, lasting more than 24 15 
hours or leading to death, with no apparent cause other than that of vascular 16 
origin” (Aho et al., 1980). Transient ischaemic attacks (TIAs) have the same 17 
clinical characteristics as stroke, but symptoms can be resolved within 24 hours. 18 
As 15 to 30 percent of cerebral infarctions are accompanied by a TIA, a TIA 19 
should be considered a warning sign of stroke or other cardiovascular 20 
complications (Stroke.org.uk, 2018).  21 
The vascular mechanisms leading to stroke can be classified as haemorrhagic and 22 
ischaemic. Haemorrhagic strokes account for a small proportion of cases (~15%) 23 
and commonly occur due to the rupturing of a vessel within the brain 24 
(intracerebral haemorrhage) or on the surface of the brain (subarachnoid 25 
haemorrhage) (Warlow et al., 2003). The majority of strokes are ischaemic, 26 
accounting for approximately 85% of all stroke cases (Figure 1-3). This type of 27 
stroke results from blood flow disruption caused by blood vessel occlusion. The 28 
reduction in blood flow can be transient or permanent and the territory of the 29 
occluded cerebral artery determines the brain area affected by the stroke and 30 




Ischaemic stroke often arises either from atherosclerotic plaques, or from a 1 
displaced embolus. Fifty percent of ischaemic strokes are a direct result of 2 
vascular blockage or stenosis often associated with an atherosclerotic plaque in 3 
a damaged artery within or leading to the brain (thrombotic stroke) (Warlow et 4 
al., 2003). The site of the occlusion is often at bifurcation points of the arterial 5 
system due to a combination of turbulent flow and weakened vessel walls at 6 
these regions. Emboli which arise during atrial fibrillation account for 20% of 7 
occlusive strokes. A clot that forms elsewhere in the body then travels to the 8 
brain where it blocks a cerebral artery (embolic stroke). The remainder are the 9 
result of occlusions in small intracranial vessels and lacunar strokes, which 10 
affect small arterioles, often caused by hypertension leading to morphological 11 
changes (Arboix, 2014). 12 
1.2.1.1 Animal models of ischemic stroke  13 
Ischaemic stroke has been modelled in a variety of animal species, enabling an 14 
extensive understanding of the mechanisms and pathways associated with 15 
cerebrovascular occlusion (Mhairi, 1992; Hunter, Green and Cross, 1995; Cenci, 16 
Whishaw and Schallert, 2002). Rats and mice have very similar cerebral blood 17 
vessel anatomy to humans and, as such, are the most widely used animals in 18 
stroke models. Studies in rodents are also economically viable due to low 19 
maintenance costs and the availability of inbred strains bred for genetic 20 
homology means that infarction size and distribution is relatively reproducible 21 
(Casellas, 2011). The middle cerebral artery (MCA) is the most commonly 22 
affected artery of acute ischaemic stroke (Ng et al., 2007). It is therefore the 23 
most commonly occluded artery in experimental ischaemic stroke models (Cenci, 24 
Whishaw and Schallert, 2002). The most widespread method of MCA occlusion in 25 
rats and mice is the intraluminal filament technique (E Z Longa et al., 1989; 26 
Yoshimoto et al., 1990; Mhairi, 1992). 27 
Modelling MCAO has several advantages. MCAO models in rat mimics human 28 
ischaemic stroke, which often originates from MCAO, and exhibits a penumbra 29 
that is similar to that of human stroke (Derugin et al., 2000). Also, the model is 30 
suitable for permanent or transient ischaemia. The procedure is relatively easy 31 
to perform and not time-consuming. Additionally, the brain injury produced by 32 
MCAO in rodents varies considerably in its size and distribution (Longa et al., 33 
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1989). Even though, the latter is considered one of the main disadvantages of 1 
this type of model, but it was an advantage within the current work, as this will 2 
allow us to compare ICP values with a variety of oedema and infarct volumes. On 3 
the other hand, this model presents some limitations. Successful MCAO cannot 4 
be confirmed visually. Also, MCAO models can result in high mortality rate 5 
(Wiendl et al., 2015). Other limitations include the error of inducing 6 
subarachnoid haemorrhage due to advancing the filament well beyond the origin 7 










Figure 1-3. Ischaemic stroke arising from a cardiac embolus.Stroke arising from a cardiac 2 
embolus accounts for around a quarter of all cases of ischaemic stroke. Reproduced with 3 















1.2.2 Impact of ICP on Ischaemic stroke 1 
There are two significant regions of tissue injury as a result of an ischaemic 2 
insult: ischaemic core and penumbra. The ischaemic core is an area of severe 3 
ischaemia (blood flow below 10‐25% of normal). Cells in this region will die 4 
within minutes due to a severe deficiency in energy stores and subsequent ionic 5 
disruption and metabolic failure. The ischaemic core is therefore non‐6 
salvageable. Reduction of blood flow within the penumbra is less severe than 7 
that of the core, often due to residual blood flow from leptomeningeal collateral 8 
vessels. Therefore, one of the most critical issues in stroke is the need to 9 
increase perfusion to the ischaemic penumbra. Cerebral perfusion pressure (CPP) 10 
is governed by a relationship between mean arterial pressure (MAP) and ICP: CPP 11 
= MAP – ICP. Under normal circumstances cerebral blood flow is maintained by 12 
the process of local cerebral autoregulation, which involves local changes in the 13 
resistance of blood vessels in response to changes in pressure and is not CPP‐14 
dependent except at the two extremes of CPP (Jordan and Powers, 2012). 15 
Cerebral autoregulation can maintain relatively constant cerebral blood. 16 
However, these autoregulatory mechanisms are exhausted within the ischaemic 17 
penumbra, and cerebral perfusion becomes CPP‐dependent (Strandgaard, 2004). 18 
Consequently, in the absence of compensatory blood pressure (BP) elevation, ICP 19 
elevation will reduce CPP and cerebral perfusion (Figure 1-4). Subsequently, this 20 
reduction in CPP may have potentially devastating effects on the CPP dependent 21 
leptomeningeal collateral vessels, which supply blood to the penumbral tissue 22 
(Beard et al., 2016). Recently, a series of preclinical studies have further linked 23 
the early increased ICP in the first 24 hours post-ischaemic stroke with collateral 24 
failure seen in a subset of ischaemic stroke patients presenting with progressive 25 
stroke (Murtha et al., 2014; Beard, Mcleod, et al., 2015; Beard et al., 2016; 26 
Lalou et al., 2018). 27 
1.2.2.1 Stroke in progression  28 
Stroke‐in progression is a term used to describe a subset of stroke patients (10‐29 
40%) who initially present with mild symptoms but suffer an early neurological 30 
deterioration (END), typically over the first 24 hours in hospital. It was assumed 31 
that patients suffering from stroke‐in‐progression showed initial clinical 32 
improvement due to spontaneous reperfusion and that the subsequent 33 
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deterioration was the result of a reformation of the clot (Caplan, 1991). 1 
However, recent imaging data strongly suggest that the vessel does not 2 
recanalize and that the neurological deterioration may be the result of 3 
leptomeningeal collateral blood vessel failure (Campbell et al., 2013). More 4 
recently, in a series of in vivo studies, Professor Spratt and colleagues suggested 5 
that, following ischaemic stroke, ICP elevation is a likely explanation for 6 
collateral failure and may be the mechanism responsible for late infarct 7 
expansion in ischaemic stroke patients (Murtha et al., 2014; Beard, Mcleod, et 8 


















Figure 1-4. Schematic drawing of relationship between ICP and CPP. According to Monro-2 
Kellie hypothesis increase in volume of cranial constituents (blood, CSF, and brain tissue) 3 
must be compensated by a decrease in the volume of other constituents. In the model of 4 
compensation, an increase in cerebral blood volume produces a decrease in cerebrospinal 5 
fluid (CSF) volume; this allows ICP and CPP to remain at a baseline level. However, in the 6 
absence of compensatory mechanisms, ICP elevation will reduce CPP. Adapted from 7 













Figure 1-5. Representation of the relationship between elevated ICP and infarct expansion in 2 
acute stroke. a) Schematic drawing of pial collateral vessels in Rat brain. Collateral vessels 3 
between the anterior cerebral artery (ACA) and the middle cerebral artery (MCA) are marked 4 
with yellow circles. b) Following the hyperacute phase after permanent MCAO, >8 hours, the 5 
irreversibly damaged ischaemic core (grey zone) is surrounded by asymptomatic tissue 6 
(oligemia or non-hypoperfused tissue). If ICP remains low, the collateral perfusion will help 7 
limit the extent of the ischaemic core after stroke. Red arrows indicate direction of blood 8 
flow during permanent MCAo. c) Dramatic elevation of ICP at around 24hrs, will lead to 9 
reduction of collateral blood flow putting previously asymptomatic tissue at risk, (i.e. new 10 











1.2.3 Mechanism responsible for ICP elevation post‐stroke 1 
It is widely accepted that cerebral oedema is the sole determinant of increased 2 
ICP in stroke as stated in the Monro‐Kellie Doctrine. Following the occurrence of 3 
stroke, cerebral oedema of the brain begins to develop during the first 24-48 4 
hours and reaches its maximum extent at 3-5 days (Ropper, 1984; Schwab et al., 5 
1996). Therefore, ICP has been assumed not to be a significant problem during 6 
the first 24 hours.  7 
Cerebral oedema is an excess accumulation of fluid in brain tissue, causing 8 
detrimental swelling. Cytotoxic and vasogenic oedema are the two most 9 
important clinical types of cerebral oedema. Cytotoxic oedema is localized and 10 
will occur within minutes to hours. In this type of oedema, the brain blood 11 
barrier (BBB) remains intact. It involves extracellular water passing into cells 12 
due to the failure of cellular ion pumps. Thus, there is cellular retention of 13 
sodium and water leading to cellular swelling (Katzman et al., 1977). Vasogenic 14 
oedema occurs more slowly, over hours to days. This phenomenon is due to the 15 
endothelial tight junctions disruption which leads to a breakdown of the BBB, 16 
resulting in intravascular water penetrating extravascular compartments 17 
(Katzman et al., 1977). 18 
By contrast to the traditional interpretation, the relationship between oedema 19 
and ICP is more complicated than it appears. Recent animal studies have 20 
revealed that, even in small strokes, animals with little oedema had a significant 21 
increase in ICP, reaching its peak 24 hours post-stroke onset (Silasi, MacLellan 22 
and Colbourne, 2009; Bragin, Bush and Nemoto, 2013). Interestingly, a recent 23 
study using a preclinical rodent model of ischaemic stroke reported that ICP 24 
elevation within the first 24 hours post-stroke was independent of oedema size. 25 
This finding casts doubt on the causative relationship of oedema and ICP that 26 





1.2.4 Stroke induced disturbances in CSF circulation  1 
Ischaemic stroke can be a major stressor in the physiology of brain cells, tissue, 2 
and fluid transport. This could lead to altered CSF secretion or drainage as an 3 
outcome of ischaemic stroke and, consequently, altered ICP (Davson, Domer and 4 
Holungsworth, 1973). As discussed earlier in this Chapter, the choroid plexus is 5 
known to be a major site of CSF secretion; thus, alterations to its function as a 6 
result of an ischaemic stroke can have an effect on the CSF secretion. The 7 
influence of cerebral ischaemia on blood-CSF barrier (BSCFB) integrity have been 8 
examined in the MCAO rodent model. Ennis and Keep (2006) observed a 9 
reduction on blood flow that supply the choroid plexus within lateral ventricle 10 
(Ennis and Keep, 2006). Additional morphological experiments have identified 11 
swelling of the choroid plexus epithelium and markers of proliferation through 12 
bromodeoxyuridine staining post-stroke (Ennis and Keep, 2006). 13 
In terms of CSF microcirculation, multiple preclinical stroke models were 14 
employed to measure the influence of stroke on glymphatic transport using 15 
dynamic contrast-enhanced MRI (DCE-MRI) (Gaberel et al., 2014). This study 16 
found that the glymphatic system was severely impaired after subarachnoid 17 
haemorrhage (SAH) and in the acute phase of ischaemic stroke but was not 18 
altered after carotid ligation or intracerebral haemorrhage. In addition, 19 
glymphatic perfusion after SAH was found to be improved by 20 
intracerebroventricular injection of a tissue‐type plasminogen activator. It 21 
should be mentioned that the very recent paper by Nedergaard and her group 22 
reported that the glymphatic system is the major contributor to the acute tissue 23 
swelling in the brain in the early stage after ischaemic stroke (Mestre et al., 24 
2020). Their findings demonstrated that within 30 minutes after MCAO, a 25 
spreading depolarization was initiated along with subsequent contraction of 26 
vessels which, in turn, enlarged the perivascular spaces resulting in enhanced 27 





1.3 CSF circulation and glymphatic flow using Magnetic 1 
Resonance Image 2 
1.3.1 Non-MRI tracer methods  3 
Glymphatic transport have been studied using two-photon laser scanning 4 
microscopy through a closed cranial window (Iliff et al., 2012; Mestre et al., 5 
2018). This method enables real‐time in vivo observations and can examine 6 
differences in behaviour based on molecular size. However, one criticism is that 7 
two‐photon laser‐scanning microscopy is an invasive method that requires the 8 
removal of a portion of the animal's cranial bone, and visualization is limited to 9 
the subcortical regions (at a depth of 100 μm). Further, observations of a 10 
fluorescent tracer by laser‐scanning microscopy, can only visualize the surface of 11 
the brain and only provide a snapshot view of isolated components of the 12 
glymphatic system.  13 
Alternative imaging methods such as MRI can provide a tomographic image and 14 
evaluation of CSF flow pathways, perivascular influx, parenchymal uptake, and 15 
clearance rates. In addition, its non-invasiveness, tunability (i.e. diffusion 16 
weighted, T1 and T2 weighted, Phase contrast), and lack of ionising radiation 17 
makes it favoured for brain imaging. MRI probes hydrogen protons in water 18 
molecules, making it ideal to measure compartments with high water content, 19 
such as the CSF and interstitial fluids. 20 
 21 
1.3.2 MR imaging methods  22 
Several published reports have attempted to visualize the CSF dynamic within 23 
the CNS, including the glymphatic system, using MRI exogenous or endogenous 24 
tracer studies. 25 
1.3.2.1 MRI exogenous tracer methods  26 
Paramagnetic contrast agents, such as gadolinium (Gd) chelates, are often used 27 
to highlight areas of interest or view more defined structures. Iliff et al. (2013) 28 
first employed MRI using intrathecal administration of Gd chelates as a tracer to 29 
monitor glymphatic function. In that study, dynamic contrast-enhanced MRI 30 
(DCE-MRI) was applied to capture temporal and spatial characteristics of Gd 31 
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chelates tracer transport via the glymphatic system. Briefly, by using DCE-MRI, 1 
the transport of the Gd chelates tracer was tracked in the CSF and brain 2 
parenchyma over time through a time series of post-contrast–enhanced images. 3 
They also compared the influx of small molecular weight Gd‐Diethylene Triamine 4 
Penta acetic Acid (Gd-DTPA, MW 938 Da) with a larger molecular weight 5 
polymeric Gd‐chelate (GadoSpin, MW 200 kDa) over the early infusion period. 6 
This demonstrated clear differences in whole‐brain distributions between the 7 
small and large Gd chelates tracers.  8 
There were certain assumptions made in this system when employing DCE-MRI 9 
and gadolinium tracers. First, the Gd chelates tracer is treated by the brain as a 10 
metabolic waste product within the CSF and intersitial space. Second, brain 11 
physiology is not altered after injecting the Gd chelates tracer. 12 
DCE-MRI methods have also been employed to study the glymphatic system after 13 
a number of neurological injuries and diseases. The impairment of glymphatic 14 
system in diabetes animals were examined by monitoring the clearance profile 15 
of the injected GD-DTPA tracer (Jiang et al., 2017). It has been demonstrated 16 
that the glymphatic system was severely impaired in diabetes, leading to an 17 
accumulation of tracers in multiple brain regions which correlated with the 18 
degree of cognitive decline. Interestingly, when compared with functional 19 
behavioural tests and vascular dysfunction, MRI measures have been shown to be 20 
highly sensitive indices of pathological changes occurring early during the 21 
development of diabetes mellitus (DM) (Jiang et al., 2017). 22 
In humans, following intrathecal gadobutrol (Gadovist/MW 550 Da) 23 
administration, the tracer distributed widely throughout the entire brain and 24 
spinal cord, thereby indicating the presence of a glymphatic system in the 25 
human brain (Eide et al., 2018). Further, the intrathecal MRI method was 26 
applied in a prospective study of idiopathic normal pressure patients (iNPH) 27 
(Ringstad, Vatnehol and Eide, 2017). MRI images findings indicated delayed 28 
enhancement and decreased clearance of Gadovist at the Sylvian fissure. This 29 
study also found that parenchymal enhancement peaked overnight in both iNPH 30 
patients and control groups, suggesting a crucial role of sleep (Ringstad, 31 
Vatnehol and Eide, 2017). There have been a number of published MRI studies 32 
which map and model CSF flow through the glymphatic system based on DCE-MRI 33 
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data. Lee et al. (2015) first used two compartment kinetic modelling to quantify 1 
CSF-ISF exchange rates in different postures. Based on their proposed analytical 2 
model, glymphatic transport was shown to be more efficient in the lateral 3 
position compared with other positions. Further, an optimal mass transport 4 
(OMT) method was proposed for studying the glymphatic system based on DCE-5 
MRI images (Ratner et al., 2015). This method provided evidence of both 6 
diffusion and advective solute transport modes in the brain parenchyma. More 7 
recently, a quantitative DCE-MRI approach (T1 mapping) was applied to quantify 8 
longitudinal relaxation time measurements both before and after contrast 9 
enhancement (Lee et al., 2018). In their study, they demonstrated that from the 10 
total amount of MRI contrast agent injected into the cisterna magna of rat, 11 
merely 19% enriched the brain parenchyma and the remainder escaped via other 12 
routes. 13 
1.3.2.2 MRI endogenous tracer 14 
Endogenous tracer methods utilize the water signal of CSF as an internal tracer 15 
for CSF flow information. This approach is completely non-invasive and suitable 16 
for human applications but is less sensitive when it comes to determining CSF 17 
flow compared to the exogenous tracer method.  18 
Phase-contrast (PC) MRI is a technique that provides qualitative and quantitative 19 
assessment of the movement of CSF (Battal et al., 2011). The sequence is based 20 
on the use of bipolar gradients that create a phase shift of moving spins 21 
proportional to their velocities in the gradient direction (Bryant et al., 1984). A 22 
number of MRI studies have employed the PC technique to quantify CSF flow 23 
velocity in different anatomical locations (sylvian aqueduct, foramen magnum) 24 
for the diagnosis of several CNS pathologies such as NPH (Bradley, 2015),Chiari 25 
type I (Meadows et al., 2000) and syringomyelia (Brugieres et al., 2000). While 26 
phase contrast methods have been shown to be powerful tools for evaluating CSF 27 
pulsatile flow (Mean velocity of CSF ~5-8 cm/s) (Sakka, Coll and Chazal, 2011), it 28 
has generally been difficult to measure the slow CSF net flow (~1 µm/s) (Sakka, 29 
Coll and Chazal, 2011). 30 
Diffusion weighted imaging (DWI) is another approach that uses water molecules 31 
in the system as an endogenous freely diffusible tracer. Evaluation of diffusion 32 
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using MR techniques was first presented by Stejskal and Tanner in their seminal 1 
paper (Stejskal and Tanner, 1965). In brief, they modified a standard T2-2 
weighted spin-echo sequence by applying a symmetric pair of strong diffusion-3 
sensitizing gradients (DG's) on either side of the 1800radiofrequency refocusing 4 
pulse. This approach was later combined into an imaging sequence, which 5 
enables diffusion coefficients to be spatially mapped (Basser, Mattiello and 6 
LeBihan, 1994). There have been several attempts to analyse ISF dynamics in the 7 
brain using diffusion‐based techniques. A study in rodents to evaluate 8 
glymphatic function used an ultralong echo time, low b‐value, multi-direction 9 
diffusion‐weighted MRI sequence (Harrison et al., 2018). That study indicated a 10 
significant increase in fluid movement with vascular pulsation compared with 11 
diastole. A recent study conducted in healthy human subjects aimed to evaluate 12 
sleep by measuring the slow and fast components of the apparent diffusion 13 
coefficient (ADC) of water in the brain (Demiral et al., 2019). This study 14 
provided evidence of increased CSF volume during sleep in humans. The 15 
diffusion of water can be impeded by tissue microstructures such as in white 16 
matter, resulting in a state called anisotropic diffusion. Glymphatic system 17 
function was also investigated using "diffusion tensor image analysis along the 18 
perivascular space" (DTI‐ALPS) in Alzheimer patients (Taoka et al., 2018). The 19 
results of that study demonstrated a reduction in water diffusivity along 20 
perivascular space in those patients, which may reflect impairment of the 21 















1.3.3 17O-labelled water as MRI contrast agent  1 
The tremendous biological relevance of 17O water (H217O) comes from its use as 2 
an MR tracer with particular application to the measurement of flow and 3 
metabolism.  4 
1.3.4 17O properties 5 
Oxygen 17 (17O), one of the most abundant elements, has been the subject of 6 
study for centuries. Given its abundant and reactive nature, oxygen is of central 7 
importance to biological, chemical, and physical processes. Three naturally 8 
occurring isotopes of oxygen exist, of masses 16. 17. and 18. 16O is by far the 9 
most abundant of these isotopes. Giauque and Johnston discovered the oxygen 10 
isotopes 17O and 18O (Giauque and Johnston, 1929). The first observation of the 11 
17O nuclear magnetic resonance signal was reported by Alder and Yu in 1951 12 
(Alder and Yu, 1951). 17O is a stable, non-toxic isotope of oxygen with a natural 13 
abundance of 0.037%. a nuclear spin of 5/2 and a gyromagnetic ratio (γ) of 14 
−36.281 rad s−1 T−1. As the spin of 17O nucleus (I=5/2) is exhibit a quadrupole 15 
moment, Q, where the charge distribution surrounding the nucleus is asymmetric 16 
and therefore and the electric field gradient can interact with the nucleus and 17 
exhibit a torque on the nucleus. For 17O, the nuclear ground state splits into six 18 
sublevels in the applied magnetic field (since 2 × (5/2) + 1 =6) and therefore 19 
multiple transitions are expected. In analytical chemistry, the dramatic 20 
chemical shifts and sensitivity to electric field gradients have made 17O useful to 21 
investigate the structure, bonding, and dynamics of oxygen‐containing 22 
compounds. 23 
1.3.4.1 Metabolized H217O as endogenous contrast agent  24 
In comparison to another isotope of oxygen, oxygen-15, which is used as a 25 
positron emission tomography tracer (15O-PET), 17O-MRI can be used as a non-26 
invasive method without any radioactive exposure to directly measure cerebral 27 
oxygen metabolism (Arai et al., 1998; Zhu et al., 2005; Graaf et al., 2008). 17O 28 
molecules can be delivered either in the form of free gas or dissolved in water. 29 
Following inhalation of 17O2 gas, it binds to the haemoglobin (Hb) in the blood 30 
and then enters the brain via the arteries and blood circulation. The 17O-labeled 31 
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oxygen gas will be metabolized in the brain mitochondrion to produce H217O as 1 
shown in the following equation: 2 
 4H+ + 4e− + O1
17
2 → 2H2 O1
17  (2.2) 
The production rate of the metabolized H217O water reflects the rate of oxygen 3 
metabolism in the brain tissue (Rolfe and Brown, 1997). Thus, using the 17O in 4 
the brain will provide important information regarding the oxygen metabolism of 5 
the brain tissue. Another advantage of 17O over 15O is that no on-site production 6 
is needed (Zhu and Chen, 2011). In case of 15O experiments, the tracer must be 7 
produced on-site due to its very short half-life of approximately 2 mins. Further, 8 
since 15O and H215O are both positron emitters, it is difficult to differentiate 9 
these two compounds with PET potentially complicating the measurement of 10 
H215O accumulation (Herscovitch, Mintun and Raichle, 1985). On the other hand, 11 
17O is only detectable by means of MR if it is bound to protons as water 12 
molecules (H217O), which is a unique feature of 17O-NMR techniques (Zhu et al., 13 
2005). This phenomenon allows the selective detection of metabolically 14 
generated H217O without confounding signals from the 17O molecules bound to 15 
haemoglobin.  16 
1.3.4.2 17O-labelled water as an exogenous contrast agent 17 
Detection of externally administered 17O-labelled exogenous tracers (e.g., H217O) 18 
in vivo has been used by several investigators for cerebral blood flow (CBF) 19 
measurement (Arai et al., 1998). After administrating a bolus injection of H217O, 20 
an initial rapid increase in H217O concentration in brain tissues can be observed. 21 
Then the concentration of H217O in the brain starts to decrease; meanwhile some 22 
H217O molecules are brought back to the brain from the body by blood 23 
recirculation. These two processes give rise to a net effect of H217O washout and 24 
finally achieve a new steady state of H217O concentration in the brain. Hence, 25 
assessment of CBF and water movement across blood brain barrier (BBB) can be 26 
assessed by monitoring the behaviour of H217O signal (Arai et al., 1998).  27 
Glucose homeostasis plays a key role in numerous fundamental aspects of life, 28 
and its dysregulation is associated with many important human diseases such as 29 
cancer. During cancer progression, tumour cells gain energy by anaerobic 30 
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glycolysis (Warburg effect) and therefore have an elevated glucose turnover 1 
compared with normal tissue (Vander Heiden, Cantley and Thompson, 2009). At 2 
present, 2-deoxy-2-[18F] fluoro-glucose (18F-FDG) is the gold standard to monitor 3 
the metabolic rates of glucose (Kao et al., 1998). As an alternative to PET, 4 
administration of highly labelled 17O‐glucose, together with dynamic17O‐MRS 5 
have provided a non‐radioactive alternative to FDG-PET to follow up glucose 6 
consumption during glycolysis (Borowiak et al., 2017). 7 
1.3.4.3 17O-labelled water contrast agent for studying CSF 8 
In recent years, similar H217O MR imaging approaches have been applied to 9 
evaluate CSF status in animals (Igarashi et al., 2014) and humans (Kudo et al., 10 
2018). Igarashi et al. (2014) conducted MRI experiments utilizing H217O JJVCPE 11 
imaging to investigate water flux into CSF in AQP1 and AQP4 knockout mice. 12 
These observations seem to indicate that water influx into the CSF is regulated 13 
by AQP4 (not by AQP1). Further, water movement within the perivascular space, 14 
rather than in choroid plexus and arachnoid villi, was found to be essential for 15 
CSF volume homeostasis. In human studies, following intravenous administration 16 
of H217O, transition into the brain parenchyma and CSF regions has been 17 
reported (Kudo et al., 2018). In this study, dynamic steady‐state sequences were 18 
acquired to detect the T2‐shortening effect of H217O. Different kinetic 19 
parameters between the brain parenchyma and CSF spaces were found. The 20 
cerebral cortex and subarachnoid spaces on the brain surface showed a prompt 21 
signal drop, indicating quick transmission of H217O from arteries to these regions. 22 
By contrast, the signal drop in the ventricle containing the choroid plexus was 23 
significantly delayed, indicating that fluid exchange is less active in the ventricle 24 







1.4 Thesis aims 1 
1. To investigate the relationship between CSF dynamics, vasogenic oedema, 2 
and ICP following experimental stroke. 3 
2. To demonstrate the true magnitude of the CSF water flow through the 4 
glymphatic system by using a novel MRI tracer, namely, H217O as opposed 5 
to the conventional gadolinium-based tracers (Gd-DTPA). 6 
3. To build on the understanding of the function of AQP4, by modulating it 7 




2 Chapter 2: Magnetic Resonance Imaging  
This Chapter describes the theory of magnetic resonance imaging (MRI) and how 
to form an MR image from a sequence of radiofrequency and magnetic field 
gradient pulses. The imaging techniques relevant to this thesis are introduced, 
followed by a detailed description of the hardware requirements of an MR 
system. Information has come from multiple sources; (Callaghan, 1993), (Levitt, 
2013), (Cercignani, Dowell and Tofts, 2018), (Elster, 1994), unless specifically 
stated. 
2.1 Dipole to Image 
2.1.1 Nuclear spin angular momentum 
An elementary particle possesses a variety of properties such as mass or charge, 
another being its intrinsic angular momentum, also known as spin. Electrons, 
protons, and neutrons all possess spin angular momentum, which is quantised 
and is related to the spin quantum number, 𝐼. The magnitude of the spin angular 
momentum is given by the formula: 
 |L| = ħ √𝐼(𝐼 + 1) (2-1) 
Where ħ is Planck's constant (h= 6.63 × 10-34 m2 kg s-1) divided by 2π. Also, the 
direction of the spin angular momentum is quantized and hence the possible z 
components are given by: 
 L𝑧 = m𝐼 ħ (2-2) 
Where, m𝐼 =  −𝐼, −𝐼 + 1, … 𝐼.  
𝐼 may take zero, integer, or half integer values. The number of orientations of a 
possible spin angular momentum with spin I, is 2I +1. For hydrogen nuclei (1H), 
the spin quantum number is 𝐼 = 
1
2
  giving two spin states, thus: 
2 45 
 







2.1.2 Magnetic moment  
Nuclei and particles with a spin quantum number larger than zero have an 
observable associated magnetic moment. This magnetic moment, µ, describes 
the tendency of an object to interact with an external magnetic field. µ is 
related to the nuclear spin through a nuclei-specific constant called the 
gyromagnetic ratio, γ (for hydrogen, γ=2.675×108 rad s-1T-1). Where µ is given by: 
 µ = γħI  (2-4) 
When a static magnetic field, B0, is applied to the spin system along the z axis, 
magnetic moments are aligned in the field with certain allowed orientations, 
(m𝐼), giving 2I+1 energy levels (see Figure 2-1), While in the absence of a 
magnetic field, these energy levels are degenerate. 
 
Figure 2-1. Zeeman energy levels. Splitting of the energy levels of 1H (I=1/2) and 17O nucleus 
(I=5/2). The diagram progresses from the no magnetic field to the Zeeman splitting. 
This behaviour is the so-called Zeeman effect, where the energy of interaction 
for each orientation is given by: 
 E = −γħ m𝐼B0 (2-5) 
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(2-6) 





= e(−∆E/K𝐵T) (2-7) 
Where  N↑ is the population of the spin up state (m𝐼=1/2) and 𝑁↓ is the population 
of the spin down state (m𝐼=-1/2), KB is the Boltzmann constant (1.3805 x 10
-23JK-1) 
and T is the temperature in degrees Kelvin. This difference in population of the 
two states induces a net magnetisation, which represents the vector summation 
of all the magnetic moments of the individual nuclei.  














Where µx, µy, µz are the components of magnetic moments for the specific 
nucleus, i, in the x, y and z directions. At equilibrium, the net magnetisation is 
aligned along the direction of the main magnetic field (B0), this equilibrium net 







Where Ns, is the number of spins. It is worth noting at this time that factors 
which influence the MRI signal; field strength of the scanner B0, the natural 
abundance and gyromagnetic ratio, γ, of the particular nuclei.  
2.1.3 Larmor Precession  
When looking at individual nuclear magnetic moments, µ, placed in a magnetic 
field, they do not align exactly with B0, and rather precess about B0 (see Figure 
2-2).  
 
Figure 2-2. Schematic representation of the magnetic moment of a nucleus and its precession 
about a magnetic field, Bo. 
The frequency of precession is called the Larmor frequency (ω0) which is an 
angular frequency, giving by: 
 ω0 = −γB0 (2-12) 
According to quantum theory of radiation, ω0 is frequency at which the nuclei 
absorb energy and is related to the energy difference between levels (ΔE). We 
can now rewrite equation (2-6): 
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 ΔE = ħωo (2-13) 
The higher the magnetic field strength, the greater ω0 and ΔE (Figure 2-1). 
Different nuclei have a different ω0 because of their different gyromagnetic 
ratios, γ. For the hydrogen nucleus, 1H, at 7 Tesla, the value of γ is 42.58 
MHz/Tesla, which gives a precession frequency of ∼ 300 MHz.  
2.1.4 Radiofrequency pulse  
RF radiation is electromagnetic radiation and is a combination of an oscillating 
electric field (which does not interact with M0) and an oscillating magnetic field 
perpendicular to each other. If the oscillating magnetic field, B1, of the RF pulse 
is applied perpendicular to the external magnetic field, B0, the net 
magnetisation will precess about the B1 field with a frequency:  
 ω1 = −γB1 (2-14) 
The B1 field is only able to exert a constant direction torque if its frequency (ω1) 
is close to the precession frequency, ω0. To visualize the effect of an RF pulse 
on M0, it is common to consider a reference frame rotating at the RF frequency, 
ω1, about the z-axis. The new frame of reference is denoted (x’, y’, z ) and is 
called the rotating frame (see Figure 2-3). In this rotating reference frame, the 
B1 field appears stationary. Additionally, if ω1= ω0 (On-resonance) the 




Figure 2-3. The evolution of the bulk magnetisation vector, M, under the application of an RF 
pulse B1 in rotating frame. 
During an RF pulse the net magnetisation precesses about the B1 field. The flip 
angle, α, by which the magnetisation is tipped away from the z-axis, is 
dependent on the power of the RF pulse and the length of time that it is 
applied: 
 α = ω1t𝑝 =  γB1t𝑝 (2-15) 
where t𝑝, is the duration of the RF pulse. Arbitrary α can be achieved but 
commonly pulses have either α = 900 or 1800. 
2.1.5 Spin echo  
The most basic method for recovering phase coherence is the Spin Echo (SE) 
which was first introduced by Hahn in 1950 (Hahn, 1950). The simplest 
experiment is the application of 1800 pulse after the initial 900 pulse. Following 
a period, τ, of dephasing, the 1800 pulse flips the orientations of the dephasing 





Figure 2-4. Simplified pulse diagram of the spin echo imaging sequence.  
2.1.6 Generating MR Image 
Once the magnetisation has a transverse component, the detection of its 
precession about B0 can be examined. To detect the signal, the same RF coil (or 
a separate RF coil) as that for transmission of the B1 field can be used. A change 
of the magnetic flux, Ф, which is caused by the precessing net magnetisation, 
induces an electromotive force (emf). The emf induced in a coil by a change in 





The MRI signal produced by the precessing net transverse magnetisation can be 
expressed mathematically as follows: 
 s ∝ e(iφ) (2-17) 
Where ϕ is the phase of the transverse magnetisation, as a function of time and 
can be expressed as: 




 s ∝ e(iγB0t) (2-19) 
MR imaging seeks to acquire spatial information about the sample. Therefore, 
the resonance frequency of nuclei must be encoded as a function of their spatial 
position. This can be achieved using pulses of magnetic field gradients, which 
forms the basis of MRI (see section 2.5.3). To spatially encode nuclear spins, a 
magnetic field gradient is applied in the direction that the spatial encoding is 




 , Gy =
∂Bz
∂y




The Larmor frequency of the spins at position (x1) is then a function of the 
applied gradient: 
 
ω(𝑥1) = γ(B0 + Gx. x1) 
(2-21) 
It is often convenient to use the concept of a rotating frame of reference, where 
the new reference frame rotates about the z-axis at ω1, the same frequency as 
the B1 field of the RF radiation. At resonance (ω1 = ω0), the net magnetisation 
will appear stationary due to the effects of the B0 field disappearing. The signal 
intensity is now acquired as a function of time and the applied gradient:  
 s ∝ e(iγGx.x1t) (2-22) 
MRI Data acquired with respect to time and to gradient strength and duration is 




Figure 2-5. Acquiring data in k-space for MR imaging.Acquisition of an echo in the presence 
of a read gradient fills one horizontal line of k-space. The vertical position of each line of k-
space is determined by the strength of the phase encoding gradient applied during the 
pulse sequence. An image is reconstructed by applying two Fourier transforms, first in read 
direction and second in the phase direction, of the k-space data. 
 
Thus, the position and separation of points along each axis of k-space are 




 γG𝑥. 𝑡𝑥  , ky =
1
2π
 γGy. 𝑡𝑦 (2-23) 
By using the substitution, k𝑥 =
1
2π
 γG𝑥. 𝑡𝑥 , and integrating the signal for over the 
whole sample, now the total signal can be expressed as the following: 




Where ρ(𝑥) is the spin density of a sample at position 𝑥. It is easy to see in 
equation (2-23) that the signal S(k) is the Fourier transform of the spin density 
(ρ(𝑥)). To generate a 2D MR image from the data in k-space data, the data must 
be Fourier transformed twice, first in the read direction (k𝑥) and then in the 
phase direction (k𝑦): 





ei2π(k𝑥.𝑥+k𝑦.y)d𝑥 dy (2-25) 
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For MR imaging, we generate transverse magnetisation, Mxy, only from spins 
contained in a small and well-defined slice of the whole volume (see Figure 2-6). 
This is achieved by applying the RF pulse, with a defined frequency bandwidth 
Δω, during the application of a magnetic field gradient. 
 
Figure 2-6. Slice selection. The resonance frequency is varied by the use of a magnetic field 
gradient in the z-direction. Applying a RF-pulse with the right frequency bandwidth, Δω, 











2.2 MRI Relaxation  
2.2.1 Transverse relaxation 
Transverse relaxation (spin-spin relaxation), T2, is a measure of the rate at 
which phase coherence is lost (see Figure 2-7). This is can be described 








Following a 900 excitation the solution of equation (2-26) is simply: 
 Mxy = Mo e
−t
T2 (2-27) 
The rapid tumbling motion of molecules, which contain nuclear magnetic 
moments, results in a rapidly fluctuating local magnetic field, Blocal. This tiny 
fluctuating local field is superimposed on the larger static B0 field, causing 
random fluctuations in the Larmor frequency. This results in stochastic 
dephasing of the spins, leading to irreversible decay of the transverse 
magnetization. In addition, there is the dephasing due to inhomogeneities in the 
B0 magnetic field and local differences in magnetic susceptibilities. These types 
of effects are constant in time, and they act on a spatially macroscopic scale. 
The combined transverse relaxation is often called the T2* where: 





Incoherent dephasing due to T2* effects are reversible. This can be achieved by 




Figure 2-7. T1 relaxation process. Diagram showing the process of transverse relaxation 
after a 900 RF pulse is applied. Initially, the transverse magnetization (black arrow) has a 
maximum amplitude as the spins rotate in phase. The amplitude of the net transverse 
magnetization decays as the spins move out of phase with one another (shown by the small 
black arrows). 
2.2.2 Longitudinal relaxation 
Longitudinal relaxation, T1, is the process by which the net longitudinal 
magnetization (Mz) returns to its equilibrium state (M0) (see Figure 2-8). 
Mathematically, this process is described by the following term in the Bloch 








Following a 900 pulse, the solution of Equation (2-29) describes an exponential 
growth of Mz towards its equilibrium value M0: 
 Mz = Mo(1 − e
−t
T1) (2-30) 
The process by which the excited spins lose their energy to the surrounding 
system is called spin-lattice relaxation. It is, in fact, the mechanism by which 





Figure 2-8. T1 relaxation process. Diagram showing the process of T1 relaxation after a 90
0 
RF pulse is applied. The z component of the net magnetization, Mz is reduced to zero, but 
then recovers gradually back to its equilibrium value (M0). 
2.2.3 Other Relaxation mechanisms 
2.2.3.1 Spin coupling 
The magnetic moment of each spin generates a small local magnetic field with a 
direction dependent upon the alignment of the spin either parallel or anti-
parallel with B0. These local fields alter the B0 field experienced by another spin 
in close proximity. These interactions of magnetic moments can be transmitted 
either through space (dipolar coupling) or via the bonding electrons (scalar or 
indirect coupling). For molecules in solution undergoing tumbling and rotating, 
the dipolar coupling is averaged to zero since it is dependent upon the distance 
between, and the orientation of, the nuclei. Scalar coupling, however, is not 
affected by B0 field strength or molecular tumbling. 
2.2.3.2 Relaxation mechanism of 17O 
In the case of dipolar nuclei (I = 1/2), the main interaction is generally the 
magnetic dipole-dipole interaction between the nuclei. Nuclei with I = 1/2 
possess a spherical distribution of the nuclear charge and are, therefore, not 
affected by the electric environment within the molecule. The so-called 
quadrupolar nuclei (i.e., those with I > 1⁄2), such as 17O, possess an electric 
quadrupole moment in addition to the magnetic dipole moment. The electric 
quadrupole moment produces a non-symmetric nuclear charge distribution (non-
spherical charge) that interacts with the electric field gradient in the 




Figure 2-9. Charge distribution. Spherical (red) and non-spherical nuclei (green). 
The temporal fluctuation in this interaction induced by molecular motion can 
dominate 17O relaxation processes and determines both T1 and T2 relaxation 

















The term (𝑒2𝑄𝑞) is the 17O quadrupolar coupling constant for bulk water, and η 
is an asymmetry parameter (0≤ η≤1). 𝜏𝑐 is the rotational correlation time and ω 
is the 17O Larmor frequency.  
The T2/T2* relaxation of 17O water in a biological sample or water is smaller than 
the T1 relaxation time of 17O because of the combined effects of the 17O-1H 
scalar coupling and the nucleus exchange on the 17O transverse relaxation 
process. In vivo rat brain studies show that the longitudinal and transverse 
relaxation times of the 17O signal in natural abundance H217O, are on the order of 
a few milliseconds and are field independent (T2 = 3 ms, T2* = 1.8 ms at both 
4.7T and 9.4T; T1 = 4.5 ms at 4.7T versus 4.8 ms at 9.4T).  
In NMR spectroscopy, the 17O nucleus in water can interact with the two 1H 
nuclei, resulting in the 17O signal being a 1:2:1 triplet at extremely low water 
concentration. However, the 17O triplets collapse to one single and well-defined 
H217O resonance peak in a biological samples, due to rapid 1H nucleus exchange 
and quadrupolar relaxation leading to a large line broadening effect.  
2.2.3.3 The detection of 17O “indirectly”, via effect on 1H relaxation.  
The MR sensitivity of 17O is about five orders of magnitude lower than that of 1H 
due to the low natural abundance of 17O (0.037%) the approximately seven‐fold 
lower gyromagnetic ratio. Hence, direct detection of 17O has inherently very low 
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SNR and therefore has posed a fundamental challenge to the development of 
these techniques. An alternative to direct detection of 17O, is to detect the 
effect of the quadrupolar 17O nucleus on the much larger 1H MRI signal from 
H217O molecules. This phenomenon was first investigated by Meiboom (1961) and 
occurs via scalar coupling between the quadrupolar 17O nucleus and bonded 1H 
nuclei. This effect is further magnified by the rapid exchange of H+ ions with the 
H217O molecule: 
 H+ + O1
17 H− = H2 O1
17  (2-32) 
According to Meiboom, for low concentrations of H217O in H216O, the resulting 1H 


















Where P is the fraction of water molecules containing 17O, J is the scalar 
coupling constant for 1H-17O bond, T1 is the 1H longitudinal relaxation time and τ 
is the 1H exchange lifetime. Hence, the presence of H217O water can be detected 
by a reduction in the 1H signal on T2-weighted MRI.  
Both 17O-1H scalar coupling and the chemical exchange between H217O and H216O 
are all sensitive to some physiological parameters such as pH (Meiboom, 1961). 
At near-neutral pH, the scalar coupling has a maximal effect for enhancing the 
apparent transverse relaxation rate, while this effect can completely disappear 
when pH is shifted away from neutral. 
2.2.3.4 Paramagnetic Relaxation 
Gadolinium (Gd) chelates are the most widely used of all MR paramagnetic 
contrast agents. The gadolinium ion is strongly paramagnetic and contain seven 
unpaired electrons, giving rise to very large magnetic moment, since the 
2 59 
 
magnetic moment of the electron is about 700 times larger than that of the 
nucleus. Gadolinium contrast agents induce significant enhancement of both 
transverse and longitudinal relaxation times through dipole interaction between 
free water nuclei and electron spins. The relationship between the change in 
relaxation rate (i.e. R1=(1/T1) and R2=(1/T2)) and the contrast agent 
concentration, C, is linear assuming fast water exchange between tissue 
compartments: 
 R1 = R1
0 + r1C (2-35) 
 
 R1 = R1
0 + r1C (2-36) 
Where 𝑅1
0 and 𝑅2
0 are the native tissue longitudinal and transverse relaxation 
rates, and r1 and r2 are relaxivity constants (units of mM-1 s-1) reflecting the 












2.3 Pulse sequences 
2.3.1 TR and TE 
The application of various RF pulses and the alteration of receiving times have a 
major impact on the contrast of the resultant image (Figure 2-10). TR is the 
repetition time and is the time between the beginning of a pulse sequence, and 
the beginning of the next identical pulse sequence for the same slice of spins. TE 
is the echo time and is the time between the RF pulse which initially generates 
transverse magnetisation, and the peak signal received by the coil. 
 
Figure 2-10. Effect of TR and TE on MR image contrast.  
 
2.3.2 Multi spin echo sequence (RARE & MSME) 
The RARE (rapid acquired relaxation enhanced) technique is based on the CPMG 
(Carr-Purcell-Meiboom-Gill) sequence, where transverse magnetization following 
a slice selective 90º pulse is refocused by a train of slice selective 1800 pulses 
generating a series of echoes (Meiboom and Gill, 1958). Each echo is separately 
phase-encoded, and the phase encoding is incremented within one echo train to 
accelerate the acquisition (see Figure 2-11). The contribution to image contrast 
will be greatest for echoes acquired at the centre of k-space. Hence, the 




Figure 2-11. Simplified pulse diagram of the RARE imaging sequence. 
Quantitative T2 mapping can be achieved using the multi-slice-multi-echo 
(MSME) method. As with the RARE technique, multiple spin echoes are generated 
using the CPMG sequence with slice selective RF pulses. However, with MSME 
technique the same phase gradient is applied to each echo, whereby each echo 
is used to obtain an image with a different TE. Each voxel in an image is fitted 
to a single exponential decay using equation (2-28) to provide a map of 
transverse relaxation time throughout the imaged sample. 
 
Figure 2-12. Simplified pulse diagram of the MSME sequence. 
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2.3.3 Gradient echo  
The gradient echo pulse sequence allows the formation of a gradient echo, 
where the signal intensity is dependent on the T2* signal decay of the sample. 
With TR less than 5xT1 and pulse angles less than 900, the maximum steady state 
signal is obtained using The Ernst angle (𝛼𝐸) is calculated using: 




This demonstrates that the maximum steady state signal intensity occurs with a 
smaller pulse angle as the repetition time of the pulse sequence is decreased. 
2.3.3.1 FLASH sequence 
This sequence was first described by Haase et al. (1986) and is termed as FLASH 
(fast low angle shot) image. Repetition times for FLASH are typically tens of 
milliseconds, with echo times of a few milliseconds. In a FLASH sequence, it is 
important to note that when the TR is less than or equivalent to T2*, the 
gradients from next repetitions of the sequence may refocus spin coherence 
from previous read gradients. This would add signal to the acquisition of the 
next echo, causing artefacts and changing the expected contrast of the image. 
To eliminate this effect, all phase coherence should be destroyed or spoiled by 




Figure 2-13. Simplified pulse diagram of the FLASH sequence. 
2.3.4 Inversion pulse 
The Inversion Recovery (IR) technique is the gold-standard method for T1 
mapping. It consists of inverting the longitudinal magnetization and sampling the 
MR signal at several later inversion times (TIn) along its exponential recovery 
(see Figure 2-14). The IR pulse sequence is repeated N times, each time applying 
the same (typically adiabatic) inversion pulse, followed by a different inversion 
time (TI), and an imaging module (e.g. spin echo (SE), and echo planar imaging 
(EPI)). TR must be on the order of the longest measured T1 to achieve sufficient 
magnetization recovery. The general equation used for the fitting procedure is 
given by: 
 Mz = M0(1 − 2e
−TIn
T1 ) (2-38) 
Where TIn is the inversion recovery time of the nth IR scan. By varying TI, T1 can 





Figure 2-14. Simplified pulse diagram of Inversion Recovery (IR) sequence. This method is 
based on several IR measurements with different inversion times (TI). 
2.4 Diffusion Weighted Imaging  
Stejskal and Tanner (1965) showed that the echo magnitude can be sensitised to 
the random motion of the molecules caused by diffusion. In their experiment, a 
pair of diffusion gradients were applied on each side of the refocusing 1800 RF 
pulse (see Figure 2-15). 
 






The relation between MR signal and the bipolar gradient parameter scan be 
written as: 
 S𝐷𝑊𝐼 = S0 exp
(−bD) (2-39) 
where (S0 is the signal at the absent of diffusion gradients (b = 0)). D is diffusion 
coefficient (mm2/sec). b value is the diffusion weighting factor, For the spin 
echo diffusion weighted sequence seen in Figure 2-15, the calculation for b is: 












Calculating the diffusion coefficient of each voxel allows a diffusion map to be 
generated. Using the average value of diffusion coefficient in three orthogonal 
directions ((Dxx + Dyy + Dzz)/3), reduces the multi-directional diffusivity at each 
point into a single number that can be considered a consolidated apparent 








2.5 Magnetic Resonance Instrumentation 
2.5.1 Main Magnet 
Superconducting systems are used almost exclusively and form the basis of the 
vast majority of clinical MRI systems. A typical superconductor used for MR is a 
Niobium-Titanium (NbTi) alloy in a copper matrix and anywhere from 50 to 400 
km of the wire is required for a modern MR magnet. NbTi coils are often kept at 
approximately 4.2K, which is the boiling point of liquid helium. In the current 
thesis, all MRI data were acquired using a Bruker PharmaScan 7T system. It has a 
16 cm clear bore size with 72 mm free access for the animal.  
2.5.2 Shimming 
From the bore of the magnet inwards, the first unit is normally the shims coils. 
The magnet usually requires shimming to correct field distortions, and so reach 
an acceptable level of homogeneity. In general, there may be a combination of 
passive and active shims. Passive shims are an array of thin metal plates placed 
in trays along the bore and their purpose is to remove Bz inhomogeneities. Active 
shims are a matrix of electromagnets (coils) inside the cryostat, in which each 
coil carries a different current. The shim coils produce small magnetic field, that 
vary as functions of position (e.g. dBz/dx, d2Bz/dx2). These small fields 
superimpose on the B0 field and are used to improve the B0 homogeneity.  
2.5.3 Gradients 
The next unit is the gradient coil set. Normally containing 3 actively shielded 
gradients, x, y and z. The gradients make the magnetic field vary with position, 
providing spatial encoding of the Larmor precessional frequency and therefore 
allowing a determination of where the MR signal is coming from in 3D space (see 
equation (2-20)). The quality of the gradient system is characterized by the 
maximum gradient strength (Gmax) and the ratio of Gmax over the shortest time 
required to switch on the gradient (slew rate). For the Bruker PharmaScan 7T 
system used in this research, the gradient strength is 300 mT/m and slew rates 
of 6840 T/m/s. 
2 67 
 
2.5.4 RF coils 
The closest piece of equipment to the patient is RF coil. A transmitter RF coil 
provides pulsed, radiofrequency radiation at the Larmor precessional frequency 
and generates a magnetic field, B1 that is orthogonal to the B0 field (i.e. in the 
x-y plane) (see section 2.1.4). Transmitter coils may also be used for receiving 
the MR signal. Further improvements in signal-to-noise ratio (SNR) may be 
obtained by using a separate local receiver coil. For this experiment described in 
this thesis the B1 transmit field was generate using a volume birdcage coil and 
the MRI signal was detected using a 4-channel phased array rat head receiver 
coil.  
 
Figure 2-16. Representative of basic component of MRI Scanner. 
2.5.5 RF transmission / MR signal reception and digitization  
2.5.5.1 RF synthesizer  
The central computer controls the RF frequency ω1, the RF synthesiser generates 
a low power electrical signal with this frequency. Note that the frequency 
synthesiser is also linked to the receiver unit to provide a reference frequency.  
2.5.5.2 RF modulator  
Through the RF modulator, the RF reference wave is modulated into RF pulses 
with modified amplitude and time according to the sequence design.  
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2.5.5.3 RF amplifier  
The RF transmission pulses are then scale up to high power by changing the gain 
of the amplifier using a transmit attenuator (300-1000 kW) to produce a large-
amplitude RF pulses for transmission to RF transmitter coil.  
2.5.5.4 Decoupling box  
During transmit pulse, the decoupling boxes move the receiver coil OFF 
resonance. Then during acquisition, it moves the transmit coil off resonance 
2.5.5.5 RF preamplifier  
The MR signal is detected by the RF receiver coil and is extremely weak (on the 
order of millivolts). To prevent contamination by environmental noise, the signal 
is immediately amplified to a higher power signal (on the order of volts) through 
a pre-amplifier.  
2.5.5.6 RF demodulator  
The MR signal then passes into the receiver unit where the signal transformed to 
the audio frequency range. This is achieved by mixing the signal with a 
reference frequency, a process called demodulation. This simplifies the analysis 
of the data. To be able to discriminate between frequencies either side of the 
carrier or central frequency, quadrature demodulation is used. 
2.5.5.7 Image digitization 
An Analog-to-Digital converter (ADC) is used to change the analog signal into 
digital representation for input to a computer system. The number of bits in the 
ADC determines the dynamic range of the receiver and the sampling rate 
determines the bandwidth of the acquisition. The ADC on the pharmascan 




3 Chapter 3: Methods 
3.1 Animal preparation and Surgical Procedures 
In this thesis, all surgical procedures and cannula implantation for infusion 
studies were carried out by Mrs Lindsay Gallagher (Personal license number 
60/713). Study design, surgical assistance, MRI imaging, MATLAB coding for 
image analysis, physiological data analysis, and infusion experiments were 
carried out by myself.  
3.1.1 Preparation of animal for surgery and imaging 
All experiments and procedures in this thesis were carried out under license 
from the UK Home Office (Personal Licence number 60/11925, working under 
Project Licence numbers 60/3759 and 60/3618) and in accordance with the 
Animals (Scientific Procedures) Act, 1986, incorporating European Directive 
2010/63/EU and approved by the University of Glasgow Ethical Review Panel. 
Also, the Animal Research: Reporting in vivo Experiments (ARRIVE) guidelines 
(http://www.nc3rs.org.uk/arrive-guidelines) was observed during planning, 
experimentation, analysis, and documentation of all procedures.  
3.1.2 Animal Housing 
Adult male Wistar Kyoto (WKY) or Wistar rats were obtained from Charles River 
Laboratories and housed in an animal care facility at the University of Glasgow. 
After their arrival, all rats were acclimatised for one week before any 
experimentation. Rats were housed in groups with water and food freely 
available and were maintained on a 12-hour light/dark cycle. 
3.1.3 Anaesthesia  
Anaesthesia was induced in an anaesthetic gas chamber, with 5% isoflurane 
(Baxter Healthcare Ltd, UK) administered in a 30:70% O2:NO2 mixture. The depth 
of anaesthesia was assessed by means of the withdrawal reflex, where the 
footpad of the hindlimb is tightly squeezed to evoke a reflex withdrawal of the 
foot. Once deeply anaesthetised, the rat was immediately transferred to a 
designated area within the laboratory and the fur overlying any planned incision 
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sites was removed using electric clippers (Wella, Germany) and cleared using a 
handheld vacuum (Black & Decker, USA). Then, the rat was transferred to 
operating table within the laboratory and was artificially ventilated following 
tracheal intubation or tracheotomy if rat was not recovered following surgery. 
Following removal from the anaesthetic chamber, the dose of isoflurane was 
reduced to between 2% and 3% in the same gas mixture stated previously, to 
maintain surgical anaesthesia.  
3.1.4 Surgical procedures 
3.1.4.1 Induction of middle cerebral artery occlusion  
Permanent occlusion of the left MCA was performed by intraluminal thread 
occlusion, as previously described (Enrique Zea Longa et al., 1989b). All surgery 
was performed under a light operating microscope (Zeiss, Germany). A small 
ventral midline incision was made. Blunt dissection near the intersection of the 
sternomastoid and the sternohyoid muscles exposed the underlying carotid 
bifurcation. The common carotid artery (CCA) and internal carotid artery (ICA) 
were separated from the vagus nerve. A small cut on the ventral side of the CCA 
below the bifurcation was performed and a 4-0 nylon monofilament with silicone 
coated tip (403934PK10 or 404134PK10 Doccol Corporation, USA) from the 
bifurcation point of the right CCA and gently advanced into the circle of Willis 
until reaching a mild resistance, to occlude MCA. The filament was permanently 
left in position by a double knot around the CCA and ICA. The wound was closed 
using a 4-0 silk suture. In case of successful filament placement with complete 
occlusion of the MCA confirmed by MRI, the rat was placed in a preheated cage 
(with the heating pad under it) for recovery from anaesthesia.  
Sham-operated animals were submitted to the above surgical procedure with the 
exception of the filament introduction. Briefly, animals were underwent skin 
incision, separation of the Vagus nerve from the CCA, and skin suturing, in the 
absence of CCA occlusion. Post-suturing, then returned to the heated cage to 




Figure 3-1. Diagram illustrating the intraluminal filament model of MCAO. (A) Common 
carotid artery (CCA), external carotid artery (ECA), and pterygopalatine artery (PPA) were 
tied off with a secure tie and a silicon-coated nylon filament was inserted to occlude the 















3.1.4.2 Intracranial pressure measurement  
Intracranial pressure (ICP) measurements were obtained while under 
anaesthesia. Following MRI scanning at 24 hours post-MCAO or sham surgery, rats 
were re-anesthetised (5% isoflurane in 30:70 O2/NO2 mixture) and transferred to 
a stereotaxic frame where the head was secured in ear and tooth bars. The co-
ordinates (Bregma 1.3 mm posterior, 2 mm lateral) for the lateral ventricles 
were identified from the rat brain stereotaxic atlas (Paxinos & Watson) and, 
where necessary, adjusted slightly to accommodate any brain swelling identified 
on the T2 weighted MRI scans. Two burr holes were drilled over the ipsilateral 
and contralateral lateral ventricles and, for ICP monitoring, a 25-gauge needle 
connected by an air-free fluid system was placed in the ipsilateral ventricle and 
attached to a pressure transducer for continuous ICP recording. The probe was 
secured to the skull with cyanoacrylate glue to avoid leakage. The correct 
position of the ICP probe within the ventricle was confirmed by the presence of 
CSF pulsation within the catheter. Prior to ICP recording, pressure transducers 
were calibrated with a Sphygmomanometer and the ICP waveform signal was 
confirmed by response to abdominal compression, ensuring clear cardiac and 
respiratory waveforms were visible. 
 
Figure 3-2. ICP recording from a rat. (A) Picture from the surgical procedure. The ventricular 
probe has already been placed and connected to the transducer to verify patency. (B) 
Illustration of location of the ICP and CSF probe on the rat skull. (C) ICP waveform signal 
was confirmed by clear cardiac and respiratory waveforms were visible. (D) In the case of 
post stroke rats, the coordinate needs to be adjusted slightly to accommodate any brain 
swelling. This can be achieved by acquiring T2 weighted MRI scans and then matching the 
T2 weighted slice with corresponding atlas slide. The coordinates will be adjusted to 
accommodate any brain swelling.  
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3.1.4.3 Cisterna magna cannulisation for MRI study 
For MRI tracer infusion studies, all anaesthetised animals were transferred to a 
stereotaxic frame where the head was secured with ear and tooth bars. The 
head was tilted (45 degrees, snout down), and a midline skin incision was made 
to expose the dura mater overlying the cisterna magna space. A cisterna magna 
(CM) cannula (22-gauge PEEK, SAI, RCMC-01) connected to a closed-end PE10 
tube (2.5 cm long, 0.28 mm ID × 0.61 mm OD, Braintree Scientific) loaded with 
artificial CSF (aCSF: NaCl 140 mmol/L, KCl 3 mmol/L, NaH2PO4 12 mmol/L, 
NaHCO3 18 mmol/L, CaCl2 2.5 mmol/L, pH 7.4) was advanced 2 mm into the 
intrathecal space and secured with cyanoacrylate glue to avoid leakage (see 
Figure 3-3). Finally, the skin and muscle incisions were sutured closed.  
 
 
Figure 3-3. CM cannula position.(A) and (B) An example of incorrect CM cannula position. 
(C) cannula was correctly advanced into the cisterna magna. 
In the early development experiments, a dye (0.5% in desired solutes) was added 
to the aCSF, to help in confirming the correct position of CM catheter. At the 
end of each experiment the brain was carefully dissected out of the skull and 
the flow of solutes was confirmed by visualising the movement of the dye along 
penetrating vessels on the surface of the rat brain. However, it was noticed that 
because of the iron content of the dye, it also acted as a weak paramagnetic 
contrast agent, causing an increase in T1 weighted signal. In addition, the dye 
decreased transverse relaxation times, resulting in signal loss in T2 weighted 
image (see Figure 3-4). In later experiments, the dye was not employed and the 
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correct position of the CM catheter within the cisterna magna space was 
confirmed by the presence of CSF pulsation within the catheter.  
 
Figure 3-4. Blue dye effect on T2 weighted images.  
 
3.1.5 Physiological monitoring  
Throughout the period of anaesthesia, a number of physiological parameters 
were monitored regularly, controlled and recorded at regular intervals. Body 
temperature was continuously monitored throughout surgery and MRI procedures 
with a rectal thermocouple (Thermalert TH-5, Physitemp) and maintained at 37 
± 0.5°C using homeothermic blanket (Harvard) and external heat lamp. The 
femoral artery was cannulated with PE-50 tubing for continuous monitoring of 
arterial blood pressure and heart rate (Biopac Systems, MP100). Arterial blood 
pressure values were acquired and monitored by connecting the femoral artery 
catheter to a blood pressure transducer which was linked to an MP150 Biopac 
system (Biopac systems Inc, USA).The “Acknowledge” software (Biopac systems 
Inc, USA) was used to acquire and present the mean arterial blood pressure 
(MAP) along with ICP and cerebral prefusion pressure (CPP) on a computer 
monitor. For the measurement of arterial blood gases and pH, a blood sample 
(~100μl) was withdrawn from the femoral artery cannula into a glass capillary 
tube and the tube was immediately taken to the blood gas analyser (Rapidlab 
248/348, Siemens). The blood gas analyser adjusted the blood gas and pH values 




Figure 3-5. Example of continuous ICP, BP, and CPP measurements from an individual rat. 
 
3.1.6 Animal recovery from surgery 
At the end of pMCAO procedures in Chapter 4, where rats were recovered from 
surgery for 24 hours, the arterial cannula was removed and the small incision in 
the artery was closed overusing diathermy forceps. The wound was closed using 
4-0 suture. The isoflurane concentration was decreased to 0% and the rats were 
ventilated with 100% oxygen until they became responsive to foot pinching and 
started to breathe without the ventilator. At this point the rat was disconnected 
from the ventilator and the intubation tube was removed. The rat was 
supplemented with 50% oxygen via a facemask until breathing became steady 
and the animal started to regain consciousness. Then, the rat was transferred to 
a clean cage lined with soft absorbent pads, containing softened food and water. 
The cage was transferred to a recovery room maintained at ~25°C during the 
recovery period, the rat was closely monitored for at least 2 hours post-surgery 






3.2 MRI image pre-processing steps 
All MRI data in this thesis were acquired using a Bruker Pharmascan 7T/16 cm 
system controlled by Paravision 5.1 software (Bruker BioSpin, Ettlingen, 
Germany). The system had a gradient coil insert (internal diameter = 90 mm, 
300 mT/m) and a four-channel phased-array surface receive coil used for rat 
brain imaging.  
MRI data were processed using Matlab code developed in-house (Matlab R2018a, 
MathWorks Ltd., U.K.). All acquired MRI data in Chapters 6, 7 and 8 underwent 
several correction and pre-processing steps, which are summarized in Figure 3-6.  
 






3.2.1 Retrieve and rescale MRI Data  
All acquired MR images were exported as DICOM files. Before starting any post-
processing steps, image data were rescaled, as necessary, to the original 
intensity measurements using the Bruker format files. To do this, the image data 
were multiplied by the scaling factor, called Reco_Map_Slope, for each time 
point for each subject. 
3.2.2 Resizing MRI images  
In the current work, different MRI weighted images were acquired with different 
slice thickness. For example, the slice thickness of the T2 weighted images was 
1.5 mm, while the 3D T1 weighted images was about 0.23 mm (Figure 3-7). In 
order to accommodate these variabilities in slice thickness, a protocol was 
developed to register and stack multiple T1 weighted image slices to reflect the 
imaging slice thickness of the T2 weighted images. A similar approach was used 
when 3D T1 weighted images were compared with T1 mapping images, which had 
a 2mm slice thickness.  
 
Figure 3-7. MRI image slice thickness adjustment. (A) Four evenly distributed T1 weighted 
sagittal slices (0.23 mm) were selected from near midline at the level of the aqueduct to 
cover the 1.5 mm thickness of theT2 weighted scans (B).  
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3.2.3 Brain extraction 
Skull-stripping (or brain extraction) usually results in a binary brain mask of an 
MR image after removal of non-brain structures. In this work, all MR images were 
manually masked to separate the brain from non-brain tissues and, therefore, to 
reduce the computational complexity of the subsequent processing. In addition, 
the deformation of the non-brain tissues during the experiment affects proper 
co-registration of the volumes (see Figure 3-8).  
 
Figure 3-8. Schematic representation of brain extraction steps. The left image shows the 
original MRI image. This is multiplied by a manually drawn binary mask encompassing the 








3.2.4 Motion correction  
The small signal changes due the presence of the H217O tracer (~ 2-10 %), can be 
obscured by the apparent signal differences that can result from subject 
movement. To minimise subject motion, the rat was fixed in the cradle with 
both a tooth bar and ear bars. Because head movement in the scanner cannot be 
completely eliminated, retrospective motion correction was performed as a pre-
processing step. This is especially important for long experiments, as is the case 
in the current thesis (> 80 minutes), where the animal's brain can sometimes 
move during the experiment. For each animal, head motion was compensated by 
rigid-body alignment of each post-contrast image to the first time point of the 
pre-contrast image (Figure 3-9).  
 
Figure 3-9. Visual assessment before and after T2 weighted MR image co-registration. (A) 2D 
histogram of two overlapping images before co-registration. (B) 2D histogram of two 
overlapping images after co-registration using rigid transformation. In the overlapping 
images, grey areas correspond to areas that have similar intensities, while magenta and 
green areas show places where one image is brighter than the other. There is a noticeable 





3.2.5 Image smoothing  
Filtering techniques have the advantage of reducing the noise without affecting 
the acquisition process. There are number of common approaches that reduce 
the amplitude of noise fluctuations, but most of these methods also degrade 
sharp details such as lines or edges (Ming Zhang and Gunturk, 2008). In the 
current work, filtering methods were used, such as median filter and anisotropic 
diffusion filter techniques to remove noise and retain the edges in the image 
(Figure 3-10).  
 
Figure 3-10. Filtering results for one slice of MRI dataset. (A) T2 weighted image before 
applying filter along with (B) a line profile plot of the signal intensity (line shown in blue). (C) 
T2 weighted image after applying anisotropic diffusion filter along with (D) a line profile plot 






3.2.6 Common spatial space 
To maintain the same spatial position/orientation and reduce variability 
between animals, one animal was selected from each group as the reference 
against which all the other animals’ images within the same group were aligned. 
To that end, each rat brain was aligned to the reference animal using an affine 
registration algorithm. All transformed MR images, including the baseline and 
contrast-enhanced scans, were averaged to create a template image with high-
contrast. This image was manually segmented into multiple regions of interests 
(ROIs) for further analysis (see Figure 3-11). 
 
Figure 3-11. Schematic diagram illustrating the processing steps to acquire common spatial 
registration of all images and subsequent segmentation. First, for each rat all post-contrast 
images were registered to a baseline image using a rigid transformation process. Then, 
images were co-registered for each individual rat using an affine transformation process. 







4 Chapter 4: CSF outflow resistance, the possible 1 
mechanism responsible for ICP elevation 2 
following ischaemic stroke 3 
4.1 Introduction 4 
Early neurological deterioration (END) can occur within the first 24-48 hours 5 
following acute ischaemic stroke, with prevalence being relatively common 6 
(>14%), and is strongly associated with poor outcome (Seners and Baron, 2018). 7 
END was defined as an increase in the National Institutes of Health Stroke Scale 8 
(NIHSS) score of > 4 points within the first 24 hours after admission (Seners et 9 
al., 2015). Although some cases of END have a straightforward cause, such as 10 
symptomatic intracranial haemorrhage and malignant oedema, approximately 11 
~2/3 of cases remain unexplained (Seners et al., 2015). These unexplained END 12 
cases are associated with persistent proximal occlusion, large diffusion-perfusion 13 
mismatch, and diffusion weighted imaging lesion growth beyond the initial 14 
ischaemic penumbra (Hsu et al., 2015).  15 
Several mechanisms have been proposed, involving either compromised 16 
hemodynamic or other tissue-based mechanisms. Suggested mechanisms based 17 
on compromised hemodynamic include thrombus extension (Tisserand et al., 18 
2014), collateral failure (Beard et al., 2015), and reduced mean arterial pressure 19 
(Kjeldsen and Berge, 2015). Other tissue-based mechanisms have included 20 
excitotoxicity (Castillo, Dávalos and Noya, 1997), inflammation (Vila et al., 21 
2003), hyperthermia (Audebert et al., 2004), oedema (Frank and Frank, 2011), 22 
hyperglycaemia (Seners et al., 2015), and hypoxia (Read et al., 2000). Although 23 
these mechanisms may make some contribution, there is a lack of strong 24 
evidence associating them with END.  25 
An intriguing alternative mechanism has recently been proposed suggesting that 26 
elevated ICP, resulting in reduced collateral flow and cerebral perfusion, may be 27 
responsible for unexplained END (Gaberel et al., 2012). However, the 28 
mechanism for this rise in ICP is currently unknown. Conventionally, only 29 
patients with large malignant strokes are considered to be at risk of elevated 30 
ICP, due to space occupying vasogenic oedema within the closed cranial 31 
compartment (Schwab et al., 1996). This logic has been extended to infer that 32 
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ICP does not become elevated in cases of smaller, non-malignant strokes, since 1 
there is little or no vasogenic oedema. However, we can find no evidence in the 2 
clinical literature to support this broad assumption, presumably because the 3 
risks associated with invasive ICP measurement prevent its use. This assumption 4 
is also contradicted by recent animal experiments, which show dramatic 5 
increases in ICP occurring around 24 hours after stroke onset, even following 6 
small strokes where there is little or no vasogenic oedema (Murtha et al., 2015). 7 
This evidence leads us to hypothesize that a mechanism, other than oedema, is 8 
responsible for ICP elevation in these cases. Inspection of a mathematical model 9 
of ICP indicates that changes in the CSF dynamics may be responsible for the 10 
observed increases in ICP post-ischaemic stroke (Mann et al., 1978; Marmarou, 11 
Shulman and Rosende, 1978). Therefore, in the present study, we have 12 
investigated the relationship between CSF dynamics, vasogenic oedema, and ICP 13 














4.2 Methods 1 
4.2.1 Surgical procedure 2 
Male Wistar Kyoto (WKY) rats (350 to 400 g, 22 to 26 weeks old) were initially 3 
anesthetised (5% isoflurane in 30:70 O2/NO2 mixture) in an induction chamber, 4 
then intubated, and artificially ventilated (with 2-3% isoflurane in 30:70 O2/NO2 5 
mixture at flow rate 1-2 L/min). Animals were randomly allocated to either a 6 
permanent middle cerebral occlusion group (pMCAO, n=8) or a sham surgery 7 
group (sham, n=6). Permanent occlusion of the left MCA was performed as stated 8 
in Chapter 3, section 3.1.4.1. For sham group rats, surgery to reveal the MCA 9 
was carried out but the artery was not occluded. Immediately following surgery, 10 
rats were transferred to the MRI scanner and diffusion weighted imaging (DWI) 11 
was conducted to assess baseline lesion volume. Rats were then recovered from 12 
the anaesthesia and, 24 hours after surgery, re-anaesthetised for assessment of 13 
final infarct volume using T2 weighted MRI. The animal was then transferred into 14 
the surgery room for ICP measurements. The experimental protocol is shown 15 
schematically in Figure 4-1. 16 
4.2.2 Magnetic Resonance Imaging and Analysis  17 
A pilot MRI T2 weighted sequence was first acquired to determine the correct 18 
geometry. A DWI scan (4-shot, spin-echo, EPI) was performed 30 minutes after 19 
MCAO allowing quantitative apparent diffusion coefficient (ADC) maps to be 20 
produced (TE = 22 ms, TR = 4,000 ms, matrix = 96 x 96, field of view = 25mm x 21 
25 mm, three directions (x, y, and z), b values = 0 and 1,000 s/mm2, eight 22 
coronal slices, and 1.5 mm thickness). A T2 weighted (RARE) scan was performed 23 
to assess infarct volume at 24 hours (TE = 46.6 ms, TR = 5,000 ms, RARE factor 8, 24 
averages 2, matrix 256 × 256, FOV 3.0 cm × 3.0 cm, 8 slices, and 0.75 mm 25 
thickness). 26 
4.2.3 ICP measurement and CSF infusion 27 
Following MRI scanning at 24 hours post-MCAO or sham surgery, rats were re-28 
anesthetised (5% isoflurane in 30:70 O2/NO2 mixture) and transferred to a 29 
stereotaxic frame where the head was secured in ear and tooth bars. ICP probe 30 
was placed in the ipsilateral ventricle and attached to a pressure transducer for 31 
4 85 
 
continuous ICP recording as described in Chapter 2, section 3.1.4.2. CSF catheter 1 
was inserted into the contralateral lateral ventricle and secured to the skull with 2 
cyanoacrylate glue, then connected to an infusion pump (Graseby /3150 Syringe 3 
Pump). CSF dynamics were probed via a steady-state infusion method, involving 4 
stepwise increases in the intracerebroventricular infusion of artificial 5 
cerebrospinal fluid (aCSF) (Hussey, Schanzer and Katzman, 1970). The baseline 6 
ICP pressure was monitored for 30 minutes before starting infusion of aCSF. The 7 
infusion rate was adjusted incrementally (1.67, 3.33, 5.00, 8.30, 11.67, 16.67, 8 
25.00 and 33.3 μL/min), with 4-6 minutes allowed for a steady-state ICP to be 9 
established after each increase (see Figure 4-2). During the infusion experiment, 10 
mean arterial pressure (MAP), CPP and ICP were continuously monitored in all 11 
rats. Blood gases (pH, partial pressure of oxygen (PaO2), carbon dioxide (PaCO2)) 12 
was measured before and after the infusion as described in chapter 3.  13 
4.2.4 Mathematical modelling 14 
Marmarou and colleagues developed a mathematical model of the CSF/ICP 15 
system (Marmarou, Shulman and Rosende, 1978). Here we have extended their 16 
steady-state case to include growth in brain oedema. In the closed cranial 17 
cavity, steady-state ICP exists when rates balance. 18 
 𝐐𝒑𝒓𝒐𝒅  + 𝐐𝒐𝒆𝒅𝒆𝒎𝒂 = 𝐐𝒂𝒃𝒔 (4-1) 
Where, Q𝑝𝑟𝑜𝑑 is the rate of CSF production and Q𝑜𝑒𝑑𝑒𝑚𝑎 is the rate of oedema 19 
growth. Assuming the rate of CSF absorption across the arachnoid villi, Q𝑎𝑏𝑠, is 20 
proportional to the corresponding pressure drop ∆P= PICP – Pss. the venous sagittal 21 
sinus pressure Pss is small (∆P ≅ PICP), with aCSF outflow resistance, R, gives: 22 
 
 
𝐏𝑰𝑪𝑷 = 𝐑𝐐𝒂𝒃𝒄 = 𝐑(𝐐𝒑𝒓𝒐𝒅 + 𝐐𝒐𝒆𝒅𝒆𝒎𝒂) 
 
(4-2) 
In the case of the steady state infusion experiments, as the rate of infusion of 23 
aCSF is greater than (Q𝑝𝑟𝑜𝑑 +  Q𝑜𝑒𝑑𝑒𝑚𝑎), this becomes: 24 
 ∆P𝐼𝐶𝑃 = RQ𝑎𝑏𝑐 ≅ RQ𝑖𝑛𝑓 +  c (4-3) 
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where Q𝑖𝑛𝑓 is the rate of infusion of aCSF. It can be seen from equation (4-3) 1 
that the CSF outflow resistance is then obtained from the slope of the plot of 2 
∆P𝐼𝐶𝑃 vs Q𝑖𝑛𝑓.  3 
4.2.5 Data Analysis 4 
Quantitative ADC maps, in units of square millimetres per second, were 5 
calculated from the Stejskal-Tanner equation using Image J software 6 
(http://rsb.info. nih.gov/ij/). A 23% reduction in mean contralateral ADC was 7 
used to determine ischemia lesion volume from the multi-slice ADC maps (Figure 8 
4-3) (Gerriets et al., 2004). Infarct volume was determined at 24 hours from T2 9 
weighted images by manual tracing of the hyperintense lesion area on each slice 10 
(Figure 4-4). This was then summed and multiplied by the slice thickness. The 11 
oedema-corrected lesion volume (LVe) and the space occupying effect in 12 
percent of oedema uncorrected lesion volume (SE) were calculated from 13 
equations derived by Gerriets (2004): 14 
 





 SE = LV𝑢 − LV𝑒 (4-5) 
HVi and HVc refer to the volumes of the ipsilateral and contralateral 15 
hemispheres, respectively. LVu represents the uncorrected lesion volume as 16 
delineated on the T2 weighted images. All volumetric measurements were 17 
performed independently by two independent investigators. To examine 18 
interobserver reproducibility, investigator 2 determined infarct and oedema 19 
volumes on the same images and the calculated values were compared with the 20 
results obtained by investigator 1. Any cases with >10% discrepancy was flagged 21 
for review. 22 
4.2.6 Impact of aCSF infusion on oedema size  23 
To ensure that infusion of aCSF does not contribute to the development of brain 24 
oedema, a pilot experiment was conducted with the same infusion rates and 25 
durations used in the original experiments. An MRI compatible catheter was 26 
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inserted into the cisterna magna via Dural puncture and placement was 1 
confirmed by the presence of CSF pulsation within the catheter. The catheter 2 
was secured in place with cyanoacrylate glue and connected with peristaltic 3 
infusion pump. Following surgery, the rat was transferred to the MRI scanner, 4 
where it stayed for the whole duration of the experiment. The rat was fixed into 5 
position with ear bars and a tooth bar, preventing any motion of the head. An 6 
initial T2 image was then acquired. Next, aCSF was infused, with the rate of 7 
infusion increased in steps manner similar to infusion rates and durations as used 8 
in the original experiments (Figure 4-10). T2 images were acquired at each 9 
infusion rate. At the end of the experiment, Gadolinium based tracer (Gd-DTPA) 10 
was infused, and a T1 weighted MRI scan was obtained to confirm that the 11 
catheter was held in place during the entire infusion study. 12 
4.2.7 Impact of increased ICP on collateral flow  13 
Following the induction of pMCAO, the rat (n=2) was returned to the stereotaxic 14 
frame with its head was secured by a tooth and ear bars. A cisterna magna (CM) 15 
catheter was inserted for aCSF infusion and ICP monitoring as described in 16 
Chapter 2, section 3.1.4.3. The catheter was connected with peristaltic infusion 17 
pump. A femoral arterial line was placed by surgical cutdown for continuous 18 
arterial blood pressure. For Laser speckle contrast imager (LSCI) imaging, the 19 
surface of the skull was exposed and thinned to ensure adequate transparency, 20 
hence signal during imaging. Real time changes in cortical blood flow were 21 
recorded by the LSCI (PeriCam PSI HD system, Perimed, Stockholm, Sweden), 22 
which is sensitive to the motion of intravascular red blood cells. The 23 
experimental protocol consisted of a baseline recording started at 30 minutes 24 
from the onset of stroke and continued until 2 hours post-MCAO. Then, ICP was 25 
increased by infusion of aCSF into cisterna magna of a rat. The infusion rate was 26 
increased in a stepwise manner, until the change of ICP reached 30 mmHg, with 27 
no significant change in arterial blood pressure (see Figure 4-11).  28 
4.2.8 Statistical analysis  29 
A sample size calculation was performed using pilot data (G*Power v.3.1.3 30 
software) (see Figure 4-5), which estimated that six animals per group were 31 
required to detect a 60% difference in CSF outflow resistance and 6 mmHg 32 
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difference in ΔICP between the sham and pMCAO groups with standard settings 1 
of alpha 0.05, power 0.8 (Erdfelder, 2007). Students t-tests were performed on 2 
physiological parameters for illustrative purposes to highlight changes between 3 
pMCAO and sham rats. Mann–Whitney U-tests were performed to compare mean 4 
ICP and CSF resistance values between sham and post-stroke groups. Spearman’s 5 
correlation analysis was used to determine the correlation between ICP and 6 
oedema volume, infarct volume and CSF resistance. For the CSF infusion test, 7 
statistical analysis was performed with the Wilcoxon signed-rank test on ICP, 8 
MAP, and CPP to detect differences between each infusion step point and 9 
baseline values. Data are presented as mean ± standard deviation unless 10 













Figure 4-1. Experimental protocol. Immediately following pMCAO, rats underwent baseline 2 
MRI scanning for assessment of lesion volume and brain volume measurements. Rats were 3 
then recovered from anaesthesia and at 24 hours after MCAO, T2 weighted MRI was carried 4 
out for infarct volume and oedema measurements. Following MRI scanning, rats then 5 












Figure 4-2. An example ICP recording as a function of time during a continuous infusion of 2 
aCSF. (A) Baseline ICP recording before starting infusion of aCSF. (B) Infusion rates were 3 
increased incrementally, and steady-state pressures were established (black line) at each 4 
infusion rate before increasing the infusion rate to the next level. (C) Relaxation phase; After 5 
infusion is stopped, ICP relaxes back to the initial baseline. (D) Mean pressure is plotted as 6 
a function of flow rate for infusion level. The initial slope of this curve constitutes the CSF 7 













Figure 4-3. Representative ADC map at 30 minutes after MCAO (n=6). The area of 2 
hypointensity of the ADC map is representative of ischaemic lesion. 3 
 4 
 5 
Figure 4-4. Representative T2 weighted images 24 hours after MCAO (n=6). The area of 6 



















Figure 4-5. Pilot experiments were conducted on two rats, one after sham (N=1) and another after 




4.3 Results 1 
4.3.1 Exclusion criteria 2 
A total of 17 Wistar Kyoto (WKY) rats were used in this series of experiments. 3 
Two animals in the MCAO group were excluded due to technical problems (CSF 4 
leaks, unstable BP and death). Hence, 15 animals were available for data 5 
analysis: Sham (n=6), MCAO (n=6), LSCI (n=2), and aCSF + MRI (n=1).  6 
4.3.2 ICP and Physiological variables 7 
ICP oscillation with pulse pressure and respiration was detected in all 8 
experiments (Figure 4-6A). Median ICP at baseline in the pMCAO group at 24 9 
hours (18.6 ± 5.84 mmHg) was demonstrated to be significantly greater than the 10 
sham group (6.01 ± 0.56 mmHg) (p=0.002) (Figure 4-6B). Physiological variables 11 
before and after infusion of aCSF are shown in Table 4-1. MAP was slightly lower 12 
at baseline in the pMCAO rats compared with the sham operated rats, however, 13 
this difference was not statistically significant. CPP (MAP – ICP) was significantly 14 
lower at baseline in pMCAO rats compared with the sham operated rats (65 ± 10 15 
mmHg vs. 89 ± 8 mmHg, p = 0.049). There were no statistically significant 16 
differences between groups for intra-operative physiological indices with the 17 
exception of PaCO2 (Table 4-1).  18 
4.3.3 Oedema and Infarct volume vs. ICP 19 
Mean oedema volume was 128.4 ± 19.3 mm3 (range 100-146 mm3) at 24 hours 20 
post-MCAO. The growth rate of oedema formation (0.09 ± 0.01 mm3/min) was 21 
estimated by dividing the oedema volume by 1,440 minutes (i.e. 24 hrs). Mean 22 
oedema-corrected infarct volume was 342.5 ± 65 mm3 (range 225–397 mm3). 23 
There was no significant correlation between mean ICP at 24 hours and infarct 24 
volume (R2 = 0.09, p = 0.5) or oedema volume (R2 = - 0.03, p = 0.5) (Figure 4-7A 25 




4.3.4 ICP response to aCSF infusion 1 
The time course for MAP, CPP and ICP changes after aCSF infusion in both pMCAO 2 
and sham groups is shown in Figure 4-8. After the start of aCSF infusion, ICP 3 
increased significantly (p < 0.001 for all time points) in both the pMCAO and 4 
sham group. Figure 4-9A shows how the steady state ICP changed from baseline 5 
(ΔICP) increases with increasing infusion rate. For both groups, plotting ΔICP 6 
versus infusion rate resulted in a linear relationship, in confirmation of equation 7 
(4-3). At the end of infusion, ICP dropped to the initial baseline value. 8 
4.3.5 CSF outflow resistance 9 
CSF outflow resistance was calculated for each animal, as in equation (4-3), 10 
from the initial slope of the ΔICP vs infusion rate plots, for infusion rates 11 
between 0 and 11.67 μL min-1 (Figure 4-9B). The mean CSF outflow resistance 12 
measured for the pMCAO group (2.27 ± 0.15 mmHg.μL-1.min) was significantly 13 
greater than in the sham operated rats (0.93 ± 0.06 mmHg.μL-1.min) (p = 0.002) 14 
(Figure 4-9C). A significant relationship was found between CSF outflow 15 
resistance and baseline ICP measured at 24 hours, using both pMCAO and sham 16 
rats (R2 = 0. 85, p < 0.0001) (Figure 4-9D). 17 
4.3.6 CSF production rate 18 
Linear regression of the initial ICP versus infusion rate data to zero ICP (Figure 19 
4-9A) allowed an indirect estimation of CSF production rate, indicating no 20 
significant change in CSF production rate following stroke (1.4 ± 1.54 µL/min ) 21 
compared to sham controls (1.9 ± 1.49 µL/min) (p = 0.6). 22 
4.3.7 Impact of aCSF infusion on oedema size in a single rat 23 
experiment  24 
Figure 4-10 shows the T2 images acquired before and during aCSF infusion. There 25 
was no change in the T2 image with infusion. To show this more clearly, Figure 26 
4-10 shows enlarged T2 weighted images, from before the start of infusion 27 
(Figure 4-10A) and the final T2 image measured at an infusion rate of 33.3 28 
μL/min (Figure 4-10B). Between the initial and final T2 images, ~441 µL of aCSF 29 
was infused over 40 minutes. With a simple visual inspection, there is no change 30 
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between any of the T2 images. This fact is strongly highlighted in Figure 4-10C, 1 
which shows the subtraction of the two images (T2/initial - T2/final). This clearly 2 
shows there was no change in the region of hyperintense T2 signal (infarct) 3 
between the initial and final images or, indeed, any changes in the brain. To 4 
highlight this further, Figure 4-10D shows the same subtraction image, but with 5 
the contrast greatly increased to show the actual image noise. Figure 4-10D very 6 
strongly highlights that there was no change whatsoever in T2 hyperintense 7 
regions (i.e. oedema volumes), caused by infusion of aCSF. If there was any 8 
change between the initial and final T2 images due to infused aCSF increasing 9 
oedema volume, the subtraction map would show this. Thus, we conclude that 10 
ICP is not being affected by increased oedema volume. 11 
4.3.8 Impact of increased ICP on collateral flow  12 
Following pMCAO, LSCI showed that cortical perfusion was significantly 13 
decreased in the ipsilateral hemisphere compared to the contralateral 14 
hemisphere and perfusion recovery occurred at 2 hours from ischaemia onset. 15 
Progressive elevation of ICP above baseline resulted in progressive reduction of 16 
cortical perfusion in the ipsilateral hemisphere (see Figure 4-11). The current 17 
observation suggested that artificially increase of ICP result in a reduction in 18 













Figure 4-6. Example ICP recording from a rat at baseline following sham surgery. (A)The 3 
respiratory and cardiac pulses can be clearly visualised in the oscillations of the ICP 4 
waveform. (B) Median Intracranial pressure (ICP) measured at baseline, prior to infusion, in 5 
WKY rats at 24 hours following sham surgery or pMCAO. Baseline ICP was significantly 6 
















Physiological parameters  Pre- infusion  Post- infusion 
MAP (mmHg) Sham  95 ± 8.8 94 ± 10 
Stroke 84.4 ± 11 82± 17 
CPP (mmHg) Sham 89±8 88±7 
 Stroke 65±8* 67±7 
PaO2 (mmHg) Sham 182 ± 25 174 ± 22 
Stroke 160 ± 35 145 ± 32† 
PaCO2 (mmHg) Sham 32 ± 4 36.7 ± 8 
Stroke 36.3 ± 6* 52.1 ± 10 
Temp (°C) Sham 36·8 ± 0·3 36·9 ± 0·5 




Sham 7.64 ± 0.3 7.7 ± 0.4 
Stroke 7.43± 0.6 7.5± 0.3 
   
Table 4-1. Values for median MAP, PaCO2, PaO2, pH and temperature following stroke or 2 








Figure 4-7. Intracranial pressure (ICP) versus infarct volume and cerebral oedema volume all 2 
measured 24 hours after pMCAO. No significant correlation of ICP baseline prior to infusion 3 
in MCAO treated rats, with infarct volume or oedema volume was seen in this study. (A, B) 4 













Figure 4-8. Change in ICP, CPP, and MAP following stepwise infusion of aCSF into the 2 
contralateral ventricle. (A) In sham operated rats, infusion of CSF resulted in an increase in 3 
ICP, little change in MAP and an associated decrease in CPP at higher infusion rates. (B) In 4 
rats at 24 hours following pMCAO, ICP increased significantly with a marked drop in CPP (*) 5 

















Figure 4-9. CSF outflow resistance. (A) Scatter plot graph of the correlation between ΔICP 2 
and aCSF infusion rate in both pMCAO and sham animals. (B) Linear relation between ΔICP 3 
and low infusion rates in and sham group. (C) Individual CSF outflow resistance in pMCAO 4 
or sham animals. CSF outflow resistance in the pMCAO group was significantly greater than 5 
that of the sham group (p = 0.002). (D) Illustrates a significant positive correlation between 6 












Figure 4-10. MRI investigation of the effect of aCSF infusion over oedema size. (A) T2 2 
weighted image acquired before aCSF infusion (T2/initial). (B) T2 weighted image acquired 3 
after aCSF infusion (T2/final). (C) Subtracted image derived from subtraction of the two 4 
images (T2/initial - T2/final). (D) Subtracted image with higher contrast level (noise level). This 5 










Figure 4-11. Collateral blood flow map from cortical surface of two rats. (A) Following 2 
pMCAO, cortical perfusion was significantly decreased in the ipsilateral hemisphere 3 
compared to the contralateral hemisphere. (B) 2 hours post pMCAO, cortical perfusion 4 
recovered in the ipsilateral hemisphere of rat. (C) Artificial elevation of ICP (Pressure 5 
change ≈ 30 mmHg) reduces the recovered cortical perfusion in the ipsilateral hemisphere 6 
















4.4 Discussion 2 
It is conventionally assumed that ICP elevation post-stroke is the result of 3 
cerebral vasogenic oedema within the closed cranial compartment. 4 
Consequently, only patients with large malignant strokes and significant levels of 5 
brain oedema are assumed to be affected by intracranial hypertension. Though 6 
this view has persisted over several decades, no evidence can be found in the 7 
clinical literature to support this broad assumption, presumably because the 8 
risks associated with invasive ICP measurements have precluded their use in the 9 
vast majority of stroke patients. Recently this assumption has been challenged 10 
by animal experiments, which show ICP can become substantially elevated at 24 11 
hours post stroke, even following small ischaemic strokes (sub-cortical lesions) 12 
where there is little or no ‘space occupying’ oedema. Further, these previous 13 
studies found no correlation between oedema volume and baseline ICP at 24 14 
hours post-stroke (Kotwica and Persson, 1991; Murtha et al., 2015). Data from 15 
the present study support these findings and also show an absence of correlation 16 
between oedema volume and baseline ICP in the pMCAO group (Figure 4-7) 17 
(Spearman correlation R2 = - 0.03, p = 0.5). However, since the study’s power 18 
calculations were based on CSF outflow resistance pilot data, the sample size 19 
used in our experiment (n=6) is likely underpowered with regard to definitively 20 
determining a lack of correlation.  21 
It has previously been proposed that increases in ICP in the first 24 hours post-22 
ischaemic stroke may provide an explanation for patients suffering a progressive 23 
stroke or unexplained END (Beard et al., 2015). The effect of increasing ICP on 24 
collateral flow has been recently demonstrated in rats, using fluorescent 25 
microspheres to quantify flow through individual pial collateral vessels (Gaberel 26 
et al., 2012). This showed progressive reductions in collateral flow with stepwise 27 
increases in ICP (up to 50% reduction in flow at 30mmHg). Consistent with these 28 
earlier studies, the current findings suggested even minor increases in ICP 29 
resulted in a decrease in the critical cerebral perfusion pressure (CPP) which is 30 
the driving pressure of the cerebral blood flow in the absence of autoregulation 31 
(Georgiadis et al., 2015). Although CPP is regulated by both MAP and ICP, it is 32 
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remarkable how little attention the ICP component has received (Lewis et al., 1 
2014; Georgiadis et al., 2015).  2 
In the current study, laser speckle experiments (n=2) were conducted to test the 3 
hypothesis that ICP elevation reduces collateral flow post stroke. Visual 4 
inspection of collateral flow in rat with experimental MCAO have shown a global 5 
reduction in collateral vessel flow within the penumbra territory, during an 6 
artificial ICP elevation (Figure 4-11). However, the use of LSCI comes with some 7 
limitations. One significant limitation to LSCI is the shallow penetration depth of 8 
the images. Because of the illumination and detection geometry, the detected 9 
photons sample only the superficial surface of the tissue, i.e. a few hundred 10 
microns of tissue (Davis, Kazmi and Dunn, 2014). As a result, most brain 11 
applications require removal of overlying tissues such as the skull. Moreover, 12 
LSCI does not provide  quantitative perfusion values owing to the undefined 13 
mathematical relationship between speckle contrast and blood flow velocity 14 
(Kazmi et al., 2015). Further, physiologic motion artifacts are a concern. In 15 
anesthetized animals, cardiac and respiratory motion can affect image quality 16 
adversely, exhibited by greater image noise and reduced spatial resolution 17 
(Kazmi et al., 2015).  18 
It has been suggested that any reductions in the already tenuous penumbral 19 
perfusion would be expected to impact penumbral survival, leading to late 20 
infarct expansion and END. Indeed, collateral failure has been associated with 21 
infarct growth and has been proposed as a potential mechanism of unexplained 22 
END (Thanvi, Treadwell and Robinson, 2008). In support of this, recent clinical 23 
imaging studies have shown infarct growth beyond the initial penumbra and the 24 
occurrence of “new DWI lesions” at day 7 post-stroke, outside the initial area of 25 
hypo-perfusion (Alawneh et al., 2011). In addition, there have been numerous 26 
rodent studies of both permanent and transient MCAO which have shown infarct 27 
volume expanding beyond 24 hours (Roehn et al., 1995; McGarry et al., 2017).  28 
This raises the important question: if not oedema, what mechanism is 29 
responsible for the substantial ICP elevations seen at 24 hours post-ischaemic 30 
stroke? Inspection of the steady-state model of ICP (equation (4-2)) shows ICP is 31 
dependent upon CSF outflow resistance, the rate of CSF production and the rate 32 
of oedema growth. In confirmation of the mathematical model (equation (4-3)), 33 
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a linear relationship was found between the increase in ICP above baseline 1 
(ΔICP) and the infusion rate of aCSF (Figure 4-9A) for both pMCAO and sham 2 
groups. Measured values of CSF outflow resistance for the sham group (0.93 ± 3 
0.06 mmHg.μL-1.min) were consistent with previous measurements for rats, 4 
which ranged from 0.5 to 1.8 mmHg.μL-1.min (Kida, Pantazis and Weller, 1993; 5 
Nagra et al., 2010). 6 
For the first time, the current findings have shown that CSF outflow resistance 7 
increases significantly at 24 hours post-pMCAO compared with a sham operated 8 
group (Figure 4-9C). This more than a two-fold increase in CSF outflow 9 
resistance following ischaemic stroke and is of a similar magnitude to increases 10 
previously encountered in studies on hydrocephalic rats (Jones and Bucknall, 11 
1987). Further, for the first time, a significant correlation was found between 12 
the baseline ICP at 24 hours post-pMCAO and the value of CSF outflow resistance 13 
(Figure 4-9D).  14 
The slow rate of CSF production is difficult to measure, with an estimate of the 15 
rate being made by extrapolating the initial ICP versus infusion data back to zero 16 
ICP. For the sham operated group this gave the rate of CSF production as 1.9 ± 17 
1.49 µL/min, slightly lower than comparable data found in the literature (3.7 ± 18 
0.1 µL/min) measured using a ventriculo-cisternal perfusion technique 19 
(Orešković and Klarica, 2014). The rate of CSF production did not significantly 20 
change in the pMCAO group (1.4 ± 1.54 µL/min) compared to the sham group 21 
(1.9 ± 1.49 µL/min) (p=0.6). Moreover, in the pMCAO group, the rate of oedema 22 
growth (0.09±0.01 µL/min) was found to be small compared with rate of CSF 23 
production. Taken together, these results indicate the ICP elevation seen at 24 24 
hours post-pMCAO was primarily driven by increased CSF outflow resistance 25 
rather than an increased rate of CSF production or oedema growth.  26 
A progressive increase in ICP can potentially lead to increased high-velocity 27 
microvascular shunt (MVS) flow which, in turn, promotes the development of 28 
brain oedema (Bragin, Bush and Nemoto, 2013). In Figure 4-9A, there is evidence 29 
that the slope of the ICP versus infusion rate data changes above 11.7 μL min-1. 30 
To avoid this complication, CSF resistance (i.e. the slope) was measured using 31 
only the lower infusion rate (low ICP) data, where the brain system has been 32 
least perturbed (Figure 4-9D). 33 
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In the current study, blood gases measured after infusion showed a noticeable 1 
(but not significant) increase in PaCO2 values in the stroke group compared with 2 
the sham group. Acute hypercapnia may lead to increased ICP, primarily through 3 
cerebral vasodilatation and increases in cerebral blood volume (Pollock et al., 4 
2009). To test whether the elevated PaCO2 encountered during the infusion 5 
experiment might affect the baseline ICP, we continued to measure ICP after 6 
infusion was stopped. Figure 4-2 shows, once the aCSF infusion is stopped, the 7 
ICP rapidly reduces, returning to its pre-infusion baseline level. This clearly 8 
indicates that the change in PaCO2 levels during infusion did not translate into 9 
an increase in baseline ICP in the current study.  10 
In the current study, the relationship between CSF resistance and ICP was 11 
investigated at 24 hours post permanent middle cerebral artery occlusion. These 12 
types of stroke models represent with a large infarct and oedema volume. 13 
Therefore, someone could argue that the presence of large infarct/oedema have 14 
influenced the current findings of Figure 4-9 (different slopes of ICP curves). 15 
However, we should emphasize that CSF resistance values were estimated based 16 
on the linear relationship between steady state ICP levels and infusion rate (see 17 
Figure 4-2). Based on the Davison model, steady state ICP will exist only when 18 
the rate of aCSF infusion equals the rate of absorption of CSF, and independent 19 
of compliance (oedema effect), where the rate of CSF outflow is proportional to 20 
the intracranial pressure (Davson, Domer and Holungsworth, 1973). Importantly, 21 
this is seen both in the MCAO group and in the sham group. Hence, oedema size 22 
could not be said to directly affect CSF dynamics and therefore steady state ICP. 23 
Yet, it may be wise to investigate the relation between CSF and ICP on variety of 24 
different occlusion periods and recovery times, which can influence the resulting 25 
lesions volumes. This would help to obtain a range in the size of infarct and 26 
oedema, which help to obtain a clearer picture of whether the relation between 27 
CSF resistance and ICP is exist following the reperfusion or not. 28 
In summary, these are important results as they demonstrate CSF outflow 29 
resistance, not oedema, is the mechanism responsible for ICP elevation 30 
approximately 24 hours post-ischaemic stroke. This suggests the possibility that 31 
intracranial hypertension may be occurring undetected in a much wider range of 32 
stroke patients than is currently considered, not just in patients with large 33 
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malignant strokes and significant levels of brain oedema. The results presented 1 
here, in conjunction with the work of Professor Sprat and colleagues ( Murtha et 2 
al., 2014; Beard et al., 2015; Wells et al., 2015) and Professor Baron (Seners and 3 
Baron, 2018), are consistent with the following mechanism behind unexplained 4 
END; First, following ischaemic stroke, changes in CSF dynamics, namely 5 
increased CSF outflow resistance, can result in a transient elevation of ICP at 6 
approximately 24 hours from stroke onset. Second, these increases in ICP then 7 
lead to a progressive reduction in collateral flow and cerebral perfusion in the 8 
occluded arterial territory. Third, the tissue that was initially asymptomatic 9 
(outside initial ischaemic core/penumbra) then becomes at risk and ultimately 10 
evolves into infarct, leading to delayed infarct expansion and END.  11 
Future work is needed to fully investigate the temporal changes in CSF dynamics 12 
following ischaemic stroke. Ischaemic stroke can be a major stressor in the 13 
physiology of brain cells, tissue, and fluid transport. This could lead to altered 14 
CSF secretion or drainage as an outcome of ischaemic stroke and, consequently, 15 
increased ICP since it plays a fundamental role in ICP regulation under normal 16 
circumstances. It appears likely that the increase in CSF outflow resistance in 17 
the pMCAO group found in this study, was the result of altering of one or more of 18 
these CSF absorption pathways. Recent work suggests that part of the CSF is 19 
recirculated into the brain via low resistance glymphatic systems on the surface 20 
of the brain that facilitate CSF circulation ( Iliff et al., 2012). In the context of 21 
neurological injury, glymphatic function appears to disturbed following 22 
ischaemic stroke (Gaberel et al., 2014). Dysfunction of the glymphatic 23 
circulation has not yet been recognised as a source of increased ICP, but the 24 
notion that perivascular space (PVS) provides a conduit for CSF influx prompted 25 
us to reassess this idea. To date, many aspects of CSF dynamics are still poorly 26 
understood, partly due to the difficulties involved in monitoring CSF flow. 27 
Hence, in the next Chapters, we aimed to develop a new approach which would 28 




5 Chapter 5: In vivo T1 mapping and T1 weighted 
for quantifying Gd-DTPA uptake from CSF into 
brain 
5.1 Introduction  
The traditional concept of CSF hydrodynamics is being challenged by recent 
works ( Iliff et al., 2012). The traditional model believes that CSF is produced 
mainly by the choroid plexus located in the ventricular system. After circulating 
throughout the natural fluid passages of the ventricular system and subarachnoid 
space, CSF is returned to the vascular system. Recently, the glymphatic system 
was proposed as periarterial influx route of CSF from subarachnoid space (SAS) 
into the brain interstitial fluid (ISF), providing a pathway of organised convective 
fluid flow to drive clearance of interstitial wastes solutes from the brain ( Iliff et 
al., 2012). DCE-MRI studies provide a wider, more detailed picture of CSF 
circulation, above and beyond the single snapshot view enabled by florescent 
and radioactive tracers. Iliff et al. (2013) first employed MRI using an 
intracisternal tracer infusion approach to monitor CSF dynamic and glymphatic 
function. In their original MRI study, DCE-MRI was applied, and transport of the 
gadolinium-based tracers was tracked in the CSF and brain parenchyma over 
time. They also compared the influx of small molecular weight Gd‐Diethylene 
Triamine Penta acetic Acid (Gd-DTPA, MW 938 Da) with a larger molecular 
weight polymeric Gd‐chelate (GadoSpin, MW 200 kDa) over the early infusion 
period. This demonstrated clear differences in whole‐brain distributions 
between the small and large Gadolinium based tracers. The distribution of the 
Gadolinium was monitored by a time series of a 3D T1 weighted spoiled gradient 
echo (SPGR) scans, acquired during and after tracer delivered into the CSF 
space. The change in signal from the baseline gave an indication of the tracer 
concentration. This approach provides only values of signal enhancement, and 
not tracer concentrations (Weiskopf et al., 2013). Instead, the use of the T1 
mapping method enables quantitative and longitudinal assessments of Gd 
concentration in tissues (Lee et al., 2018). In the current work, the 3D-T1 
weighted method employed in the original MRI study by Iliff et al (2013) is 
replicated. Moreover, we employed a T1 mapping method (IR-RARE) to 




5.2.1 Animal preparation 
A total of five male Wistar rats (body weight, 285 ± 50 g, 20 to 24 weeks old) 
were anesthetised (5% isoflurane in 30:70 O2/NO2 mixture at flow rate 1-2 
L/min) in an induction chamber, then intubated, and artificially ventilated (with 
2-3% isoflurane in 30:70 O2/NO2 mixture). A cisterna magna (CM) cannula was 
inserted as described in Chapter 3 (section 3.1.4.3) and connected to a closed-
end PE10 tube loaded with Gd-DTPA (Magnevist, 13.5 mM) and attached to an 
infusion pump (Graseby 3150 Syringe Pump) for tracer delivery. Throughout the 
MRI acquisition, body temperature, respiration, BP, and blood gases (pH, partial 
pressure of oxygen (PaO2), carbon dioxide (PaCO2)) were continuously monitored 
as described in chapter 3. 
5.2.2 Intracranial pressure measurement 
To investigate the effects of tracer infusion rate on cranial compartments, ICP 
was measured during different rates of infusion in a single rat. ICP probe was 
inserted into lateral ventricle as described in Chapter 2, section 3.1.4.2. Data 
were recorded with MP150 Biopac system (Biopac systems Inc, USA) and analysed 
with the “Acknowledge” software (Biopac systems Inc, USA).  
5.2.3 Magnetic Resonance Imaging Acquisitions 
The scanning protocol consisted of baseline scans followed by the intrathecal 
infusion of Gd-DTPA (21 mM; 80 μL at 1.8 μL/min; total time ~45 min). Both T1 
weighted and T1 map MRI images were continuously acquired in consecutive 
order over a period of approximately 120 minutes (Figure 5-1).  
To measure the concentration of Gd-DTPA, a T1 map was acquired using a 2D 
single slice inversion recovery sequence (IR-RARE). Inversion was performed 
using a hyperbolic secant pulse. The following imaging parameters were used: 
NA = 2; Inversion time = 30, 130, 230, 330, 430, 530, 630, 730, 830 and 930ms ; 
TR = 10000 ms; FOV = 2.0 x 2.0 cm; Matrix size = 150 x 256 , yielding an original 
image resolution of 0.2× 0.12× 1.5 mm. The total acquisition time for the 
experiment was 8 minutes 12 seconds.  
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To generate images with a T1 weighted shortening effect, 3D T1 weighted FLASH 
images were acquired in the sagittal plane. The following imaging parameters 
were used: TR/TE = 15 ms/3 ms, flip angle = 15°, NA = 1, FOV = 3.0×3.0×3.0 cm, 
acquisition matrix size = 128×128, yielding an original image resolution of 0.234× 
0.234× 0.234 mm. The total scan time = 3 minutes 5 seconds.  
5.2.4 MRI data analysis  
The general post-processing procedure consisted of image resizing, brain 
extraction, image smoothing, and head motion correction, as previously 
described in Chapter 3, section 3.2. To generate T1 maps, a voxel-wise T1 
calculation was performed using the IR-RARE sequence data, with image 
intensities fitted as a function of the inversion times, TI . The general equation 
used for the fitting procedure is: 





The unknown variables (M0 and T1) were calculated using the Nelder-Mead 
simplex nonlinear least squares fit algorithm (Swift and Connick, 1962).  
GD-DTPA concentration maps (C) were then calculated from the T1 map using 














Taking the longitudinal relaxivity of GD-DTPA at 7T as r1= 3.18 ± 0.09 mM
−1sec−1 
(Kalavagunta, Michaeli and Metzger, 2014). 
In the T1 weighted data, Gd-DTPA yields a shortening of T1 and, thus, an increase 






𝑆1𝑝𝑜𝑠𝑡 −  𝑆1𝑝𝑟𝑒 
𝑆1𝑝𝑟𝑒 
 × 100 
 
(5-3) 
The percentage change in T1 values and T1 weighted signal were plotted and the 
mean area under the curve (mAUC), which represented the area under the 
enhancement curve for 120 minutes, was calculated.  
5.2.5 Coefficient of variation  
To assess the relative variability of gadolinium distribution across individual rats, 
the Coefficient of variation (CoV) was calculated by dividing the standard 
deviation (SD) by the mean (CoV = SD/Mean) for each rat independently. Mean 
and CoV maps were generated for visual assessment.  
5.2.6 Sample size estimation for future hypothetical study using 
either T1 weighted or T1 map dataset 
Each dataset was treated as a preliminary study from which to estimate the 
number of rats per group, N, required in a hypothetical in vivo study to show 
meaningful differences between control and experimental group, with specified 
statistical power. We chose a conventional significance level of α = 0.05, and a 
study with 80% power. To detect 30 % difference between the two groups at 
each voxel the required number of animals in each arm of the study is given by 
(Florey, 1993): 
 N =







Where  𝑍a= 1.96.  𝑍1−β = 0.8416. 𝑇1,𝑠𝑡𝑑is the standard deviation of the T1 map or 
T1 weighted datasets, from group-wise average images, at particular voxel. 





Physiological parameters were analysed using two-way ANOVA followed by 
Sidak’s test to correct for multiple comparisons. Comparison of MRI data was 
statistically analysed using the Mann–Whitney U test, with P < 0.05 as being 
significantly different (Graphpad Prism Software, California, USA). Spearman’s 
correlation analysis was used to determine the correlation between T1 map and 
T1 weighted dataset. Data are presented as mean ± SEM or mean ± SD.  
 
 
Figure 5-1. Experimental protocol.Following surgical implantation of an intracisternal 
cannula, the rat was placed in the supine position inside the MRI scanner and kept under 
anaesthesia. Pre-contrast baseline images were acquired. Next, during sequential 
acquisition of T1 weighted / T1 map images, 80 μL at 1.8 μL/min of Gd-DTPA was infused 













5.3.1 Physiological data 
All rats in the present study had stable physiological variables throughout the 
experimental protocol (Table 5-1). Physiological variables showed no significant 
changes throughout the entire experimental duration (p = 0.65 for pH, p = 0.19 
for PaO2, p = 0.22 for PaCO2, p = 0.12 for MAP, and p = 0.34 for body 
temperature). 
5.3.2 Impact of infusion rate on ICP 
To avoid any physiological complication due to increased ICP generated by the 
infusion pump, ICP was measured at different infusion rates. As shown in Figure 
5-2, infusion rates of 3 5, 0.9, 1.8, and 2.7 μL/min did not appreciatively alter 
ICP, whereas increasing the infusion rate to 3.6 μL/min, significantly elevated 
ICP. The infusion rate used in the current thesis (1.8 μL/min) did not increase 
ICP. 
5.3.3 Gd-DTPA distribution within glymphatic system  
In the presence of the paramagnetic Gd-DTPA tracer, the T1 relaxation time is 
reduced, in a concentration dependent manner, see equation (5-2). In Figure 
5-3, representative IR-RARE scans at the level of the midline sagittal plane are 
shown, for T1 maps and concentration maps. The pre-contrast T1 map (t=0) 
displays CSF filled cerebral ventricles as areas with high T1 values (T1 ~ 2.5 s) 
whereas normal brain tissue is characterised by T1 values in the ~ 1.5 s range 
(Figure 5-3A). White matter regions in the cerebellum and corpus callosum can 
be clearly distinguished from grey matter as they exhibit lower T1 values. Both 
the T1 map and corresponding Gd-DTPA concentration map show time-dependent 
anatomical routes of perivascular influx (Figure 5-3B) over the early infusion 
period. The gadolinium was detected first in the basal cisterna, then in the 
ventricles, within minutes of injection. The concentration gradient then 
gradually built up from subarachnoid space into the most superficial part of the 
brain as early as 20 minutes after injection. Over time, Gd-DTPA slowly diffused 
into deeper structures of the brain. Later timepoints showed advancement 
throughout the brain, in the pineal recess and cerebellum, and more anterior 
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regions, such as the anterior cortex and the olfactory bulbs. Within the cortex 
subregions, anterior cortex exhibit Gd-DTPA uptake, yet the middle cortex 
remained free of detectable Gd-DTPA. Further, no Gd-DTPA enhancement was 
observed in deep brain white matter (Figure 5-3A). Quantification of Gd-DTPA 
uptake in multiple regions revealed heterogeneity of glymphatic inflow (Figure 
5-4A). Figure 5-4B shows the mean AUC values (mAUCs), reflecting transit and 
uptake rates of Gd-DTPA, demonstrating differences in rates of glymphatic 
inflow in anatomically discreet regions.  
5.3.4 Comparison of T1 weighted and T1 map methods 
The temporal evolution of the time curves derived from the T1 weighted and T1 
maps showed similar enhancement patterns (Figure 5-5A). Moreover, mAUC, 
which is an approximate index of the tracer distribution volume in the tissue, 
from multiple ROIs showed a strong correlation (R2 = 0.79; p<0.01). 
Visual inspection of the CoV parameter maps indicates the high quality of T1 map 
with no gross artifacts (Figure 5-5C). By contrast with the T1 map, the T1 
weighted images showed an inhomogeneous and slight higher CoV among rats 
(Figure 5-5D). The CoV for T1 maps ranged from 0 to 0.9, while the CoV of T1 
weighted ranged from 0.2 to 2.  
In order to assess the reproducibility of both the T1 weighted and T1 map 
methods, CoV maps across all rats were generated. Visual inspection of the CoV 
parameter maps indicates the high quality of the T1 maps with no gross artifacts, 
with values ranging from 0 to 35 % (Figure 5-5C). By contrast, the CoV maps from 
the T1 weighted images showed an inhomogeneous and higher CoV among rats, 
ranging from 0 to 100 % (Figure 5-5D). 
To inform future imaging studies using T1 map or T1 weighted methods, we 
calculated sample sizes (N) for a hypothetical study (α = 0.05 and 80% power) to 
detect a 30 % difference (see Figure 5-6). Under these conditions, the T1 
weighted imaging method would require N=15 animals to detect a statistically 
significant difference between experimental and control groups (see Figure 
5-6A). Whereas, using the T1 mapping method would only require N=10 animals 




Table 5-1. Physiological variables in rats, following tracer infusion. BP, blood pressure; 
PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; Temp, 
temperature values are within physiological ranges for H2
17O Gd-DTPA and aCSF. 







Physiological parameters  30 min  90 min 120 min 
Pa02 (mmHg) 136 ± 2 138 ± 3 142 ± 14 
PaC02 (mmHg) 34.4 ± 4 31.3 ± 6 31.3 ± 6 
Temperature (°C) 37 ± 0.5 36.8 ± 0.3 36.9 ± 0.4 
pH 7.5 ± 0.04 7.5 ± 0.08 7.5 ± 0.03 





Figure 5-2. Defining the effect of CM infusion on ICP. Ventricular ICP (mmHg) was monitored 
and aCSF infused continuously at different infusion rates (0.9, 1.8, 2.7, and 3.6 μL/min) in a 
single rat. Infusion rates of 0.9, 1.8, and 2.7µl/min did not change the ICP, while a further 












Figure 5-3. Gd-DTPA transport along glymphatic systems. (A) Population averaged Gd-
DTPA concentration map (N = 5) over different times from the onset of the infusion. (B) 





Figure 5-4. The temporal evolution of percentage change of T1 values induced by Gd-DTPA 
at different brain regions. (A) Comparisons of percentage change of T1 values in major brain 
regions (Hypothalamus, Hippocampus, Olfactory bulbs, Corpus callosum, Brainstem, Pineal 
recess, and anterior Cortex) over 2 hours period following start infusion of Gd-DTPA. (B) 
mAUC for each ROI’s were calculated. (C) the anterior cortex was compared with deep 
middle cortex, demonstrating the difference of the extent of Gd-DTPA inflow into these two 












Figure 5-5. Glymphatic transport of Gd-DTPA captured by T1 map and T1 weighted. (A) 
Representative sagittal MRI demonstrating the temporal evolution of Gd-DTPA over 120 min 
of recording. (B) Comparisons of percentage change of T1 values and T1 weighted signal in 
major brain regions (hypothalamus, olfactory bulbs, cerebellum, cortex, 4th ventricle, 
hippocampus, corpus callosum, brain stem, 3rd ventricle, and pineal recess). The temporal 
evolution of percentage T1 weighted signal from each region was extracted from nine 
different brain regions and plotted against T1 values (mAUC). Each filled circle represents a 
brain region: red = Hypothalamus, green = Olfactory bulb, light blue = Cerebellum, magenta 
=anterior Cortex, yellow = 4th Ventricle, blue = Hippocampus, black = Corpus callosum, 
grey=Brainstem, brown = 3rd Ventricle, and light green=Pineal recess. Coefficient of 













Figure 5-6. An estimated sample size map T1 weighted data compared with T1 map data. 
Sagittal equivalent slices (A) T1 weighted and (B) T1 map group wise average images, 













5.4 Discussion  
In this Chapter we were able to assess glymphatic function using the same T1 
weighted MRI protocol as previously published (Iliff et al., 2013). In addition, we 
also employed T1 mapping MRI, from which the tissue concentration of the Gd-
DTPA tracer could be mapped. These concentration maps demonstrated 
glymphatic transport patterns consistent with previous studies (Iliff, et al., 2013; 
Lee et al., 2018).  
A higher infusion rate of the Gd-DTPA tracer into the glymphatic systems, would 
provide a better visualization of glymphatic system. On the other hand, rapid 
infusion of fluid into the CSF system may interfere with CSF input/output rates, 
which in turn will alter ICP and the reliability of measurements (Marmarou, 
Shulman and Rosende, 1978). Here, the infusion rate did not appreciably alter 
pressure (see Figure 5-2). Therefore, the results obtained in this study should 
not be obscured by the infusion rate. The same infusion rate was also used in 
previous MRI and fluorescence experiments in mice alongside rats, where a 
comparable pattern of tracer distribution was observed in both species (Xie et 
al., 2013).  
The dynamic Gd-DTPA concentration maps showed that the time of tracer 
transport from the cisterna magna to the brain tissue adjacent to the 
perivascular space, occurred within approximately 10 minutes from the onset of 
Gd-DTPA infusion. In all the selected brain regions the concentration plateaued 
with time, giving no indication of early clearance. Notably, Gd-DTPA tracer did 
not arrive at the deeper brain interstitium (i.e. middle cortex and white matter 
regions) over the two hours scanned (Figure 5-4C). Indeed, Iliff et al.(2013) also 
failed to detect Gd-DTPA tracers in deep white matter brain regions despite 
acquisitions performed up to 4 hours after intracisternal injection, while 
observing enhancement in more superficial areas starting ~45 minutes after 
injection (Lee et al., 2018).  
The percentage signal change over time maps generated using the T1 weighted 
and the T1 mapping methods, paralleled each other (see Figure 5-5). However, 
the quantitative T1 mapping method showed a higher reproducibility than the 
conventional T1 weighted. The variation in T1 weighted method was most 
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prominent in the superficial cortical areas and was reflected in a highly 
increased Coefficient of variation (CoV) (Figure 5-5C). A relatively small 
deviations in head positioning may lead to signal variation in T1 weighted images 
among animals which may explain some of these variations (Thomas et al., 
2005). It is the stated policy of the United Kingdom government to replace, 
reduce or refine the use of animals in research. From these experiments we 
were able to conclude that the T1 mapping was less variable than the T1 
weighted method. For a hypothetic study, using typical values of effect size and 
power, this would translate into a reduction in group size form N=14 to N=10.  
While the T1 mapping method provides a relatively stable measurement, 
conventional T1 weighted MRI images have higher spatial and temporal resolution 
than the corresponding T1-maps. In detail, the T1 weighted 3D volume scans had 
0.23 mm slice thickness, while the T1-map slice thickness was 2 mm. Further, T1 
map method (IR-SE) requires an extremely long scan time (~8 min) in compare to 
T1 weighted (~3 min). 
Clearance of Gd-DTPA has previously been proposed to potentially resemble 
clearance of brain macromolecules with similar properties (Iliff et al., 2013), 
including amyloid-β and tau (Yang et al., 2013; Iliff et al., 2014). A key question 
that remains to be answered in the body of neuroscience research, is whether 
the flow of Gd-DTPA tracer represents the true magnitude of CSF/water flow or 
it is only representing the flow of the Gd-DTPA within the CSF. In the current 
work, the spatial pattern and ingress of Gd-DTPA from the CSF space into the 
brain tissue were demonstrated using both conventional T1 weighted and 
quantitative T1 map. In the next Chapter, we aim to develop a novel MRI method 
that detects isotopically enriched water (H217O, 90% 17O, 19 Daltons) to directly 




6 Chapter 6: Direct imaging of glymphatic flow 
using H217O MRI 
6.1 introduction 
The transport of solutes within the brain parenchyma is of fundamental 
importance to nutrient delivery and the clearance of metabolites, 
neurotransmitters, and toxic macromolecules (e.g. β-amyloid). Conventionally, 
interstitial solutes were considered to be transported via diffusion, but several 
evidence suggested an additional bulk flow of the interstitial fluid (ISF) (Cserr 
and Ostrach, 1974; Rosenberg, Kyner and Estrada, 1980; Rennels et al., 1985). 
Recently, the glymphatic system was proposed as a clearance mechanism that 
relies on aquaporin-4 (AQP4) water channels, expressed in the end feet of 
astrocytes, to drive the movement of CSF through brain interstitium, washing 
away toxic proteins and other waste as it proceeds (Iliff et al., 2012).  
The extent to which the glymphatic system accelerates solute transport in the 
brain interstitium is highly controversial, with both computational modelling and 
experimental studies being undertaken (Syková and Nicholson, 2008; Brinker et 
al., 2014; Asgari, de Zélicourt and Kurtcuoglu, 2016; Jin, Smith and Verkman, 
2016; Holter et al., 2017). However, it should be emphasized that all the 
previous works and hypotheses of CSF dynamics and the glymphatic system were 
based on evaluating the transport of solutes with molecular sizes larger than 
that of water (e.g. Gd-DTPA, 938 Da). These results could be misinterpreted and 
lead to the wrong conclusions regarding CSF dynamics and the glymphatic flow. 
More importantly, AQP4 water channels were proposed by Dr. Nedergaard and 
her colleagues as a critical contributor to the bulk flow of ISF through 
extracellular spaces, yet as tracers will not pass through AQP4, most likely 
means that they did not clearly demonstrates the importance of AQP4 
(Papadopoulos and Verkman, 2013).  
The fact that these large tracers cannot be transported through AQP4 channels 
most likely means that previous tracer studies underestimated the true 
magnitude of ISF flow, which will depend on the rate at which CSF water 
molecules enter the interstitium. Therefore, we reasoned that using water 
molecules as a tracer would yield novel insights into glymphatic flow and the 
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role of AQP4 channels. Hence, we implemented a novel MRI method that detects 
isotopically enriched water (17O water, 90% 17O, 19 Da) via the effect of the 
quadrupolar 17O nucleus on the 1H MRI signal (Meiboom, 1961). The stable 17O 
isotope possesses a quadrupolar nucleus which reduces the T2 relaxation time of 
bonded hydrogen nuclei (see Chapter 2, section 2.2.3). This effect is further 
magnified by the exchange of hydrogen atoms with other surrounding water 
molecules. Thus, the presence of 17O water can be detected by a reduction in 
the 1H signal of T2 weighted MRI scans.  
In this work, first, we provide a compelling method capable of detecting water 
flow using an 17O enriched water (H217O) tracer, several image optimization 
measures were considered. Second, we used H217O to visualize brain-wide 
subarachnoid CSF-ISF exchange in live rat brains. Further, we directly compared 
our new method with the current standard for imaging glymphatic flow in-vivo, 
namely DCE-MRI using Gd-DTPA as previously described in Chapter 5. We found 
that glymphatic flow imaged using our H217O tracer was much more rapid and 
extensive than when imaged using a Gd-DTPA tracer. We propose that this H217O 
MRI approach may provide a new strategy for evaluating glymphatic system and 










6.2.1 Study 1: Optimising 17O enriched water MRI for imaging CSF 
parenchymal flow 
6.2.1.1 Influence of 17O-1H scalar coupling on 1H relaxation of water / 
Phantom experiment 
The efficacy of MRI contrast agents is determined mainly by their relaxivities (r1 
or r2). The relaxivity of an MR contrast agent affects MRI detection sensitivity 
and, ultimately, reflects how the relaxation rate of a solution (1/T1 or 1/T2) is 
altered as a function of the tracer concentration [C]. For transverse relaxation it 







0 + 𝑟2[𝐶]; (6-1) 
The relaxivity (r2) is a measure of the strength of the contrast agent, which 
determines the concentration [C] required to generate readily observable 
contrast. For all contrast agents, relaxivity depends on extrinsic factors such as 
the applied field, temperature and other physiological parameters (Koenig and 
Brown, 1984). To experimentally measure the relaxivity of H217O, phantom 
solutions were placed in sealed falcon tubes. Those solutions contained different 
concentrations of H217O (NUKEM Isotopes Imaging GmbH) varying from natural 
abundance (0.037%) to 10% dissolved in distilled water (pH=7.5). 
6.2.1.2 Sensitivity of H217O T2 weighted signal to pH ranges  
Tissue pH values have been found to be altered following neurological conditions 
(Siesjö, 1992; Mehrabian et al., 2018). Cerebral ischaemia promptly induces a 
marked reductions of tissue pH to around 6.0 in the territory of the occluded 
vessel and can be easily explained by increased lactate formation, and hydrolysis 
of ATP (Rehncrona, 1985).  
Meiboom (1961) studied the proton chemical exchange in 17O-enriched water 
solution at different pH values. It was found that the change in enhanced T2 
relaxation, due to both 17O-1H scalar coupling and the chemical exchange 
between H217O and H216O, can completely disappear when pH is shifted away 
6 126 
 
from neutral. To investigate whether the proton exchange rate between H217O 
and H216O is sensitive to pH, a second set of phantoms was prepared with a fixed 
H217O concentration (2.5%) and different pH levels varying between 2 and 12. 
The pH was adjusted by the addition of small amounts of HCL or NaOH solution 
and measured with pH Indicator Strips. The pH was measured both before and 
after the relaxation measurements. 
6.2.1.3 MRI acquisition  
T2 values were measured with an MSME sequence that is based on the CPMG 
sequence, where the transverse magnetization from a 900 pulse is refocused by a 
train of 1800 pulses, generating a series of echoes (see Chapter 2). As the data 
from each echo is acquired with a different TE, this enables the T2 relaxation 
times to be calculated. The following imaging parameters were used: number of 
averages = 2; slice thickness of 2.0 mm; number of echoes = 64, with echo 
spacing = 7.3ms; repetition time TR = 6000 ms; FOV = 2.0 x 2.0 cm; matrix size= 
256 x 256. The total acquisition time for the experiment was 19 minutes 12 
seconds. 
6.2.1.4 Measurement of T2 map  
To calculate T2, circular ROIs were drawn on the images using the Image 
Sequence Analysis (ISA) tool package (Paravision 5.1, Bruker).This uses a fitting 
function [y= A+S0*exp (-t/T2)], where A is a constant baseline, S0 is the initial 
signal intensity and T2 represents the transverse relaxation time. The transverse 
relaxation rate (R2) was calculated using the equation R2 = 1/T2 (s-1). The 
transverse relaxivity was calculated as the slope of the linear regression line of a 
plot of relaxation rate against concentration of 17O enriched water.  
6.2.1.5 H217O tracer imaged with high-Signal to Noise Ratio (SNR) T2 
weighted imaging in rat brain 
The challenge related to the use of H217O as a potential MRI tracer from 1H MRI 
imaging, is that H217O has a low 1H transverse relaxivity in biological samples 
(Alder and Yu, 1951). Therefore, the 1H signal intensity induced by variations in 
H217O concentration is relatively small in tissue, due to the dominance of 
competing relaxation mechanisms. Furthermore, this small change must be 
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differentiated from basal fluctuations in the 1H signal that occurs due to 
instrumental instabilities or physiological processes such as periodic motion and 
vasomotion (Van Dijk, Sabuncu and Buckner, 2012). To overcome this issue, 
H217O must be used at relatively high concentrations level. In the current 
project, animals were administered with 90% 17O-enriched water. Additionally, it 
is necessary to optimize data collection sequences in order to further improve 
the signal to noise ratio (SNR) and detection limits. 
6.2.1.6 Optimisation of T2 RARE pulse sequence: SNR and optimal 
parameters 
The SNR in an MR image is defined as the ratio between the amplitude of the 
signal and the standard deviation of the noise (McRobbie et al., 2006). to 
improve SNR, a number of imaging parameters were optimized:  
I. Reduce receiver bandwidth (RBW=±32.7 kHz): RBW determines the range 
of frequencies that will be sampled by the frequency encoding gradient. As 
RBW decreases, less inherent noise is sampled along with the signal, thus, 
the signal to noise ratio increases.  





 𝑅𝐵𝑊 ∞ 
1
∆𝑇𝑠
  (6-3) 
Where ∆𝑇𝑠 is the sample time between two successive frequency encoding points. 
Hence by increasing the sample time, more MRI signal to be captured.  
II. Increasing Field of view (FOV=60 × 60 mm2): For conventional sequences, 
increasing the voxel size results in a gain in SNR, with SNR proportional to the 
voxel volume. Voxel size can be increased by decreasing the imaging matrix 
for a fixed FOV, however, though this makes the scans faster it also results in 
more ghosting artefacts. Hence in the current work, it was found that 
increasing the FOV, keeping same matrix size, gave less ghosting artefact. 
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Less artefact was crucial in the current work, as the change in signal that 
need to be detected is very small (~2%). 
III. Signal averaging (NA=4), TR (~3000 ms) and RARE factor (12): The SNR, 
which is proportional to the square root of the NA, improves as the NA 
increases, but acquisition time also increases linearly with the NA. For fixed 
scan time NA can be expressed as:  
 𝑁𝐴 =  
𝑇𝐴
𝑇𝑅
 ∙  
𝑅𝐴𝑅𝐸 𝑓𝑎𝑐𝑡𝑜𝑟
𝑁𝑝ℎ𝑎𝑠𝑒
 ∙ (6-4) 
 
In order to increase NA without lengthening the acquisition time, other 
parameters such as TR and RARE factor were compromised. The MRI 
acquisition parameters before and after optimisation were summarised in 











6.2.2 Study 2: Comparison between H217O and Gd-DTPA in 
evaluating glymphatic flow 
6.2.2.1 Study Design  
Male Wistar rats (280 to 350 g, 20 to 24 weeks old) were randomly assigned to 
three experimental groups: 1) H217O (n=8), 2) Gd-DTPA (n=8), and 3) aCSF (n=4).  
6.2.2.2 Surgery and physiological monitoring 
All rats were initially anesthetised (5% isoflurane in 30:70 O2/NO2 ratio) in an 
induction chamber, intubated, and artificially ventilated (with 2-3% isoflurane in 
30:70 O2/NO2 ratio). The animal was then transferred to a stereotaxic frame 
where the head was secured with ear and tooth bars. A CM cannula was inserted 
as described in Chapter 3 (section 3.1.4.3) and connected to a closed-end PE10 
tube (2.5 cm long, 0.28 mm ID × 0.61 mm OD, Braintree Scientific) loaded with 
the desired tracer (13.5 mM Gd-DOTA, 90% 17O water or aCSF) and attached to 
an infusion pump for tracer delivery. Using methods described in Chapter 3, 
body temperature, BP, HR and blood gases were continuously monitored for the 
duration of each experiment. At the end of each experiment, the animal was 
euthanised.  
6.2.2.3 Magnetic Resonance Imaging  
Two different tracers were used for this experiment: Gd-DTPA (Magnevist, 21 
mM; MW, 938 Da; Bayer HealthCare Pharmaceuticals, Inc.) and H217O (90% 17O-
enriched water, NUKEM Isotopes, Germany). Furthermore, aCSF was used as a 
control condition for H217O (n=4). The scanning protocol for all studies consisted 
of 3 baseline scans followed by the intrathecal infusion of tracer via the CM 
catheter (50 μl at 1.8 μl/min; total time, 28 min). MRI images were continually 
acquired over a period of 85 minutes. To visualize the glymphatic systems using 
gadolinium (T1 weighted shortening effects), 3D T1 weighted FLASH images were 
acquired in the sagittal plane (TR/TE = 15 ms/3 ms, flip angle = 15°, NA=1, field 
of view (FOV)=3.0×3.0×3.0 cm, total scan time = 3 min 5 s, acquisition matrix 
size = 128×128×128, yielding an original image resolution of 0.234× 0.234× 0.234 
mm). To visualize the glymphatic systems using H217O (T2 weighted shortening 
effects), T2 weighted images were acquired with a high signal-to-noise fast spin-
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echo sequence (T2 RARE). The experimental protocol is shown schematically in 
Figure 6-1.  
6.2.2.4 MRI data analysis  
MATLAB R2018b (MathWorks, UK) code was developed in-house for 
postprocessing MRI images. The general postprocessing procedure consisted of 
image resizing, brain extraction, head motion correction, image smoothing and 
voxel-by-voxel conversion to a percent signal change map (see Chapter 3, 
section 3.2). Briefly, protocol was developed to register and stack multiple T1 
weighted slices in order to reflect the T2 weighted imaging slice thickness. 
Further, a brain mask was created for the removal of non‐brain tissue, improving 
the performance of the following coregistration steps: using rigid body alignment 
of each scan to the mean pre-contrast image, scan-to-scan misregistration 
caused by head movement was corrected. The resulting registrations were 
visually inspected to ensure adequate alignment. To ensure that voxel intensity 
represented a percent change relative to the average baseline image, all time-
series images were subtracted and divided by the baseline average image using 
the following expression For the Gd-DTPA T1 weighted study: 
 
∆𝑺% =
𝑺𝟏𝒑𝒐𝒔𝒕 −  𝑺𝟏𝒑𝒓𝒆 
𝑺𝟏𝒑𝒓𝒆 
 × 𝟏𝟎𝟎 
(6-5) 
For the H217O/aCSF T2 weighted study: 
 
∆𝑺% =
𝑺𝟏𝒑𝒓𝒆 − 𝑺𝟏𝒑𝒐𝒔𝒕 
𝑺𝟏𝒑𝒓𝒆 
 × 𝟏𝟎𝟎 
(6-6) 
where ∆𝑆% is the percent signal change from the baseline (𝑆1𝑝𝑟𝑒). The T1 
weighted and T2 weighted averaged baseline images were used to anatomically 
guide the placement of regions of interest (ROIs). MATLAB code was developed 
to create maps of the tracer arrival time, were created on a voxel-by-voxel 
basis.  
The averaged baseline images as well as the contrast‐enhanced MRI images were 
used to anatomically guide placement of each region‐of‐interest (ROI). The 
mean values of image intensities in preselected anatomical areas were measured 
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on the registered images over time, which produced temporal evolution curve of 
percentage signal change in every specific ROI, due to the uptake tracer by 
regional brain tissue. 
The 1-dimensional Einstein diffusion equation can be solved to give the 
probability density function, P(x,t), for particles undergoing Brownian motion: 







)  (6-7) 
Where D is the diffusion coefficient and x is the particle displacement from its 
initial position x0, during an observation time, t. For this Gaussian function the 
root mean square displacement, xrms, of an ensemble of particles is given by: 
 𝑥𝑟𝑚𝑠 = √2𝐷𝑡  (6-8) 
 
6.2.2.5 Statistics 
No statistical methods were used to predetermine sample size, the sample sizes 
used were similar to those reported in a previous study (Iliff et al., 2013). 
Statistical tests were performed using GraphPad Prism (GraphPad Prism 
Software, California, USA). Statistical comparisons between groups were 
performed by repeated measures two-way ANOVA followed by Sidak’s test to 
correct for multiple comparisons. All tests were considered statistically 










Figure 6-1 Experimental protocol.Following surgical implantation of an intracisternal 
cannula, the rat was placed in the supine position inside the MRI scanner and kept under 
anaesthesia. First, 3 precontrast baseline images were acquired. Then, during sequential 
acquisition of T1/T2 images, 50 μl at 1.8 μl/min of either Gd-DTPA (Magnevist, 21 mM) or 90% 
17O-enriched water was infused through the cannula over 28 minutes, and T1/T2 imaging 


















6.3.1 Study 1: Optimising 17O enriched water MRI for imaging CSF 
parenchymal flow 
6.3.1.1 H217O relaxivity  
Transverse relaxation rates (R2) were measured in H217O enriched water solutions 
ranging from 0 to 10 % H217O, with pH 7.4 at 37 °C. Images of the phantoms are 
shown in Error! Reference source not found.B, where the darker circles belong 
to the samples with higher concentrations of H217O. In a comparison with the 
phantom arrangement in Error! Reference source not found.A, it is evident 
that the signal intensity is directly correlated to the H217O concentration in each 
tube. The transverse relaxivity (r2) of H217O was calculated as 2.32 s-1mol-1 from 
the slope of the R2 dependence on concentration (Error! Reference source not 
found.C). By following the pH dependence of the relaxation times, it is clear 
that equal concentrations of H217O tracer do not produce the same magnitude of 
T2 change when pH is shifted away from neutral (Error! Reference source not 
found.) (Meiboom, 1961b). 
6.3.1.2 H217O tracer imaged with high-Signal to Noise Ratio (SNR) T2 
weighted imaging in rat brain 
The SNR was evaluated as mean signal/noise standard deviation. Figure 6-2 
shows the plot of SNR at different slice position before and after T2 weighted 
RARE parameters optimisation. Following the adjustment of MRI parameters, a 
~800% increase in the SNR was achieved.  
However, it is important to note that image quality depends not only on high 
SNR but also on the contrast to noise ratio (CNR) and visibility of the regions of 
interest and the absence of image artefacts. In the current sequence 
optimization approach, improving the SNR (by increasing voxel size) came at the 
cost of reducing CNR as shown in figure 6-5. This drop in CNR is potentially due 
to the increased partial volume effect due to the increasing of voxel size. Other 
possible reason for these differences in CNR is perhaps the result of different 
repetition times (TR) between Bruker and our optimised RARE. Or even due to 
use of different echo time (TE). However, it is noteworthy that our main aim in 
the current approach was to enhance the sensitivity of detecting H217O signal, 
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even if it came at the cost of CNR quality, which was basically not one of our 
interests in this study. 
6.3.2 Study 2: Comparison between H217O and Gd-DTPA in 
evaluating glymphatic flow 
6.3.2.1 Exclusion and protocol violations. 
Animals were removed from the study if they died or were physiologically 
unstable during the experiment or if the study was not completed due to 
technical issues. A total of 20 animals were included in this study. Three rats 
(two in the H217O group and one in the Gd-DTPA group) showed no MRI signal 
change when the contrast agent was infused. Infusion failed either due to 
leakage or an incorrect CM cannula position. The animals were euthanized at 
that point and were excluded from the study. In addition, one rat from the 
control group (aCSF) had unstable blood pressure during the experiment and was 
excluded from the study. Hence, a total of seventeen rats were analysed for the 
3 study groups: aCSF (n=3), H217O (n=7), and Gd-DTPA (n=7).  
6.3.2.2 Physiological variables  
Physiological variables before and after infusion of MRI tracer are shown in Table 
6-2. Mean arterial pressure (MAP) was not statistically significant (p = 0.9424). 
Mean values for all groups remained within normal limits. Other physiological 
variables were stable throughout the experimental protocol with no significant 
differences between groups (p = 0.3506 for pH, p = 0.4852 for PaO2, p = 0.5204 
for PaCO2 and p = 0.9521 for body temperature). 
6.3.2.3 Perivascular influx of H217O into the brain parenchyma  
Figure 6-6 shows the temporal evolution curve of percentage signal change 
observed in preselected anatomical regions. The curves plateaued once the 
infusion ceased with the exception of the parenchymal regions (olfactory bulb 
and cortex), where a gradual change in signal continued until the end of 
scanning. Compared with aCSF control conditions, the average change of signal 
from baseline over time was significantly larger in (A) prefrontal cortex (p< 
0.0001), (B) pineal recess(p< 0.0001), (C) cerebellum (p< 0.0001), (D) pituitary 
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recess (p< 0.0001), (E) olfactory bulb (p< 0.0001), and (F) 4th ventricle (p< 
0.0001) (see Figure 6-6). 
6.3.2.4 Dynamic distribution of H217O and Gd-DTPA contrast 
The distribution pattern of H217O tracer was directly compared against the Gd-
DTPA tracer. Figure 6-7 shows a time series of colour-enhanced sagittal sections 
depicting the percentage signal change and distribution of the H217O tracer 
following injection into the cisterna magna. Figure 6-7 shows a time series of 
colour-enhanced sagittal sections depicting the percentage signal change and 
distribution of the Gd-DTPA tracer following injection into the cisterna magna. 
These are representative examples from one rat imaged with the H217O tracer 
and another rat imaged with the Gd-DTPA. 
The dynamic time series of T1 weighted MR images clearly revealed the time-
dependent anatomical routes of perivascular influx when using tracers such as 
Gd-DTPA with a molecular size larger than water (Magnevist, MW, 938 Da). The 
Gd-DTPA agent first appeared in the cisterna magna and was then transported 
along vessels of the circle of Willis. Gd-DTPA continued to be transported along 
the olfactory arterial complex and into the olfactory bulb at~10 minutes after 
injection (Figure 6-7. ). Finally, there was slow parenchymal enhancement of 
Gadolinium, continuing in some regions up to 85 minutes after injection (Figure 
6-7. , 85 min). However, Gadolinium under the current experimental protocol 
was not detected in the deep cortical regions.  
Following the infusion of the H217O tracer, the dynamic time series of T2 
weighted MR images clearly revealed a CSF parenchymal flow that was strikingly 
more rapid and extensive than that observed using conventional Gd-DTPA 
tracers. The H217O tracer rapidly appeared as early as 3.5 minutes following 
injection within the perivascular spaces of surface arteries and within regions 
close to the cisterna magna such as the cerebellum. H217O then began to move 
progressively deeper into the brain parenchyma and subsequently dispersed 
broadly within the whole brain parenchyma within ~10 minutes after injection 
(Figure 6-8). By comparing the H217O tracer distribution with that of the Gd-
DTPA, it is evident that, within the first few time points after injection, the 
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H217O tracer distribution differed radically from the pattern observed with the 
Gd-DTPA tracers. 
6.3.2.5 The influx of the H217O tracer was faster and was much more 
extensive across the whole brain  
To provide a quantitative assessment of the temporal behaviour of both Gd-DTPA 
and H217O uptake within the whole brain, the times that the tracer arrived at 
each voxel after injection were estimated. This was achieved by identifying the 
time points at which the signals rose and kept rising for at least three successive 
time points. By comparing the arrival time maps shown in Figure 6-9, it can be 
seen that Gd-DTPA tracer took longer to reach certain brain regions, suggesting 
the lower bulk speed of the Gd-DTPA-tracer or more resistance. The signal 
changes induced within the parenchyma by Gd-DTPA peaked between 70 and 80 
minutes after injection. By contrast, the H217O penetrated into the brain very 
rapidly and was distributed quickly, peaking throughout the whole brain 
between 10 and 30 minutes after injection. 
From previous diffusion MRI experiments using a long observation time (600ms) 
(Qaisi et al., 2020), we measured the plateau diffusion coefficient of water 
within the rodent cortex as 0.00062 mm2/s. From equation 6-8, the root mean 
square displacement, xrms, of water for experiment times of 3.85min (231s), 
7.65min (459s), 11.08min (665sec) and 14.83min (893sec) was calculated to be 
0.53mm, 0.75mm ,0.91mm and 1.05mm, respectively. Gd-DTPA diffusivity in a 
tissue mimic material (polyvinyl alcohol-cryogel) have been performed in our lab 
using MRI, giving a diffusion coefficient of 0.00026 mm2/s. From equation 6-8, 
the root mean square displacement, xrms, of Gd-DTPA for experiment times of 
7.65 min (459s), 11.08 min (665sec) and 14.83 min (893sec) were calculated to 
be 0.49 mm ,0.59 mm and 0.68 mm, respectively. 
6.3.2.6 Comparison of regional tracer uptake  
To assess the relative kinetics within the subregions of the brain, the temporal 
evolution curve was calculated after injection of the MRI tracer (H217O or Gd-
DTPA) in the prefrontal cortex, pineal recess, cerebellum, pituitary recess, 
olfactory bulb and 4th ventricle (Figure 6-12). Since the change in MRI signal 
induced by H217O is a T2 shortening effect and Gd DTPA is a T1 shortening effect, 
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we were not able to perform direct comparisons of the percentage signal change 
over time induced by both tracers. To overcome this limitation, the mean 
percentage signal changes over time were normalised by dividing each time 
point by the maximum percentage signal change over the entire time period 
within the selected ROIs. The percentage signal change for H217O demonstrates 
an early and robust change in signal over the early infusion period in all brain 
parenchymal regions when compared with Gd-DTPA.  
In the H217O dataset, larger signal changes were observed in the 4th ventricle and 
pineal recess compared with the brain parenchymal regions, with exception of 
cerebellum (Figure 6-11). These observations were consistent with those of the 
Gd-DTPA tracer (Figure 6-12). This could suggest that large portion of H217O 
molecules, even though they are freely diffusible molecules, preferentially 
travel along the perivascular channels in similar distribution patterns to other 



























Figure 6-2. Measuring the relaxivity of H2
17O solutions. (A) Schematic drawing shows the 
layout of the phantoms. Numbers denote the percentage of H2
17O is solution. (B) Images of 
the phantoms acquired with MSME. (C) Relative increase of the proton relaxation rate as a 
function of H2






Figure 6-3. Influence of pH on T2 relaxation rates. (A) Schematic drawing showing the layout 
of the phantoms. Numbers denote pH values. (B) Image of the phantom acquired with 

















MRI parameters Bruker default T2 
RARE sequence 
Optimised T2 RARE 
sequence 
TR (ms) 6000 3000 
TE (ms) 100 61.32 
FOV (mm2) 30 × 30 60 × 60 
Data matrix 256 200 
RARE factor 8 12 
Number of averages 2 4 
Bandwidth (kHz) ±50.0 ±32.7 
Voxel size (mm3) 0.097 × 0.097 × 1.5 0.3 × 0.3 × 1.5 
Scan duration (min) 3.21 3:12 
Slice thickness (mm) 0.75 1.5 














Figure 6-4. SNR computed for T2 weighted images obtained with conventional RARE and 
optimised RARE sequence parameters. (A) The optimization of T2 weighted RARE 
sequence parameters enabled an increase in SNR (~1200%) compared with the default T2 
weighted RARE sequence. (B)The mean image intensity ratio of the signal to standard 
deviation (SD) of noise. ROI is used for SNR estimation. 
 
Figure 6-5. CNR computed for T2 weighted images obtained with conventional RARE and 
optimised RARE sequence parameters. (A) Grey and white matter CNR of RARE and 
optimised RARE images. (B) CSF and white matter CNR of RARE and optimised RARE 




      Time from infusion 
Physiological parameters Before infusion 30 min 80 min 
MAP (mmHg) H217O  88.1 ± 6.7 90.6 ± 8.2 85.9 ± 9.3 
Gd-DTPA 93 3± 5.1 94.7 ± 7.2 92.9 ± 6.6 
 aCSF    90.5 ± 6.4 88.9 ± 8.7 87.5 ± 9.4 
PaO2 (mmHg) H217O 146.1 ± 5.7 144.6 ± 7.4 140.6 ±10.6 
Gd-DTPA 138.3 ± 10.1 143.7 ± 12 141.5 ± 7 
 aCSF    142.5 ± 7.4 145.9 ± 8.2 148.5 ±10.4 
PaCO2 (mmHg) H217O 40± 6.6 37.2 ± 8 36 ± 9.7 
Gd-DTPA 36.9 ± 7 36.7 ± 8.5 42.3 ± 6.9  
 aCSF 40·2 ± 6·6 41·1 ± 5·5 45.3 ± 10.5 
Temp (°C) H217O 37 ± 0.6 37.2 ± 0.5 37.3 ± 0.3 
Gd-DTPA 36.9 ± 0.7 36.7 ± 0.8 36.8 ± 0.6 




H217O 7.5 ± 0.06 7.5 ± 0.08 7.4 ± 0.1 
Gd-DTPA 7.5 ± 0.02 7.4 ± 0.05 7.5 ± 0.2 
aCSF 7.5 ± 0.03 7.5 ± 0.05 7.5 ± 0.3 
    
Table 6-2: Physiological variables in rats, following tracer infusion. MAP, mean arterial 
pressure; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; 
Temp, temperature values are within physiological ranges for H2
17O Gd-DTPA and aCSF. 





Figure 6-6. Comparisons of time-to-signal curves for H2
17O and aCSF in specific brain 
regions. Signal-to-time curves for H2
17O (blue circles) and aCSF (black box) are shown for 
the (A) Prefrontal cortex, (B) pineal recess, (C) cerebellum, (D) pituitary recess, (E) olfactory 
bulb, (F) 4th ventricle, and (G) Temporal muscle. (H) The average signal change was 
calculated within the period from the injection start of H2
17O and aCSF to the end of the 
scan. Significant differences denoted by asterisks: *p < 0.05, **p < 0.01, ***p < 0.001. Data 







Figure 6-7. Representative sagittal temporal evolution maps of Gd-DTPA from the onset of 





Figure 6-8. Representative sagittal temporal evolution maps of H2
17O water from the onset of 










Figure 6-9. Representative arrival time maps.The upper panel images show a rat infused 
with H2
17O (MW, 19 Da) and the bottom panel images show one rat infused with Gd-DTPA 
(Magnevist; MW, 938 Da). Corresponding tracer arrival time maps for four sagittal slices, 
with shorter arrival times indicated by brighter colours. Black colour indicates that the 















Figure 6-10. Comparisons of time-to-signal curves for H2
17O and Gd-DTPA in specific brain 
regions. Analyses were displayed to demonstrate the change of signal curves , which is 
normalised by its maximum value, for H2
17O (blue circles) and Gd-DTPA (red box) for the (A) 
Prefrontal cortex, (B) pineal recess, (C) cerebellum, (D) pituitary recess, (E) olfactory bulb, 
and (F) 4th ventricle. Significant differences denoted by asterisks: *p < 0.05, **p < 0.01, 






Figure 6-11. Comparisons of kinetic parameters of H2
17O among different brain regions. 
Average percentage signal change were calculated for 4th ventricle, cortex, cerebellum, 
olfactory bulb, and pineal recess. Significant differences denoted by asterisks: *p < 0.05, 
**p < 0.01, ***p < 0.001. Data presented as mean ± SD. 
 
 
Figure 6-12. Comparisons of kinetic parameters of Gd-DTPA among different brain regions. 
Average percentage signal change were calculated for 4th ventricle, cortex, cerebellum, 
olfactory bulb, and pineal recess. Significant differences denoted by asterisks: *p < 0.05, 




































































































































Figure 6-13. 3D visualization constructed images representing perivascular influx of H2
17O 
and Gd-DTPA.(A) 2D T2 weighted MRI with the anatomical structures displayed. (B) 3D 
visualization constructed from T2 weighted images demonstrates H2
17O distribution along 
perivascular spaces and in all brain regions. (C) 3D visualization constructed from T1 
weighted images demonstrates Gd-DTPA distribution along perivascular spaces with 


















In this study, we employed the MRI H217O method, which enabled the direct 
imaging of glymphatic water transport in the in-vivo rat brain for the first time. 
The magnitude of the T2 effect in various water solutions enriched with different 
H217O concentrations and pH values were determined. The changes in T2 
relaxation rate were linearly correlated with the percentage of H217O 
enrichment. The H217O MR sensitivity was also optimised in rat brain, leading to 
a high SNR T2 weighted method. Further, this new method was directly 
compared with the current in-vivo gold standard of DCE-MRI with gadolinium-
based contrast agents (Gd-DTPA).  
Water molecules have previously been used as tracers by exploiting various 
isotopes. For example; tritiated water (3H2O) has been used to investigate CSF 
transport by measuring the radiation levels of blood samples using a liquid 
scintillation counter(Bulat, Klarica, et al., 2008); H215O has been imaged with 
Positron Emission Topography (Schneider et al., 1995), though its short half-life 
(122.2s) makes it impractical to study glymphatic function; the stable 17O 
isotope is not radioactive but possesses a quadrupolar nucleus (I=5/2) that can 
be imaged using MRI, although direct imaging of 17O signal is difficult due to its 
low gyromagnetic ratio and low natural abundance (0.037%) (Richardson, 1989). 
However, the presence of H217O can be detected indirectly via the effect of the 
quadrupolar 17O nucleus on the 1H MRI signal (Ronen and Navon, 1994), where 
the quadrupolar 17O nucleus reduces the T2 relaxation times of bonded hydrogen 
nuclei. This effect is further magnified by the exchange of hydrogen atoms with 
other surrounding water molecules (see Chapter 2, section 2.2.3). H217O 
produced from 17O2 gas has been used to image metabolism (Tailor et al., 2004) 
and H217O has also been administered as a tracer to image cerebral blood flow 
(Arai et al., 1998). In a series of studies Nakada et al. also employed indirect 1H 
detection of H217O to investigate the interstitial circulation. However, they used 
an intravenous bolus injection of H217O (20% 17O) and showed that the exchange 
of blood water with the interstitial fluid and CSF, was dependent on AQP4 and 
not AQP1 (Igarashi et al., 2013; Huber et al., 2018; Kudo et al., 2018). They also 
used the same intravenous bolus method to demonstrate that water influx into 
CSF was significantly impaired in SP-bearing transgenic mice (Igarashi, Suzuki, et 
al., 2014). However, these previous studies did not directly investigate the 
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glymphatic system. In this work, to directly image glymphatic water transport 
within the rat brain, the H217O tracer was infused directly into the CSF at the 
cisterna magna, replicating the delivery approach used by Nedergaard et al in 
their seminal Gd-DTPA experiments. In order to detect the small signal changes 
generated from infusing tiny amounts of H217O, it was necessary to employ a 
much greater concentration of H217O (90% 17O-enriched water) and use a high 
SNR T2 weighted imaging sequence (SNR 200:1). 
Serial MRI revealed a glymphatic flow that was strikingly more rapid and 
extensive than previously observed using conventional Gd-DTPA tracers (Iliff et 
al., 2013). To better understand the speed of the H217O into the neuropil 
interstitium, we generated maps of tracer arrival time (see Figure 6-9). The 
speed of the H217O influx reflects the rates of CSF-ISF exchange throughout the 
brain. Whereas H217O permeated virtually the entire brain volume within 10 
minutes of injection, penetration of the higher–Gd-DTPA tracer was far slower 
and also more restricted. Interestingly, such rapid and extensive water 
movements were observed previously in small molecular tracer experiments. A 
much earlier study using deuterium oxide (D2O) found high rates of water flux 
from vascular compartments and rapid distribution throughout brain and CSF 
compartments (Bering, 1952). These data suggested high rates of water flux 
which were more rapid and incompatible with previously estimated rates of CSF 
and ISF flow using larger tracers. 
Reason for the discrepancy between the transport of H217O and Gd-DTPA tracers 
was the difference in the molecular weight of the tracers employed. As observed 
in previous data, molecular tracers that lack a specific molecular transport 
pathway (such as ion transporters or channels) are only able to reach the 
parenchyma through a 20-nm clefts between overlapping astrocyte end feet (Iliff 
et al., 2013). Water, however, is able to travel freely from perivascular space 
into intersitial space through end feet gaps and the process can be speed up 
through intracellular space mediated by highly selective AQP4 water channels 
(Verkman et al., 2013). These channels are expressed in astrocytic end feet that 
surround the entire vasculature in the CNS. Hence, previous experimental 
studies may have systematically underestimated subarachnoid CSF flow into the 
brain by basing their analyses on tracers larger than water. Asgari et al. (2015) 
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modelled the astrocytic syncytium between CSF and the compartment of the 
brain interstitium by including in their model AQP4 on the plasma membranes, 
an abundance of AQP4 on the perivascular surfaces, and 20nm inter-end feet 
gaps. They demonstrated that the resistance to water flow through ECS is two 
orders of magnitude larger than through the intracellular space (ICS) of 
astrocytes (Asgari, de Zélicourt and Kurtcuoglu, 2015).  
While the current MRI imaging have shown a rapid and extensive distribution of 
H217O within the brain tissues, curiously the tracer does not penetrate deep into 
white matter regions within cerebellum (Figure 6-8). This absent of 
enhancement can be explained either because the penetration into white 
matter, which is away from the perivascular spaces, is too slow, or the lack of 
enhancement was attributed to concentrations of H217O probably being too small 
to be detected. Furthermore, following the rapid wash in of H217O withing brain 
parenchyma, we did not observe an indication of any early wash out of H217O 
over the entire study period (Figure 6-11).  
There is much debate in the literature regarding the existence (Iliff et al., 
2013), or lack thereof (Verkman et al., 2013), of a bulk convective flow of ISF. 
Arterial perivascular solute transport by dispersion can account for this 
behaviour. Dispersion refers to transport of solutes by the combined effect of 
diffusion and a macroscopic fluid motion with zero mean, i.e., oscillatory flow. 
However, previous computational modelling studies have suggested that arterial 
pulsation cannot be the sole driving force of net bulk flow as this would require 
additional driving forces. Furthermore, they concluded that rapid dispersion of 
solutes as a consequence of arterial pulsation does facilitate faster transport 
along perivascular routes inflow.   
In the current study, we estimated the root mean squared (rms) displacement of 
water molecules in the brain to be 1.05 mm in 15 minutes, whereas, for Gd-
DTPA molecules, it is 0.68 mm. This reflects the larger molecular weight of Gd-
DTPA (938 Da) compared with H217O (19 Da). In addition, Gd-DTPA molecules are 
restricted to the extracellular compartment, whereas H217O is able to more 
freely diffuse into cells. However, comparing the estimated water displacements 
due to only diffusion, with the actual H217O images (Figure 6-4), it appears 
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unlikely that diffusion alone explains the rapid brain wide distribution of H217O 
after 15 minutes, supporting the argument for a bulk convective flow of the ISF.  
6.4.1 Discussion of Alternative interpretations 
An alternative hypothesis of CSF physiology has been proposed by Klarica et al ( 
2019).They showed when tritiated water (3H2O) was injected into the CSF space 
of cats, water was absorbed locally into cerebral capillaries and finally drained 
into the sinuses. However, when macromolecular 3H-inulin was infused into the 
CSF, large amount of tracer remained within the CSF compartments (Bulat et 
al., 2008). Based on these and other observations, they proposed that CSF 
production and absorption occurs at the level of the capillaries and depends on 
hydrostatic and osmotic forces. Klarica et al. ( 2019) also suggested a continuous 
bidirectional mixing of water between the blood, ISF and the CSF compartments, 
with no unidirectional net flow of CSF along the CSF spaces. 
The suggestion by Klarica et al. of an absence of unidirectional flow within CSF 
spaces, is not supported by our H217O experiments (Figure 6-8). Infusing H217O 
into the cisterna magna leads to a high uptake in the 4th ventricle (representing 
CSF space) and pineal recess (representing subarachnoid spaces and proximal 
perivascular channels), which implies that H217O largely flows through the CSF 
compartment and subarachnoid space. Also, AQP4 channels are absent from the 
endothelium of the capillaries within the brain, hence we proposed that the 
endothelial wall can be viewed as a high resistance pathway for the water. 
Further, the H217O signal change was greatest along the ventral brain surface and 
along the margins of the pineal recess and the olfactory bulb. These anatomical 
structures were previously identified by Illif et al. (2012) as the proximal 
glymphatic transport pathway for CSF within the wider subarachnoid space.  
6.4.2 Summary  
In summary, a serious limitation of previous in-vivo glymphatic experiments has 
been their use of large tracer molecules (e.g., MRI tracer Gd-DTPA, MW 938 Da) 
that cannot be transported by AQP4 water channels in the brain. We 
hypothesised that the use of these large tracer molecules would result in the 
underestimation of the rate that CSF water molecules enter the brain 
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parenchyma, thereby underestimating the true flow of interstitial water. By 
labelling actual water molecules, via H217O water, we were able to detect 
glymphatic water transport in-vivo using T2 weighted MRI. The ability of our 
H217O MRI method to directly image water transport in vivo provides an accurate 
means of studying glymphatic flow. We have conclusively demonstrated that 
glymphatic flow imaged using our H217O tracer is much more rapid and extensive 
than when imaged using a Gd-DTPA tracer. Thus, there is strong evidence that 
the interstitial fluid experiences a substantial bulk flow, which can more rapidly 
clear waste molecules from the parenchyma than diffusion alone. In the next 




7 Chapter 7: Exploring the role of AQP4 in 
Glymphatic system using H217O MRI 
7.1 Introduction  
In the previous Chapter, we have directly imaged CSF water transport in the rat 
brain in vivo for the first time. Our results revealed glymphatic flow that was 
dramatically faster and more extensive than previously thought. It was, 
therefore, a logical next step to determine the role of astrocytic aquaporin-4 
(AQP4) in the circulation of CSF water in perivascular compartments. 
Water exchanges constantly between the different compartments of the brain 
(Bering, 1952). This process can be accelerated when water molecules travel 
through highly selective aquaporin water channels (AQPs) (Preston et al., 1992). 
AQPs, driven by both passive osmotic and hydraulic pressure gradients, have the 
ability to transport water bidirectionally across cell membranes (Tait et al., 
2008; Papadopoulos and Verkman, 2013). Among the 14 different aquaporins 
that have been identified, AQP1, 4 and 9 have been reported in the brain 
(Papadopoulos and Verkman, 2013). Both AQP1 and 4 play an important role in 
maintaining volume homeostasis in the brain. AQP1 is found in the apical 
membrane of the choroid plexus epithelial cells and is involved in secretion of 
the CSF (Praetorius and Nielsen, 2006). AQP4 is the predominant water channel 
in the brain and is heavily enriched in a highly polarised manner at the astrocytic 
endfeet facing the BBB, the glia limitans of the brain surface and the 
perivascular spaces (PVS), as well as the ventricular ependymal cells and 
subependymal astrocytes (Suzuki et al., 2013).  
The permeability of AQP4 channels can be regulated as a potential therapeutic 
target (Igarashi et al., 2011; Tang and Yang, 2016) and this has been implicated 
in the pathophysiology of a range of CNS disorders. For example in Alzheimer’s 
disease (Xu et al., 2015), vascular dementia (Venkat et al., 2018), traumatic 
brain injury (Ren et al., 2013), subarachnoid haemorrhage and acute ischaemia 
(Gaberel et al., 2014).  
It has been demonstrated that convective ISF flow, via the glymphatic system is 
dependent upon the perivascular expression of AQP4 water channels (Iliff et al., 
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2012). Where AQP4 channels operate as a highway for CSF influx into the brain 
parenchyma. In a series of experiments, Nedergaard and her colleagues have 
demonstrated the important of AQP4 to the glymphatic system. In their original 
work, they injected a fluorescent ovalbumin to the cisterna magna of global 
AQP4 knockout mice and found significantly reduced CSF influx relative to 
wildtype animals (Iliff et al., 2012). This was interpreted as evidence for AQP4-
dependent convection through astrocyte endfeet. However, as ovalbumin tracers 
will not pass through AQP4 channels, they did not directly demonstrate the 
importance of AQP4.  
A major critique of the ‘glymphatic’ hypothesis involves the proposed 
contribution of AQP4 to this system. This has been questioned by Verkman and 
Smith (2018) who failed to replicate the original work by Iliff et al. in AQP4-null 
animals. They argued that AQP4 was not needed for solute removal from the 
brain (Smith and Verkman, 2018). Subsequently, study represented the work of 
five research groups using four different AQP4 knockout lines confirmed AQP4 
gene deletion impairs glymphatic CSF tracer influx (Mestre et al., 2018). Yet, all 
of the aforementioned in vivo studies have used non water tracers to track the 
movement of CSF fluid within the glymphatic compartments. Since tracer 
movement does not necessarily directly reflect underlying fluid flow as we have 
shown in previous chapter, the relative contribution of AQP4 in glymphatic flow 
remains unknown. 
AQP4 levels and function have been modulated in wild type mice by siRNA or 
pharmacological functional inhibitors such as TGN-020. Treatment with siRNA 
has been shown to reduce expression to about 76% after 3 days in vitro (Nicchia 
et al., 2003; Badaut et al., 2011). Two intra-cortical injections of siRNA were 
required to decrease AQP4 expression by 27% in vivo (Nicchia et al., 2003). A 
single dose of TGN-020 inhibits AQP4 function by 67% as soon as 2h post 
application in vitro (Mathiisen et al., 2010) and shows an effect within 20-30 
minutes in vivo (Igarashi et al., 2011; Igarashi, Tsujita, Suzuki, et al., 2013; Wei 
et al., 2017; Pirici et al., 2018). Additionally, TGN-020 can be administered 
intraperitoneally avoiding any potential effect on glymphatic function by 




We hypothesised that by using H217O as a water labelled tracer, it would be 
possible to conclusively demonstrate the key role of astrocytic AQP4 in 
glymphatic system. We hypothesised that a pharmacological inhibitor of AQP4 




















7.2.1 Surgery and physiological monitoring 
The experiment was designed to compare differences in CSF parenchymal flow 
between normal and AQP4 inhibited rats (Figure 7-1). Male Wistar rats (n=12, 
300 to 350 g, aged 20 to 24 weeks) were randomly assigned to two experimental 
groups, namely, vehicle-treated rats (n=7) and rats treated with AQP4 inhibitor 
(TGN-020, n=8). All animals were initially anesthetised (5% isoflurane in 20:80 
O2/air mixture) in an induction chamber, intubated, and artificially ventilated 
(with 2-3% isoflurane in 30:70 O2/NO2 mixture). Anesthetised rats were then 
placed in a stereotaxic frame. The cisterna magna (CM) cannula was inserted 
into the subarachnoid cisterna magna space, as described in Chapter 3, section 
3.1.4.3. Then, the CM cannula was connected to a closed-end PE10 tube loaded 
with 90% H217O tracer and attached to an infusion pump for tracer delivery. The 
animal was then transferred to MRI scanner, where the head was secured with 
ear pins and tooth bars. Using methods described in chapter 3, body 
temperature, respiration, blood pressure (BP) and blood gasses were 
continuously monitored throughout the MRI acquisition. At the end of each 
experiment, the animal was euthanized.  
7.2.2 Preparation and administration of TGN-020 
To assess the role of AQP4 in the function of the glymphatic system, selective 
AQP4 Inhibitor, 2-nicotinamido-1,3,4-thiadiazole (TGN-020) was used to block 
AQP4 mediated water transport. The in vitro inhibitory effects and in silico 
docking energies of TGN-020 with respect to AQP4 has been previously 
investigated by Huber et al. (2009). TGN-020 showed inhibitory activity in the in 
vitro with an IC50 = 3.1 Μm, furthermore, been confirmed in live animals. In 
silico studies using an rAQP4 M23 model identified the likely binding sites of 
TGN-020 as D69, M70, I73, F77, V145, I205, and R216 (Figure 7-1, purple 
residues), one of which is not conserved in hAQP4 (V145 is L145 in hAQP4 (Figure 
7-2, white residues). 
In the current study, TGN-020 (Sigma-Aldrich, St. Louis, MO) was dissolved in a 
solution of dimethyl sulfoxide (DMSO, Sigma-Aldrich, 10 mM) to increase its 
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solubility and then rapidly vortexed and maintained at 37°C until injection. The 
concentration of DMSO used for injection was adjusted at 0.2% in 0.9% sterile 
saline. TGN-020 was administered by intraperitoneal injection (200 mg/kg in 
20ml/kg body weight) 15 minutes before starting the MRI study. The vehicle 
group also received equal volumes of vehicle solution (0.2% DMSO) 
intraperitoneally 15 minutes before starting the MRI. This concentration was 
deemed to be above the physiologically effective values, as reported by other 
studies (Igarashi et al., 2011; Pirici et al., 2017; Wei et al., 2017).  
7.2.3 Magnetic Resonance Imaging  
The scanning protocol were carried out as stated in Chapter 6 of this thesis.  
7.2.4 MRI data analysis  
MATLAB R2018b (MathWorks, UK) code was developed in-house for 
postprocessing MRI images. The general postprocessing procedure consisted of 
brain extraction, head motion correction, and voxel-by voxel conversion to a 
percentage signal change map, as described in Chapter 3, section 3.2.  
A baseline T2 weighted image was acquired before infusion. This was subtracted 
from corresponding images after the infusion of H217O and the resulting 
difference image reflected the distribution of H217O in the observed brain. All 




𝑺𝟏𝒑𝒓𝒆 − 𝑺𝟏𝒑𝒐𝒔𝒕 
𝑺𝟏𝒑𝒓𝒆 
 × 𝟏𝟎𝟎 
(7-1) 
where ∆𝑆% is the percent signal change from the baseline (𝑆1𝑝𝑟𝑒).   
The placement of regions of interest (ROIs) was guided anatomically by the use 
of T2 weighted averaged baseline images and the Paxinos and Watson 2007 
(Paxinos and Watson, 2007) histological atlas for reference.The mean values of 
percentage signal change in preselected anatomical areas were measured on the 
registered images over time. This produced temporal evolution curve of 
percentage signal change in every specific ROI, due to the uptake of H217O by 
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regional brain tissue. From each curve, the area-under-curve (AUC) during the 
first 85 min was calculated.  
 
7.2.5 Evaluate the effect of pharmacological inhibition of AQP4 
following a single MRI DWI experiment 
To determine whether TGN-020 had a direct impact on astrocyte microstructure, 
Diffusion-weighted magnetic resonance imaging (DW MRI) experiment was set up 
before and after TGN-020 injection in a single 330 g Wistar rat. The anaesthetic 
protocol used was similar to that used for the main experiment. Diffusion 
weighted images (DWI) with long observation times (Δ=400 & 600 ms) of the 
whole brain were acquired, using the Stimulated echo-DWI method, before TGN-
020 injection and then at 20, 40, and 60 minutes post-injection. 
7.2.6 Ventricular volumes calculation  
T2 weighted MRI images were also assessed to estimate the size of the 
ventricular system. Ventricular volumes were estimated from T2 weighted 
images. Ventricles were manually delineated for each slice. Total ventricular 
volumes were determined by adding the areas of all the ventricular structures on 
the monitored slices, multiplied by the slice thickness. To avoid differences 
related with the brain size, the total ventricular volume was normalized with 
the total brain volume of each rat analysed.  
7.2.7 Statistics 
Body temperature, pH, PaO2, PaCO2 and MABP were analysed using a two-way 
ANOVA followed by Sidak’s test to correct for multiple comparisons. Mean area 
under the curve (mAUC) for ROIs and relative percentage signal change were 
analysed using unpaired, two tailed Student’s t-test (GraphPad Prism Software, 
California, USA). Statistical significance was set at p≤0.05. All data are 




Figure 7-1. Experimental protocol.Following surgical implantation of an intracisternal 
cannula, the rat was placed in the supine position inside the MRI scanner and kept under 
anaesthesia. TGN-020 or vehicle was administered 15 minutes prior to MRI experiment. Pre-
contrast baseline images were acquired. Then, during sequential acquisition of T2 images, 
~50 μL at 1.8 μL/min of 90% H2
17O was infused through the cannula for 28 min, and T2 














Figure 7-2. AQP4 structure and main residues in AQP4 regulation.  White residues indicate 
the human equivalent to sites which were identified in rat AQP4 (rAQP4) as having 
important regulatory functions but are not conserved in human AQP4 (hAQP4). Numbering 














7.3.1 Exclusion and protocol violations 
Image series from 3 rats were excluded from the analysis either because of 
failed infusion of H217O (2 rats) or premature termination of the experiment for 
physiological reasons (unstable BP, one rat). Hence, a total of 13 rats were 
analysed for the study groups: TGN-020 treated group (n=7), and Vehicle group 
(n=6).  
7.3.2 Effect of pharmacological inhibition of aquaporin-4 on 
glymphatic transport 
All rats included in the analyses were physiologically stable for the duration of 
the scan. Body weights, physiological parameters, and statistical comparisons 
are summarised in Table 7-1.  
To test the role of AQP4 in glymphatic inflow, TGN-020 or vehicle was 
administered 15 minutes prior to cisternal infusion of H217O, followed by serial 
acquisition of high SNR T2 weighted MR images. We first confirmed that the 
amount of H217O delivered into the CM was the same for both groups. Figure 7-3 
show that the delivered H217O (~50 μL at 1.8 μL/min; total time, 28 min) into 
CSF space, via the CM, produced consistent signal changes in all rats.  
Following the intracisternal infusion of H217O tracer, there was a significant 
overall decrease in tracer entry in rats treated with TGN-020 compared to 
controls. Figure 7-4 shows a time series of colour-enhanced multiple sagittal 
sections depicting the percentage signal change and distribution of H217O tracer 
in a vehicle treated rat. H217O signal was initially observed in CM followed by 
very rapid advancement of the signal to all brain regions (Figure 7-4). However, 
rats treated with TGN-020 exhibited significant reductions in gross H217O tracer 
distributions (Figure 7-5). In TGN-020 treated rats, H217O appeared in the ventral 
brain surface within 7 minutes of the start of the infusion. However, the inflow 
of H217O into brain parenchyma was substantially retarded. This was evident in 
the cortex (p=< 0.0001) and cerebellum (p=< 0.0001), with significantly reduced 
percentage change signal being observed in TGN-020 treated rats compared with 
vehicle treated rats (Figure 7-6). Exacerbated suppression of CSF tracer influx 
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was still observed in TGN-020 treated rats at 85 minutes after the start of the 
injection. However, penetration of parenchyma by H217O was not totally 
diminished in TGN-020 treated animals, as we think that H217O tracer could still 
reach the brain by passive diffusion process across astrocytes or through gap 
junctions, rather than through AQP4.  
7.3.3 Comparison of regional H217O uptake 
To calculate kinetic glymphatic parameters, the temporal evolution curve of 
percentage signal change was calculated from CSF and brain subregions, shown 
in Figure 7-6A. The analysis showed differences in regional brain uptake of H217O 
between the TGN-020 and the vehicle treated groups. Statistical analysis showed 
that regional uptake of H217O in the olfactory bulb ((p=< 0.0001), cerebellum 
(p=< 0.0001) and prefrontal cortex (p=< 0.0001) was statistically lower in the 
TGN-020 treated group than in the vehicle group. No significant difference was 
observed in the ventricles and pineal recess (representing subarachnoid spaces 
and proximal perivascular channels) of TGN-020 treated rats and vehicle rats. In 
parenchymal regions the maximum percentage change achieved in the TGN-020 
treated group was significantly reduced compared with vehicle treated group, 
suggesting that a large fraction of infused H217O was prevented from penetrating 
the parenchyma (Figure 7-6C).  
7.3.4 The effect of AQP4 inhibition observed by MRI DWI  
To investigate whether the AQP4 inhibitor might affect astrocyte microstructure, 
long observation time diffusion MRI experiments were performed. These showed 
differences in the apparent diffusion coefficient before and after TGN-020 
injection in the cortical region. When we measured the diffusion coefficient 
using longer observation time (600 ms), these changes became more apparent 
(Figure 7-7), suggesting microstructural changes.  
7.3.5 Ventricular volumes measurements  
To study the specific contribution of AQP4 to ventricular volume, the volume 
occupied by the CSF ventricular system was assessed in vehicle and TGN-020 
rats. Ventricle size was measured from sagittal T2 weighted images and was 
represented as the ratio of total ventricular volume/brain volume for all 
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experimental groups (Figure 7-8). As indicated in Figure 7-8, there was slight 
increase in the ventricle size of the TGN-020 group (not significant, p=0.6) 
compared with the vehicle group. 
 
 
Table 7-1. Physiological variables in rats, following tracer infusion. MAP, mean arterial 
pressure; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; 
Temp, temperature values are within physiological ranges for TGN-020 and vehicle treated 







       Physiological parameters Pre-injection  Post injection 
MAP (mmHg) TGN 020 98 ± 13 95 ± 10 
 Vehicle  94± 14 91 ± 11 
PaO2 (mmHg) TGN 020 136.3 ± 16 149.9 ± 19 
 Vehicle  157.8 ± 32 170.3 ± 40 
PaCO2 (mmHg) TGN 020 35.4 ± 5.2 37.2 ± 9.2 
 Vehicle  33.4 ± 9.7 24.7 ± 8.1 
Temp (𝐶°) TGN 020 36.7 ± 0.5 36.9 ± 0.4 
 Vehicle  36.8 ± 0.3 37.1 ± 0.2 
pH TGN 020 7.5 ± 0.04 7.5 ± 0.08 







17O uptake from the cisterna magna of TGN-020 and vehicle rats.As can be 
observed, the temporal evolution curve of percentage signal change associated with 
infusion of H2
17O into the CM of both groups are identical. By calculating the mean AUC of 
both curves, there was no statistical difference between the two groups (p=0.4). Data are 












Figure 7-4. Glymphatic transport of H2
17O in TGN-020 rat brain by T2 weighted. 
Representative sagittal MRI (three slices) demonstrating the temporal evolution of H2
17O for 
85 min of recording of one rat from the TGN-020 group. Pseudo colour scaling illustrates 
tracer distribution of 90% H2
17O at different times from the onset of infusion (i.e., 3.5, 7, 10, 




Figure 7-5. Glymphatic transport of H2
17O in vehicle rat brain by T2 weighted.Representative 
sagittal MRI (three slices) demonstrating the temporal evolution of H2
17O for 85 min of 
recording obtained of one rat from the vehicle group. Pseudo colour scaling illustrates 
tracer distribution of 90% H2
17O at different times from the onset of infusion (i.e., 3.5, 7, 10, 







Figure 7-6. Comparisons of dynamic curves for H2
17O in TGN-020 and vehicle rats. the 
temporal evolution curve of percentage signal change for TGN-020 (red circles) and vehicle 
(blue circle) are shown for the (A) olfactory bulb, (B) cerebellum, (C) anterior cortex, (D) 4th 
ventricle, and (E) pineal recess, demonstrating significant inhibition of glymphatic inflow in 
three aspects of the TGN-020 treated animal brain. Blue shading denotes the infusion 
period. (F) shows mean AUC values (mAUC) reflecting tissue uptake, quantified from the 
curves in A – E. (G). Significant differences denoted by asterisks: *P < 0.05, **P < 0.01, 








Figure 7-7. Diffusion-weighted magnetic resonance imaging in a single rat.Diffusion 
coefficient values are shown for two different observation times (400 & 600 ms) in the cortex 
region, before and after TGN-020 injection. Data presented as Diffusion coefficient values 














Figure 7-8. Total CSF volume.CSF in the ventricles was calculated and normalized with the 
















We investigated the importance of the astrocytic water channel AQP4 to brain 
wide glymphatic transport using MRI and H217O administered into the CM of 
anesthetized rats. The major finding of our study is that, following AQP4 channel 
inhibition with a TGN-020 solution, the distribution of intracisternal H217O was 
significantly impaired compared to vehicle treated rats. Thus, our observations 
provide a strong and concordant support for the glymphatic hypothesis 
demonstrating that AQP4 is the dominant mechanism for perivascular influx of 
CSF into the parenchyma. 
It has been previously demonstrated that convective flow through the 
glymphatic system is dependent upon the perivascular expression of AQP4 water 
channels (Mestre et al., 2018). Original data supporting this hypothesis came 
from the use of AQP4 null mice, in which glymphatic function was impaired by 
~70% compared to wildtype animals, resulting in a ~55% reduction in Aβ 
clearance from the brain (Iliff et al., 2014). In the present study, we provide the 
first direct comparison of in vivo glymphatic CSF influx in AQP4 inhibitor rat. The 
current data demonstrated that, after the start of the injection, elevated levels 
of H217O were immediately detected in both vehicle and TGN-020 treated rats, 
particularly along the ventral surface of the brain (Figure 7-4). However, 
following the arrival of H217O into brain interstitium, the H217O signal change 
within the parenchyma of TGN-020 treated rats was significantly reduced 
compared with vehicle treated rats (Figure 7-6). These observations illustrate 
that the perivascular localization of AQP4 contributes to the kinetics of CSF 
water influx into the brain parenchyma. Hence, the necessity of AQP4 channels 
for normal glymphatic function is believed to lie in their capacity to reduce the 
resistance of water molecules moving from the perivascular space into the brain 
parenchyma (Solenov et al., 2004) 
Regional assessment revealed decreased H217O distribution in TGN-020 rats, 
which was most pronounced in brain parenchymal regions, whereas a 
comparable pattern of tracer distribution was observed within the subarachnoid 
space (SAS) in both species (Figure 7-6). By inspecting the time enhancement 
curve of the cortical region for both groups. H217O uptake in the TGN-020 treated 
cortex was significantly reduced compared to vehicle treated animals (Figure 
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7-6). The temporal evolution curve of the H217O uptake generated for ventricles 
compartments showed similar influx pattern. The H217O uptake was also 
observed around the region close to the middle cerebral artery. One possible 
explanation is that the hindrance to AQP4 function caused the infused H217O 
tracer to take the paths of least resistance, the large interconnecting fluid filled 
spaces and major periarterial spaces, as glymphatic inflow became more 
restricted. 
Previous glymphatic data demonstrated the role of AQP4 using various 
approaches to AQP4 gene deletion (Iliff et al., 2012; Mestre et al., 2018). Here, 
the blocking of AQP4 was achieved by using a pharmacological inhibitor. TGN-
020 has small heteroaromatic group which enables deeper penetration into the 
hydrophobic region of the water channel. Previous studies showed that in vitro 
treatment with TGN-020 inhibits AQP4, with a half maximal inhibitory 
concentration (IC50) of 3 μM, is not known to have significant biological activity 
(Huber, Tsujita and Nakada, 2009). There have been several reports which 
identified TGN-020 as a potent AQP4 inhibitor (Igarashi et al., 2011; Pirici et al., 
2017; Debacker et al., 2020; Harrison et al., 2020; Oosuka et al., 2020). 
However, It is also unclear if there are any off target effects of TGN-020 on 
AQP1, given 60% homology between the two (Yool et al., 2013) and whether this 
effects CSF production and therefore potentially glymphatic function by 
reducing the amount of CSF in the system. However, evidence suggests that 
AQP1 may have a limited role in CSF production (Oshio et al., 2005), and 
therefore any off target effects that might occur likely have a limited impact. 
To understand the implications of using TGN-020 on the permeability of AQP4 
and astrocyte microstructure, we conducted DW-MRI experiment in single rat. 
Following AQP4 channel inhibition with a TGN-020 solution, a decrease in 
diffusion coefficient was readily observed in the cortex, which could give an 
indication of more restricted water diffusion, as a result of blocking AQP4 
channels (Debaker et al., 2020). However, this assumption needs further 
confirmation by conducting DW-MRI in cohorts of animals.  
It should also be noted that AQP4 is not only located within end-feet of 
astrocytes at the blood–brain barrier (BBB), but it is also highly expressed within 
ventricular ependymal cells (brain-CSF barrier) (Brinker et al., 2014). It has been 
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reported that AQP4 deficient mice exhibit a sporadic rate of spontaneous 
hydrocephalus and that kaolin-induced hydrocephalus in AQP4 deficient mice 
results in an accelerated progression of hydrocephalus (Verkman et al., 2017). 
To study the specific contribution of AQP4 to the ventricular volume, the volume 
occupied by the cerebral ventricular system was measured in both TGN-020 rats 
and vehicle rats. However, in the current study, while the ventricular volume in 
the TGN-020 group slightly increased, this increase was not significant (Figure 
7-8, p=0.6).  
Alterations in AQP4 expression or loss of polarization, or both, is now reported in 
variety of neurological disease and therefore pharmacologically manipulation of 
AQP4 may emerge as a viable therapeutic strategy of these conditions. In aging 
mice, there was a reduced parenchymal influx of CSF which found to be likely 
caused by reduced vascular compliance, increased AQP4 expression and AQP4 
mislocalization away from the astrocytic end-feet (Pizzo et al., 2018). In murine 
models of Alzheimer's disease, changes in AQP4 expression in astrocyte end feet 
could affect the clearance of beta amyloid (Aβ) from the perivascular space.(Xu 
et al., 2015). In rodent models of ischemic stroke, mice lacking AQP4 develop 
less pronounced cerebral oedema after stroke in a mouse model of severe 
permanent cerebral ischemia (Pirici et al., 2017). In rodent models of traumatic 
brain injury (TBI), AQP4 plays a role in astrogliosis after the injury (Plog et al., 
2015). In models that use kaolin to induce acute hydrocephalus, AQP4 deficient 
mice had an accelerated progression of hydrocephalus compare with wildtype 
mice (Mao, Enno and Del Bigio, 2006).  
7.4.1 Summary  
Although previous experimental studies confirm the role of AQP4 in supporting 
glymphatic flow, the precise mechanisms of this role remain unresolved (Simon 
and Iliff, 2019; Smith and Verkman, 2019). In the current work, by tracking of 
labelled water, we were able to conclusively demonstrate that these glymphatic 
flows are strongly mediated by AQP4 as previously stated. These experiments 
clearly demonstrate that the rapid penetration of H217O into the parenchyma, 
Figure 7-5, is strongly dependent on the astrocytic water channel AQP4. We also 
believe that our current method represents a promising tool for not only answer 
much of the controversy surrounding the glymphatic hypothesis, but also provide 
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8 Chapter 8: Conclusion 
This chapter contains a summary of the studies conducted throughout the thesis. 
It also discusses some of the successes and limitations of each study and outlines 
potential avenues for future development. 
8.1 Summary of the thesis  
The results that I have demonstrated in this thesis are both novel and, 
potentially, very important for understanding the role of CSF dynamics in 
elevated ICP during ischaemic stroke as well as the nature of CSF-ISF dynamics. 
Firstly, I have demonstrated in Chapter 4 that increased CSF outflow resistance, 
rather than oedema, is the primary mechanism involved in post-stroke ICP 
elevation. This was supported by a series of in vivo studies showing that ICP can 
become substantially elevated at 24 hours, even following small ischaemic 
strokes (sub-cortical lesions) where there is little or no space-occupying oedema 
(Tariq and Khatri, 2008; Murtha et al., 2014; Murtha et al., 2015; Beard et al., 
2015; Wells et al., 2015). The current results challenge nearly a century of 
accepted wisdom that oedema is the sole mechanism of increased ICP after 
ischaemic stroke.   
In the following chapters, MRI tracer methods were established to provide real-
time observation of CSF flow and the glymphatic system. In Chapter 5, by first 
reproducing the experimental work in the seminal publication of Iliff et al. 
(2013), the spatial pattern and entry of Gd-DTPA from the CSF space into the 
brain tissue were demonstrated using both conventional T1 weighted and 
quantitative T1 mapping. These gadolinium-based tracers experiments represent 
the gold standard, which has previously been used to define CSF exchange with 
the brain interstitium in rodents, non-human primates, and in humans (Iliff et 
al., 2013; Absinta et al., 2017; Eide et al., 2018).  
In Chapter 7, an H217O MRI method was established to image brain-wide CSF 
water circulation in live rat brains. This method was also directly compared with 
a Gd-DTPA. The results demonstrated that CSF flow through the glymphatic 
system using an H217O tracer was much more rapid and extensive than when 
imaged using a Gd-DTPA tracer. Finally, in Chapter 8, the role of astrocytic 
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AQP4 in the CSF parenchymal flow was directly investigated for the first time. By 
using a selective pharmacological AQP4 inhibitor (TGN-020), the distribution of 
intracisternal H217O was found to be strongly dependent on the permeability of 
AQP4 channels. These results conclusively demonstrated the crucial role of AQP4 
in the glymphatic system, as hypothesised, and will end the long running 
controversy surrounding this topic (Verkman et al., 2013; Mestre et al., 2018; 
Smith and Verkman, 2019).  
8.2 Thesis limitation  
The administration site of MRI tracers into CSF is important to consider. Large 
pools of CSF are found in the lateral ventricles and subarachnoid space of the 
brain. Access to the subarachnoid space in rodents is easiest via the cisterna 
magna (Iliff et al., 2012). Because of its easy access, in the current work, MRI 
tracers were injected via the cisterna magna. However, injection into the 
cisterna magna, especially when large volumes are to be administered might 
affect brainstem respiratory or cardiac centre function, both of which are 
critical to the generation of CSF pulsation (Kazmi et al., 2015). Therefore, 
cisterna magna injections themselves may alter flow dynamics. Tracer 
administration into the lateral ventricle, on the other hand, requires CSF to pass 
through the third and fourth ventricles before reaching the subarachnoid space, 
so tracers injected here may take longer to reach glymphatic pathways. Iliff et 
al. (2012) showed that much less dye in the parenchyma at 30 minutes after 
injection into the lateral ventricle compared to the cisterna magna. 
Additionally, ventricular cannulation requires penetration of brain tissue. Even 
passing small cannulas through the parenchyma can cause slower glymphatic 
flow (Mestre, Mori and Nedergaard, 2020). This is also a concern for 
intraparenchymal tracer injections, which are useful for determining dye 
movement from a specific brain region but not for studying overall CSF 
circulation. Future studies could consider investigating the effect of tracer 
administration site on glymphatic flow.  
Additional considerations for studying the glymphatic system include the 
sleep/wake state and anaesthetic regimen. In the current thesis, all experiments 
were conducted in rats anesthetized with isoflurane alone. General anaesthesia 
has been shown to enhance the transport of CSF tracers (e.g., Gd-DTPA). Studies 
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by the Nedergaard group reported CSF tracer transport was highest under 
ketamine/xylazine (K/X) anaesthesia and lower with α-chloralose, Avertin, or 
isoflurane, because of their varying effects on central adrenergic tone (Hablitz 
et al., 2019). At least one of the effects of anaesthesia appears to be closely 
linked to expansion of the interstitial fluid space (Xie et al., 2013), which may 
explain the enhanced transport of extracellular tracers. However, as the H217O 
tracer can more freely travel through intracellular and extracellular space, we 
would hypothesize that sleep or general anaesthesia may have less influence on 
its rate of transport. In order to address this hypothesis, future experiments are 
warranted to measure glymphatic system function in rodent brain using different 
anaesthetic regimes. It may be that water transport might be insensitive to 
differences in anaesthetic regimes, whereas those of a non-transported solute 
may be very sensitive indeed to these changes.  
Studies in this thesis were subject to some limitations. Firstly, in Chapter 4, The 
model used in this study, pMCAO, result in large strokes (infarct 228 ± 36 mm3; 
approximately 45% of contralateral hemisphere) and large volumes of oedema. 
For this reason, MCAO is described as a ‘malignant’ model of stroke. Oedema 
and infarct volumes were assessed at 24 hours post-MCAO. However, at this time 
point in MCAO models, the infarct and oedema are still evolving (Kazmi et al., 
2015). Therefore, a limitation of the current studies is that the effect on final 
infarct volume may have not been assessed accurately due to the use of the 24-
hour time point. Future work is needed to fully examine the temporal changes in 
infarct and oedema evolution post ischemic stroke and investigating if the 
causative relationship between CSF resistance and ICP elevation still exist when 
oedema is fully evolved. Hence, this give further and potentially more 
translatable insight into the effects of CSF resistance on ICP after stroke. I was 
not blind to the induction of stroke and sham surgery. This means it was obvious 
which group was being used during CSF infusion. Further, due to the nature of 
the CSF-ICP experiment, using the ‘gold-standard’ oedema calculation, wet–dry 
weight method was unfeasible. So, the oedema measurements were calculated 
from RARE T2-weighted images. Hence it is thought to include some error due to 
the manual delineation of the infarct, based on increased signal intensity. The 
development of a threshold for oedema volume calculations from T2 maps would 
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reduce inherent inter- and intra-investigator error when using this MRI 
technique.   
As noted in Chapter 5, the relatively small sample sizes may have limited the 
statistical power of this study. In Chapter 6, due to the nature of the 
investigation (H217O T2 weighted vs Gd-DTPA T1 weighted), it was impossible to 
be blinded to study subjects. The studies in Chapters 7 and 8, did not include a 
wash-out phase as the scan duration was only one and half hours from the 
commencement of infusion. The H217O method applied in this thesis used a 
“baseline” pre-injection scan, followed by post-injections scans, thus allowing 
the change in signal to be determined. However, this could be improved by using 
17O decoupling. The interaction between the 17O quadrupolar nucleus and the 
bonded 1H in water molecules, can be eliminated by irradiating at the 17O 
resonance frequency during 1H MR imaging. MRI data in chapter 7 and 8 did not 
present the dynamic images averaged across the animal group. This is because 
that H217O images were acquired with large voxel sizes (0.3 mm), which limits 
the ability to register all H217O images to the same space. Instead, we showed 
the MRI data for individual rats.  
8.3 Future direction  
How might CSF dynamics be altered following ischaemic stroke? The findings 
of this thesis demonstrate that increased CSF outflow resistance is responsible 
for ICP elevation 24 hours after ischaemic stroke. Yet, the mechanisms behind 
the increased CSF resistance are not understood. The main outflow route is 
assumed to be the arachnoid granulations as described by Dandy (1914). 
However, there is also compelling evidence of flow directly from the 
subarachnoid space to the lymphatic system (see chapter 1). Experiments 
carried out by Johnston’s lab explored the influence of inhibiting the transport 
of CSF through the nasal pathway by sealing the extracranial surface of the 
cribriform plate of sheep (Silver et al., 2002). This procedure led to significantly 
increased in ICP and increased CSF outflow resistance in response to fluid 
infusions into the ventricles. This indicates that changes in just this one pathway 
for CSF to leave the brain can compromise overall CSF clearance. If coupled with 
a stroke, could this lead to a further increase in ICP at 24 hours as CSF resistance 
is further increased?  
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Glymphatic circulation as shown in the current thesis plays a major role in 
enhancing CSF parenchyma flow. CSF outflow through the glymphatic pathway 
has been found to decline during the acute stage of ischaemic stroke. Further 
Gaberel et al. (2014) reported glymphatic impairment when vessel occlusion was 
present at 3 hours post-stroke but no impairment when vessels were 
spontaneously recanalized at 24 hours. Cortical spreading depressions, which can 
occur following excitotoxicity in stroke, may also play a role in reduced 
glymphatic function in tissue adjacent to the stroke by closing the perivascular 
spaces (Mestre et al., 2020). If the glymphatic circulation is a significant outflow 
route for CSF, the increased CSF resistance found in our study, maybe a direct 
result of glymphatic dysfunction. Future work is needed to assess different CSF 
outflow routes and their importance in increasing ICP after ischaemic stroke. In 
addition, the use of H217O as a novel CSF water tracer can provide a quantitative 
assessment of all these different CSF outflow routes.  
Many controversies and open issues exist concerning the glymphatic model. 
This includes the opposite directions of fluid flow, anatomical and functional 
differences, potential driving forces, and their role in health and disease (Carare 
et al., 2008; Bakker et al., 2016). Also, there have been several discussions on 
the possible mechanisms and forces by which the glymphatic system works. 
Three possible mechanisms have been suggested: 1) diffusion, a size-dependent 
random molecular walk, 2) advection or bulk flow, a molecular size-independent 
force produced by chemical or hydrostatic or electrical gradient, or dispersion 
(Diffusion + oscillating flow). Also, Smith and Verkman (2019) showed that the 
glymphatic system is unlikely driven by bulk flow. Their results suggest that 
water movement in the cranial subarachnoid space is driven by bulk flow, while 
that within the parenchyma is driven by diffusion (Smith and Verkman, 2019). In 
the current thesis, the ability of our H217O MRI method to directly image water 
transport in vivo provides an accurate means of studying glymphatic transport. 
Also, H217O has the advantage of considering most of the glymphatic fluid 
phenomena, as it can travel through the intracellular space mediated by highly 
selected AQP4 water channels. For this reason, it is likely that previous 
experimental studies and computational models based on large tracer molecules 
have misinterpret the glymphatic system. Hence, we do believe that our H217O 
data will provide a valuable tool for future computational models to accurately 
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predict the movement of glymphatic flow and provide some answers to several 
controversies and unresolved questions regarding glymphatic system.  
ICP is the possible explanation for ‘collateral failure' in stroke-in-progression. 
ICP elevation following ischaemic stroke can have severe consequences such as 
reduced CBF, BBB disruption and altered brain fluid movement. Further, 
increased ICP in the first 24 hours post-ischaemic stroke has been linked with 
collateral failure in a subset of ischaemic stroke patients presenting with 
progressive stroke. This allows the possibility that ICP elevation may be 
occurring undetected in a much wider range of stroke patients than is currently 
considered, not just in patients with large malignant strokes and significant 
levels of brain oedema. Future work is needed to fully investigate the temporal 
changes in CSF dynamics and ICP post-ischemic stroke and how they impact on 




Figure 8-1. Future experimental protocols. (A) Study I aimed to determine the effect of ICP 
elevation on collateral flow following ischaemic stroke, using laser speckle contrast 
imaging (LSCI) to measure the measure perfusion changes. Baseline recordings 
commenced 30 minutes from the onset of stroke and continued until 6 hours post-MCAO. 
Once perfusion recovered, CSF was infused into the cisterna magna to artificially increase 
ICP. (B) Study 2 aimed to measure the effect of increased ICP on the whole brain perfusion 
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changes following pMCAO. After baseline MRI PWI/DWI scans, PWI/DWI was cautiously 
captured following pMCAO. Infusion of CSF into the cisterna magna was initiated to 
artificially increase ICP.  
 
Potential H217O approaches for other neurological diseases. A) Investigation 
of glucose metabolism using enriched 17O‐glucose. Glucose homeostasis plays a 
key role in numerous fundamental aspects of life, and its dysregulation is 
associated with many important human diseases such as cancer. During cancer 
progression, tumour cells gain energy by anaerobic glycolysis (Warburg effect) 
and therefore have an elevated glucose turnover compared with normal tissue. 
At present, 2-deoxy-2-[18F] fluoro-glucose (18F-FDG) is the gold standard to 
monitor the metabolic rates of glucose. As an alternative to PET, our laboratory 
has developed a novel method which involves administrating highly labelled 17O‐
glucose, together with dynamic1H‐MRI which might provide a non‐radioactive 
alternative to FDG-PET to monitor up glucose consumption during glycolysis 
(Figure 8-2). 
 
Figure 8-2. A pilot study of MRI of a GBM mouse following intravenous injection of 17O-
Glucose. A) Baseline T2 image. B) T2 after 
17O-Glucose infusion (5 minutes). C) Difference 
image (red overlay), where the signal intensity is proportional to the metabolism of 17O-
Glucose into H2
17O. The tumour (Rt hemisphere) is quite visible and distinct from other 
surrounding tissue.  
 
B) Metabolic assessment of cerebral ischaemia. The ability to image aerobic 
metabolism, which is directly related to cellular energy metabolism, is a better 
predictor of tissue survival following ischaemic stroke. The current gold standard 
for imaging aerobic metabolism is 15O PET. This method has practical and 
fundamental limitations for use in the clinical stroke setting (Kameyama, 
Murakami and Jinzaki, 2016). Preliminary in vivo studies from our laboratory 
have suggested that tissue metabolism can be directly imaged by using the MRI 
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properties of the 17O isotope, namely its effect on the 1H signal when 17O2 is 
metabolically converted to H217O.  
C) Metabolic assessment of myocardial viability. Measurements of myocardial 
oxygen consumption (MVO2), which reflect the total oxygen demand of the 
myocardium, may provide an important assessment of the viability of the 
ischemic myocardium. 15O PET has been the primary non-invasive modality for 
measuring MVO2 (Wong et al., 2013), but its use is limited. An alternative 
approach based on 17O, using intravenous delivery of oxygen carriers pre-
saturated with 17O2 gas and 17O decoupled 1H MRI, is currently being undertaken 
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